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1 List of abbreviations 
3D  3-dimension, 3-dimentional 
3DISCO 3D imaging of solvent-cleared organs 
BABB  1:2 benzyl alcohol, benzyl benzoate 
BBB   blood brain barrier 
CFP  cerulean fluorescent protein 
CNS  central nervous system 
CT  computer tomography 
CUBIC  clear, unobstructed brain imaging cocktails and computational analysis 
DBE  dibenzyl-ether 
DCM  dichloromethane 
DPE   diphenyl-ether 
EAE  experimental autoimmune encephalomyelitis 
ExM  expansion microscopy 
GFP  green fluorescent protein 
iDISCO  immunolabeling-enabled three-dimensional imaging of solvent-cleared organs 
IHC   immunohistochemistry 
IL  interleukin 
MRI  magnetic resonance imaging 
NIH  National Institute of Health 
NO   nitric oxide 
OPTIClear Optical Properties-adjusting Tissue-Clearing agent 
PACT  passive clarity technique 
PARS  perfusion-assisted agent release in situ 
PNS  peripheral nervous system 
RI  refractive index 
ROS  reactive oxygen species 
SCI  spinal cord injury 
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SDS  sodium dodecyl sulphate 
SeeDB  See Deep Brain 
SHIELD stabilization to harsh conditions via intramolecular epoxide linkages to prevent degradation 
SMC  short skull-meninges connection 
SWITCH system-wide control of interaction time and kinetics of chemicals 
TBI  traumatic brain injury 
TDE  2,20-thiodiethanol 
TGF-β  transforming growth factor beta 
THF  tetrahydrofuran 
TNF-α  tumor necrosis factor alpha 
UbasM  Urea-Based Amino-Sugar Mixture 
uDISCO ultimate DISCO 
vDISCO  nanobody(VHH)-boosted 3D imaging of solvent-cleared organs 
WHO  World Health Organization 
YFP  yellow fluorescent protein 
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2 Abstract 
The effects of most diseases are not confined to a particular body region. In fact, pathologies can affect 
multiple organs and whole organisms. Therefore, a systems biology approach could deliver new insights by 
studying diseases at a whole-body level. Tissue clearing methods started revolutionizing standard histology by 
making the samples transparent and allowing the 3-dimensional (3D) imaging and analysis of whole organs 
and organisms without sectioning. In this project we aimed to develop new tissue clearing methods that are 
able to clear whole mouse bodies in order to study pathological changes throughout the entire organism. We 
based our methods on organic solvents because, so far, they are the ones that can achieve the highest level of 
transparency. First, we developed ultimate DISCO (uDISCO), a protocol that is able to clear whole mice and 
to preserve the signal from endogenous fluorescent proteins up to months, by employing less reactive organic 
solvents. Moreover, uDISCO reduces the volume of the samples by up to 65%; therefore, it permitted the 
imaging of the whole mouse central nervous system (CNS) and whole-body at subcellular resolution for the 
first time using light-sheet microscopy. Nevertheless, owing to the fact that bones and hard tissues could not 
be efficiently cleared and that the organic solvents could eventually quench the endogenous fluorescent signal, 
the reliable detection and quantification of the biological fluorescent information in all body districts have still 
represented a challenge. To overcome these issues, we developed a second pipeline called (nanobody(VHH)-
boosted 3D imaging of solvent-cleared organs) vDISCO, which exploits a pressure-driven, nanobody-based 
whole-body immunolabeling system to enhance the signal of fluorescent proteins, to preserve it for years and 
to image through dense and hard tissues such as bones and skin. vDISCO allowed us to image and quantify 
subcellular details in intact transparent mice. Using vDISCO, we reconstructed the first whole-body neuronal 
map in adult mice at subcellular resolution. Furthermore, we screened whole mice for changes caused by CNS 
damage and trauma and found degeneration of peripheral nerve terminals in the torso after traumatic brain 
injury and extensive multiple-organ inflammation after spinal cord injury. Moreover, using vDISCO we 
observed short vascular connections –named short skull-meninges connections (SMCs)–between skull 
marrow and brain meninges which were filled with immune cells upon stroke. The SMCs might represent a 
new route for immune cells to access into the brain. Taken together, our method represents a powerful tool to 
unbiasedly analyze effects of neuronal conditions in the whole organism. 
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3 Introduction 
Nature follows a very strict rule: all organisms (from tiny bacteria to big mammals) are based on a 
hierarchical organization of their different parts and all organisms are made by different components that work 
in synchrony with each other. In particular, mammals including humans and mice — well known animal 
model in biomedical research1— are characterized by a high complexity in their structural and functional 
organization with a body composed of organs, which are made by tissues, which are in turn built out of cells 
that consist of organelles and so on. All these components are never completely isolated from each other, but 
they interact, they work in synergy and they communicate to each other to make complex living organisms 
possible. 
This known concept justifies the need for studying complex organisms as whole entities and not simply as an 
assembly of many individual parts, especially when almost all diseases do not only affect the site where they 
arise but they can also cause undetected changes in other parts of the body and in some instances dramatically 
affect the entire organism. In previous decades, new research fields have appeared to target this need: there 
has been in fact an increased interest in systems biology which, through a holistic approach, has focused on 
studying complex interactions in a biological system in an unbiased manner2. However, the modeling and 
integration of the huge and complex data sets collected from whole organisms have to rely on computational 
and mathematical approaches to extract meaningful numerical datasets and information (e.g genomics and 
proteomics). 
In the field of imaging, different approaches exist to acquire and analyze whole organisms at once. Computer 
Tomography (CT) and Magnetic Resonance Imaging (MRI) technologies allow the scanning of whole bodies 
of humans and other animals. Although they are powerful tools to study live phenomena by providing the 
gross anatomy, they lack subcellular resolution and therefore they can´t provide information at single cell 
level3.   
On the other hand, in order to investigate biological samples at a cellular and subcellular level, histological 
techniques were refined in the last century4. They traditionally rely on the cutting of the body parts of interest, 
which are subsequently sliced into thin sections (10-100µm). However, the histological procedures are not 
devoid of limitations:   
 They do not allow the visualization of the organism as whole. 
 They can lead to the loss of information and to the generation of errors, because the big picture has to 
be reconstructed from separate pieces. 
 They can lead to bias in analysis, because the region of interest is predefined.  
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 Moreover, the possibility to keep samples intact is especially advantageous when investigating highly 
complex phenomena such as global inflammation or microglia activation and especially when studying cells 
with long projections such as neurons. Ideally all the cellular structures of the neurons should be enclosed in 
the imaging volume to avoid the difficult reconstruction of their morphologies from fragments. Despite the 
efforts to overcome these limitations, the development of holistic 3D histology has been hindered by the 
natural opacity of mammalian tissues, which means that high-resolution imaging of the tissue can only be 
achieved for the first few hundred micrometers in depth5. However, the development of tissue clearing 
technologies has started paving the way to solve the problems of 2D histology, although many bottlenecks that 
prevent holistic 3D high resolution imaging and analysis still exist. 
3.1  Tissue clearing technology 
Note: for the expanded version of the acronyms of the tissue clearing methods in this section, please see section 1 “List of abbreviations”. 
The opacity of most of biological tissues, including the ones from mammals, is determined by the composition 
of the tissue itself. This is because the different components of the tissue (protein, lipids, water and so on) 
have different refractive indexes (RIs)6,7; therefore when light crosses these components with different RI, it 
will be scattered in different directions.  
Tissue clearing technologies are methods that are able to render biological specimens transparent, by 
equalizing the RIs throughout the tissue and matching them with the RI of an immersion solution. The first 
translucent biological human samples had been achieved in 1911 by soaking the specimens in solutions with 
similar light refraction properties of the tissue8. However, at that time two main factors prevented the rise of 
3D histology: the lack of modern fluorescent staining approaches to label the desired biological structures and 
the lack of advanced microscopy technologies. In 2007, Dodt et al. designed and built the first light-sheet 
fluorescence microscopes (ultramicroscopes), which, in combination with benzyl alcohol/benzyl benzoate 
(BABB) clearing, represented a big breakthrough because it was finally possible to quickly image relatively 
big cleared samples without sectioning9.  
Since then, many other clearing methods have been developed. Overall, there are currently three main groups, 
based on their principles to match the refractive index and to clear the tissue. Nevertheless, none of them so 
far allow a reliable detection of the fluorescence signal at a subcellular level for intact whole body analysis 
and quantification. 
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3.1.1 Tissue clearing types 
Organic-solvent-based clearing methods 
The first tissue clearing group is based on BABB clearing principles. It is characterized by the use of organic 
solvents which can achieve the highest grade of transparency, although at the cost of fast quenching the 
fluorescence signal10,11. Since the two main components that cause light scattering in the tissue are water and 
lipids (they have lower and higher RIs respectively, compared with the RI of the proteins), the methods from 
this group aim to dehydrate and delipidate the samples completely prior to RI matching. Different solvents 
have been used to achieve the dehydration, delipidation and RI matching: the first tests were performed with 
non-toxic alcohols (e.g. ethanol) as dehydrating reagent9, although with the risk of completely quenching the 
transgenically expressed fluorescent protein signal 12. One of the main methods of this group is represented by 
“3D imaging of solvent-cleared organs” (3DISCO). 3DISCO is an organic-solvent-based clearing method that 
is extremely reproducible and easy to perform; it produces very transparent samples and it has been widely 
used in biomedical research: for example to study stem cells13, immune cells14 and cancer cells15 in thick 
tissues. In the 3DISCO method, tetrahydrofuran (THF) is used to remove the water, dichloromethane (DCM) 
to remove the lipids and dibenzyl-ether (DBE) replaced BABB to match the RI12,16,17. In Schwarz et al., tert-
butanol replaced THF to remove water from the samples18 and, according to the authors, improving the 
fluorescence signal retention.  Some years later, different research groups combined 3DISCO with whole-
mount and whole-organ labeling
19,20
 including the one of Tessier-Lavigne that called its protocol 
“immunolabeling-enabled three-dimensional imaging of solvent-cleared organs” (iDISCO)21. Recently, 
iDISCO has been updated into iDISCO+ using methanol as dehydration agent, in order to reduce the size 
shrinkage effect caused by THF22. 
Aqueous-based clearing methods 
The second group consists of aqueous-based clearing methods. In fact, these methods use hydrophilic reagents 
that are dissolved in water. The solutions can simply be with:  
 High RI molecules (e.g. glycerol23 or 2,20-thiodiethanol (TDE)24-27).  
 High concentration of sugar (e.g fructose in SeeDB28) to increase the RI and match it to that of the 
tissue. 
 A mixture of sugar and urea (e.g ScaleS29 and FRUIT30). 
 More complex chemical cocktails with both RI matching and delipidation properties: N-
methylglucamine- TDE-Iohexol in OPTIClear31 ,urea-xylitol-sodium deoxycholate in ClearSee32, 
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urea-alcohols (e.g, glycerol in Scale33), urea-sucrose-1,3-Dimethyl-2-imidazolidinone in UbasM34, or 
urea-aminoalcohol such as in CUBIC35,36 and its derivatives37-39.  
Hydrogel-based clearing methods 
The third group is based on the formation of a hydrogel scaffold in the tissue. CLARITY40 is a clearing 
method that applies hydrogel-embedding fixation followed by delipidation with electrophoresis to clear the 
tissue. First, the tissue is stabilized by the induction of the endogenous proteins in the sample to form cross-
links with acrylamide in order to form a hydrogel, then an electric field facilitates the removal of the lipids 
from the tissue via the strong detergent sodium dodecyl sulphate (SDS); in the end the tissue is immersed in 
the RI matching solution “Focus Clear” until transparency. In recent years, many other protocols have derived 
from the original CLARITY, including PACT and PARS41  that exploit passive and perfusion delipidation 
respectively, and  PACT-decal42 and bone-CLARITY43 that are both able to clear calcified tissues such as 
bones.  Moreover, whole-mount labeling protocols were developed based on hydrogel formation, including 
SWITCH44 and SHIELD45 that allow multi-round protein labeling, and CLARITY coupled with RNA 
amplification/staining and imaging46. 
3.1.2 Signal stabilization and whole mount staining 
The first applications of tissue clearing were based on the detection of endogenous florescent proteins, 
including green fluorescent protein (GFP) or yellow fluorescent protein (YFP) expressed by neurons of the 
central nervous system (CNS) in transgenic animals9,33. However, most of clearing protocols, especially the 
ones based on organic solvents, had the side effect of heavily quenching the fluorescence signal within few 
days10,12, making the samples unusable for prolonged imaging. It has been shown that the fast quenching of 
the proteins depends on several factors such as the formation of peroxides, high clearing temperatures that can 
denaturate the GFP structure47,48 and the removal of the proteins from their water environment49. Therefore, 
many efforts in protocol development aimed to preserve the fluorescent signal as long as possible18,29,34,50,51 by 
increasing the pH of the clearing solutions18,48,50,52,53, removing peroxides12,  adding substances able to 
stabilize protein conformation (e.g polyethylene glycol50,54,55) or  reducing the clearing temperature51,52. On the 
other hand, the aqueous-based clearing methods have been shown to better preserve the fluorescence signal 
although being more time-consuming protocols and not efficient in reaching complete transparency of the 
samples10.  Whole mount staining methods were introduced as a different solution for the fast quenching: for 
example in iDISCO and iDISCO+ the authors used antibodies conjugated to Alexa Fluor dyes that are more 
stable after solvent treatment and clearing. In this way they could perform repeated imaging for many 
months21,22.  
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However, to this point, the whole mount staining protocols available in the literature were not able to achieve 
the labeling of samples bigger than single organs such as a mouse brain or kidney because one of the main 
limitations is the big size of the antibodies that prevents them to penetrate deep into the tissue21. 
3.1.3 Whole-body clearing 
The possibility to clear whole organisms (such as entire mice) for unbiased studies of intact full bodies at 
subcellular resolution has been explored using perfusion systems to actively deliver the clearing agents into 
the body of the animals. In these protocols the removal of the skin remained a standard procedure in the pre-
clearing step36,39,41,42,50, since this organ acts as a barrier for penetration of chemicals and the optical properties 
of hair and strong melanin pigmentation cause additional problems during imaging11,56,57.  This perfusion 
based strategy led to the publication of methods such as whole-body CUBIC36, PARS41,42 and PEGASOS50. In 
whole-body clearing the decolorization of the blood to remove the heme pigment in fundamental because this 
pigment is one of the most abundant in mammalian bodies and it can cause light absorption and strong 
autofluorescence11,36. In CUBIC and PEGASOS, heme is eluted from the body by the treatment with an 
aminoalcohol35,36,39,50; while in PARS, this is done by SDS41,42. These methods can achieve quite a high level 
of transparency10, however the swelling of the samples after clearing or the lack of adequate imaging systems 
prevent the high resolution imaging of the intact body because the resulting whole body samples were too 
large to fit into conventional light-sheet microscopes. Recently, the group that developed CUBIC published a 
new method called CUBIC-cancer39. This updated CUBIC method is able to render the animals clear enough 
for light-sheet imaging of the entire body, although using a custom-made light-sheet microscope. CUBIC-
cancer was used to detect cancer metastases in whole mouse bodies and in the related paper it was shown that 
despite the unbiased detection of cancer metastases in whole bodies, it was still necessary to apply confocal 
imaging on specific dissected organs of interest to obtain quantitative data (e.g number of metastases in 
specific organs). The main reason of this is because like all whole-body clearing and imaging methods 
published so far, CUBIC-cancer relies on the signal of transgenically expressed fluorescent proteins which 
emit light in the visible spectrum, range where muscles and other tissues such as bones have obstructive 
autofluorescence or can limit imaging penetration6. Moreover, fluorescent proteins are generally less bright 
than most of the synthetic fluorophores (e.g Alexa dyes) used for example in immunohistochemistry and their 
signal is further diminished by the clearing and imaging steps as mentioned before. Taken together, there are 
several factors that up to date prevent the reliable quantification of single cells in whole bodies. 
Finally, all previous whole-body clearing protocols require the removal of the skin36,39,41,42,50 and this means 
that the largest organ of a body is lost. This represents an important drawback because it has been shown that 
the skin has essential functions, beyond its main role of being merely a physical barrier against external 
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environment58,59. In fact, we can find many other functional elements such as nerve endings, immune cells, 
and vessels from the blood and lymphatic circulation in the skin. All these components, together with other 
organs contribute to the functionality of the skin58,59. 
3.1.4 Side technological applications 
It is noteworthy that many of the clearing methods aforementioned paved the way for the development of 
protocols that could broaden the technical applications of tissue clearing beyond just making the sample 
transparent for deep tissue imaging. For example, the fact that the hydrogel based methods such as CLARITY 
and PACT could ratiometrically expand the size of the samples represented the groundwork for the field of 
expansion microscopy (ExM). In fact, in ExM60 the creation within the specimen of a swellable 
superabsorbent nano-porous polymer network enables the sample to increase in size by the immersion in 
water. Therefore, the physical expansion corresponds to a physical magnification, giving the possibility for 
super-resolution microscopy: stained objects42,61-63 that are closer than the diffraction limit in the untreated 
tissue can be optically resolved after expansion. Furthermore, the observation that some aqueous-based 
methods can also increase the size of the sample, led to the generation of further expansion protocols such as 
CUBIC-X37.  
3.2 CNS damage and injuries 
Diseases involving the CNS (brain and the spinal cord) can lead to devastating effects and are a major cause 
of death and disability. Injuries to the CNS affect millions of people64 worldwide and every year almost one 
million people experience a cerebral ischemia/stroke only in U.S65. Most people who survive from damage to 
the CNS will suffer from permanent neurological impairments. 
The serious consequences of CNS damage result from the fact that the CNS is the organ assigned to control 
and to coordinate all other parts of the body. In fact, the CNS extends its reach to the rest of the body by 
connecting with the peripheral nervous system (PNS), which in turn innervates every single organ. It is 
therefore clear that the damage of one part of the CNS can have detrimental sequela, not only in the neuronal 
tissue itself but also in other tissues and in regions far from the damaged site, even out of the CNS. For 
example, it has been shown that CNS injury can trigger a systemic response via activation of the inflammatory 
components66.  
At the moment, the study of such an intricate complex neuronal network and how it affects the whole body 
represent a big challenge not only in neuroscience but also in other fields especially when all the organs are 
controlled by its activity. So far, the morphological investigation of all pathophysiological changes caused by 
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CNS diseases has been conducted by analyzing each single organ of interest separately, dissecting them out 
from the body. For example, the visualization of spine reduction after traumatic brain injury (TBI) was done 
by dissecting out the brain67 or the analysis of the systemic immune cell activation after stroke was done 
dissecting out selected peripheral organs such as the femur bone or the aorta68. This focused approach makes 
difficult to discover unexpected effects in other parts of the body after CNS damage. 
Therefore, a more global approach with the ability to capture the changes at a systemic level to obtain the 
whole view of the disease is needed.  
Although whole-body imaging and scanning systems such as MRI or CT exist, none of them is able to provide 
information at single cell resolution. 
3.2.1 Traumatic brain injury  
Traumatic brain injury is defined as damage to the brain due to external mechanical forces that can include 
shockwaves69, repetitive head hits in contact sports70 or severe impacts in car accidents71. It is the leading 
cause of death and disability in high-income countries in people under 45 years old. In fact, millions of deaths 
and/or hospitalizations annually are directly attributable to TBI64,72. Until today, despite extensive research, 
there are no adequate therapeutic treatments available. The heterogeneity in trauma lesion as well as the 
complexity of subsequent pathophysiological events accounts for the failure of clinical trials73,74. Thus, TBI 
represents an overwhelming global health problem.  
According to the American National Institute of Health (NIH), TBIs that are caused by a direct head trauma 
can include: concussion (also known as mild TBI), which is a temporary impairment of brain functions due to 
a trauma75, and contusion, which is a moderate to severe TBI with bruise of the brain tissue and possibly skull 
fracture76,77. Brain contusion represents the type of TBI that is the most studied within animal models, because 
it is relatively easy to model77. 
The pathophysiology of TBI starts with its acute phase which consists of two stages. In the first phase, the 
brain tissue is immediately damaged, both physically and mechanically. This leads to primary acute effects 
such as: focal injury due to the mechanical impact, rupture of tissue which results into vascular damage and 
hemorrhages, death of glial limitans, generation of free radicals and axonal shearing77-81. These phenomena 
are followed by secondary acute effects that can evolve over minutes to months and are the results of specific 
molecular, metabolic and cellular events such as excitotoxicity82, perturbation of the calcium homeostasis83, 
increased generation of free radicals, increased peroxidation, mitochondrial dysfunction84, ischemia, 
inflammation85, infiltration of peripheral immune cells86,87, apoptosis, diffuse axonal injury88,89 and damage of 
the blood brain barrier (BBB)80. All these events can lead to neuronal, endothelial and glial cell death resulting 
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in white matter degeneration, tissue damage, brain atrophy and death77,88,89. For the TBI survivors, these 
events can lead to long-term symptoms, for instance clinical manifestations so far associated to 
neurodegenerative diseases90. In fact, considerable literature from human studies showed a strong association 
between TBI and the development and/or worsening of chronic focal and global impairments91,92 including 
neurodegenerative diseases such as dementia93,94, Parkinson´s disease95, epilepsy96, depression90 as well as 
pathologies affecting the whole body such as progressive motor decline syndromes97, hemidystonia98 and 
peripheral neuropathies99. It is reasonable to hypothesize that all the events that occur during the acute phase 
of TBI can trigger prolonged tissue degeneration causing the long-lasting effects of TBI (chronic TBI) which 
can persist for years or decades100. 
However, although it has been already shown that the initial localized focal injury can affect the whole brain 
in terms of neurodegeneration and neuronal inflammation67, little is known about the mechanisms that cause 
this phenomenon and how the focal damage can trigger changes in the rest of the body. In fact, up until now, 
it is still not clear whether peripheral neuronal connectivity is altered in remote body regions after TBI and in 
which locations such alterations might occur. 
3.2.2 Spinal cord injury 
Spinal cord injury (SCI) is the damage to the spinal cord caused by a trauma (e.g. a car accident) or from 
disease or degeneration (e.g. cancer). According to the World Health Organization (WHO), the annual global 
incidence is estimated 40 to 80 cases per million in the world population and up to 90% of these cases are the 
result of a trauma. The injury is characterized by a series of symptoms (loss of sensitivity, chronic pain, 
paralysis or bladder dysfunction) which depend on the severity and the location of the damage to the spinal 
cord. So far, research efforts were devoted in the direction of promoting axonal regeneration to re-establish 
the original neuronal network101-104. However, the treatment of spinal cord injury in clinic has been 
particularly difficult due to the inability of most of the damaged axons to regenerate17 or the inability of 
neurons to be replaced in the CNS105. In fact, there is currently a lack of effective therapies for SCI 
condition105.  
As for TBI, the pathophysiology of SCI consists of two stages: the primary injury, which is characterized by 
the initial mechanical damage (immediate hemorrhage and cell death) and the secondary injury that lasts for 
weeks or months106. The secondary injury is characterized by biochemical, cellular, tissue and vascular 
changes that worsen the effects of the SCI even further106: energy failure107, perturbation of ion 
homeostasis108, excitotoxicity109, edema110, apoptosis111,112, lipid peroxidation113, oxidative stress114, 
inflammation with release of cytokines115,116, immune cell invasion117 and vasospasm118.  Among these events, 
it has been shown that the inflammatory response plays a main role in the secondary damage generally 
17 
 
worsening the outcome after SCI119-124. One of the main components of the inflammation is represented by 
immune cells, in particular macrophages/microglia125. In physiological and healthy conditions, these cells 
have been observed as peripheral macrophages in the meningeal spaces, in the perivascular compartment and 
in the choroid plexus, while as microglia inside the CNS tissue. Upon SCI,  many studies reported that 
macrophages/microglia can detrimentally affect the injury outcome by secreting pro-inflammatory mediators 
including cytokines, tumor necrosis factor alpha (TNF-α), interleukin(IL)-1, reactive oxygen species (ROS), 
and nitric oxide (NO)121,126-128, but also have a beneficial effect via production of anti-inflammatory cytokines 
such as IL-10, and transforming growth factor beta (TGF-β)128,129. However, the mechanisms underlying this 
dual role have not been completely elucidated yet. Owing to the importance of their role in SCI, extensive 
research has been conducted to influence the activity of these cell populations in order to develop effective 
therapeutic strategies to reduce the damage after SCI. 
Besides the activation of resident microglia, an infiltration of peripheral macrophages attracted by chemokines 
into the CNS after SCI has been observed130-132. These infiltrating cells are actively involved in the 
progression of the injury together with the resident microglia cells133. As mentioned before, 
macrophages/microglia (which are the predominant immune cell population present in the spinal cord after 
injury134) can at the same time damage neurons and glia by secreting inflammatory molecules but also be 
essential  for the reconstruction of the injured tissue, for example phagocytizing cellular debris and dead 
cells133,134. It has been speculated that the dichotomy of their role is due to the heterogeneity of the 
macrophage/microglia population135,136. For example, microglia might have unique functions versus the 
infiltrating macrophages136. Therefore, it would be important to distinguish the nature and different features of 
these cellular populations. However, the investigation of the infiltrating and resident immune cells has been 
mainly conducted post-mortem in isolated spinal cords that have been dissected out from the body134,137-140. 
Other techniques have been exploited for the same purpose: MRI has been used to indirectly follow the spatio-
temporal course of macrophages invasion in vivo after nerve injury in a selected body area141; while intravital 
and 2-photon microscopy have been used after laminectomy to observe the infiltration event but only in small 
areas of the spinal cord125,142. Therefore, no study has ever shown the extent of inflammation in the body areas 
surrounding the injury site at single cell level and no study could in a global way monitor all the putative 
infiltrating routes, tracking each single cell that moves from the surrounding peripheral organs into the spinal 
cord. 
Although TBI and SCI share extensive similarities in terms of neuroinflammatory response143, in this project I 
have focused on the study of the inflammatory events after SCI. 
18 
 
3.2.3 Stroke 
Stroke or cerebral ischemia is defined by the WHO144 as “a clinical syndrome consisting of rapidly developing 
clinical signs of focal (or global in case of coma) disturbance of cerebral function lasting more than 24 hours 
or leading to death with no apparent cause other than a vascular origin”. In other words, it is a medical 
condition where the insufficient blood supply in the brain results into tissue death. In ischemic stroke the 
neurological dysfunction is the visible result of the infarction of an area of the brain, caused by the narrowing 
or the occlusion of a brain artery. Ischemic stroke is considered as a medical urgency because it is the second 
leading cause of death and the main cause of long-term disability in the world65. As in TBI and SCI, the CNS 
tissue damage resulting from brain ischemia evolves in time and space through a complex series of ionic, 
biochemical and cellular pathophysiological events. The brain is an organ particularly vulnerable to ischemia, 
because it is characterized by a high intrinsic metabolic activity and a high demand of oxygen and glucose 
supply145. In case of ischemia, the reduced delivery of both oxygen and glucose causes the failure of ionic 
pumps and of reuptake mechanisms leading to the alteration of the ionic balance, excitotoxicity and spreading 
depression-like depolarizations146. Then, subsequent oxidative stress, necrosis, apoptosis and inflammatory 
processes lead to neuronal damage147,148 and to the release of proinflammatory mediators (cytokines and 
chemokines) which attract and promote the trans-endothelial migration of peripheral leukocytes149. 
The stroke-induced inflammation plays an important role in stroke pathophysiology. It has been shown that 
the ischemic injury causes an acute (minutes to hours after stroke) and a prolonged (hours to days after stroke) 
inflammatory response, which consists of the activation of microglia in the acute phase and, as mentioned 
before, the recruitment of circulating leucocytes in the prolonged phase150-154. In rodent models, these recruited 
white blood cells are first represented by myeloid cells including neutrophils and macrophages that invade the 
brain parenchyma within hours to days, followed by infiltration of lymphocytes that occurs days to weeks 
after the initial injury155-158. Although the immediate inflammatory response tries to cope with the damage of 
the tissue by clearing dead cells and cellular debrids, the accumulation of immune cells including the 
infiltrating ones becomes quickly detrimental154. For example, these leucocytes can release pro-inflammatory 
mediators and different effector molecules such as proteases and prostaglandins, and ROS that can directly 
harm the cells, the vessels and the extracellular matrix further, eventually causing damage to the endothelial 
layer and an impairment of the BBB159,160. On the other hand, some sub-populations of the infiltrating 
leucocytes might play a protective role especially in the chronic phase (in rodents approx. two weeks after 
stroke)  including  Treg lymphocytes that can immunoregulate the inflammatory activity of T cells, secrete 
anti-inflammatory cytokines, suppress astrogliosis, prevent secondary infarcts and contribute to the 
neurological recovery161,162.  
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Owing to the key roles that infiltrating immune cells play in stroke, there has been an increasing effort to 
understand the exact mechanisms that allow the circulating leucocytes to migrate into the ischemic brain. The 
trans-endothelium access across the impaired BBB represents the route that has been investigated the 
most163,164. However, other routes for other sub-populations of cells warrant investigation to elucidate their 
contribution to the stroke outcome. In particular, a better understanding of how these sub-populations access 
the CNS and interact with the brain microvasculature would likely lead to the development of more efficient 
immune interventions for patients affected by stroke165. 
In general, the studies of the infiltration of immune cells into the brain were mostly performed using standard 
immunohistochemistry (IHC) on post-mortem material, in vivo intravital microscopy and especially by ex vivo 
flow cytometry158,166. However, these methods have certain limitations: for example in flow cytometric 
analysis, the enzymatic digestion used to process the brain samples might change the surface antigens of the 
cells; while standard IHC requires the slicing of the tissue causing partial loss of 3D information and making 
the reconstruction of the entry routes for immune cells less accurate, more difficult and time consuming for 
large volumes. The usage of in vivo imaging techniques such as intravital microscopy has given important 
insight into the mechanisms behind the adhesion and the trans-endothelial migration of these cells, although it 
can only provide information about the surface of the brain. Positron emission tomography/single photon 
emission tomography and functional MRI on the other hand do not have the resolution power necessary to 
provide single cells information. Accordingly, there is a need for improved technologies to investigate these 
specific important aspects of stroke disease. 
 
3.3 The brain lymphatic system as a route of immune cell 
trafficking  
The lymphatic system is a vascular network connecting different organs which is critical for the body´s 
immune response and for coordinating the trafficking of antigens and immune cells167. In the past, it was 
thought that the brain was not reached by this network and that the only immune cells residing in the brain 
parenchyma in healthy conditions were the microglia. However, recent studies confirmed that the CNS is not 
devoid from this network and other papers even described how brain lymphatic vessels play an important role 
in CNS diseases168. But where are the brain lymphatic vessels located? 
The meningeal compartments represent an important factor in the immune surveillance of the brain169 because 
they are populated by a variety of immune cell types that can affect the CNS functions170; however, it was not 
clear how the immune components such as immune cells could enter and leave the CNS. Only recently it has 
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been discovered that the dural sinuses of the meninges are lined with lymphatic vessels, which carry fluid and 
leucocytes and are connected to the deep cervical lymph nodes168.  It has been shown that these vessels can 
contribute to the drainage of the cerebrospinal fluid transporting leucocytes and soluble macromolecules 
together with the glymphatic system171,172 and can be a route for immune cells to access the CNS168 in health 
and disease. In fact, a recent study has reported that in mice affected by experimental autoimmune 
encephalomyelitis (EAE, a model for multiple sclerosis) the disruption of the meningeal lymphatic function 
could ameliorate the disease outcome. This has led to the hypothesis that this system can actively play a role 
in the activation of harmful 2D2 T cells that contribute to the pathogenesis of EAE173. Moreover, new studies 
have demonstrated that this lymphatic vasculature also works as a CNS-meninges drainage system for 
macromolecules such as amyloid-β and Tau174. Interestingly, they showed that the impairment of this system 
could cause the accumulation of these molecules in the brain174,175 and consequently worsen the cognitive 
deficits in animal models of neurodegenerative diseases such as Alzheimer´s disease175. 
These important newly discovered functions of the meningeal lymphatic vessels highlight them as a promising 
delivery route and direct target for new therapeutics to control neuroinflammatory and neurodegenerative 
conditions. However, the study of these small structures has been difficult: they are located between the brain 
and the skull and thus easily destroyable during the dissection of the brain from the skull for histological 
processing. So far, the histological analysis of these vessels has only been possible by either sectioning the 
complete head176 or removing the brain from the skull. In the latter case the meningeal membranes were 
carefully peeled out from the remaining bone or directly observed in the inner side of the skull168,173. However, 
all these strategies are very laborious and suffer from the limitations of classical histology, which are the 
sectioning of the region of interest or the disruption of the structures at the brain-meninges interface when the 
brain and meninges are separated. Therefore, new methods that can preserve the integrity of the brain in the 
skull and that are able to study meningeal lymphatic vessels embedded inside the head are needed. 
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4 Research Articles 
4.1 Shrinkage-mediated imaging of entire organs and organisms 
using uDISCO 
Tissue clearing methods, together with the invention of light-sheet microscopy, have contributed to the 
development of 3D-histology for the study of large transparent specimens. Nevertheless, there are still 
limitations that prevent the imaging of entire mammals such as rodents: (i) light-scattering in thick tissues, (ii) 
fast quenching of endogenous fluorescence signal and (iii) the size of the entire bodies that could not fit into 
the existing microscopes. 
To overcome these limitations, we have developed a new tissue clearing method called uDISCO. Thanks to 
the introduction of new chemical reagents (tert-butanol to dehydrate, and Diphenyl-ether (DPE) to match the 
RI) that are chemically stable and less prone to create peroxides which are harmful to the endogenous 
fluorescent proteins, uDISCO can preserve the fluorescence signal of the endogenous fluorescent proteins up 
to months. Moreover, thanks to the ability of uDISCO to clear entire organs and rodent bodies reducing their 
size up to 65%, our method allows the imaging of whole bodies by light-sheet microscopy. With uDISCO, we 
imaged for the first time at subcellular resolution entire CNS and entire bodies from Thy1-GFPM mice, where 
motor and sensory neurons express GFP. Furthermore, we applied uDISCO to reconstruct the whole 
vasculature of the CNS from rats over 7 cm and we performed unbiased detection and screening of 
transplanted fluorescent stem cells in whole body of adult mice. We also showed that uDISCO is compatible 
with antibody and histological dye stainings of 1 mm thick tissue slices not only from fresh-fixed mouse 
brains but also from over-fixed human samples. 
Taken together, uDISCO is a powerful method that can be applied for many biomedical inquires when the 
analysis of intact large organs and organisms is required. 
 
Contribution of R.C. to this work: equal contribution to the development of the method with C.P., in particular I performed: chemical screen and 
optimization of the best chemical cocktail for the protocol; characterization of the method: preservation of the fluorescent signal, comparison with 
other clearing methods, compatibility with histological staining, imaging depth, size change and ratio-metrical shrinkage evaluation; my shared first 
authors C.P., F.P.Q. and I contributed equally for the other aspects of the project: performing experiments, data analysis, interpretation of the results, 
writing the manuscript (please see section 12  for further details) 
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recent tissue-clearing approaches have become important 
alternatives to standard histology approaches. however, light 
scattering in thick tissues and the size restrictions on samples 
that can be imaged with standard light-sheet microscopy 
pose limitations for analyzing large samples such as an entire 
rodent body. We developed ‘ultimate disco’ (udisco) clearing 
to overcome these limitations in volumetric imaging. udisco 
preserves fluorescent proteins over months and renders intact 
organs and rodent bodies transparent while reducing their size 
up to 65%. We used udisco to image neuronal connections and 
vasculature from head to toe over 7 cm and to perform unbiased 
screening of transplanted stem cells within the entire body of 
adult mice. udisco is compatible with diverse labeling methods 
and archival human tissue, and it can readily be used in various 
biomedical applications to study organization of large organ 
systems throughout entire organisms. 
Until recently, histological techniques relied on sectioning 
to observe nonsuperficial cellular structures deep in tissues. 
However, investigation of complex cells with large projections, 
such as those in the nervous system, is best performed in intact 
tissue. While recently developed tissue-clearing methods have 
overcome obstacles imposed by light scattering1–10, the difficulties 
associated with specimen size remain to be addressed. Available 
clearing methods either increase or do not change the volume of 
tissues, with the exception of organic-solvent-based methods such 
as 3D imaging of solvent-cleared organs (3DISCO), which causes 
a substantial volumetric reduction instead5,6,11.
When combined with tissue clearing, light-sheet microscopy 
produces micrometer-resolution image volumes of large speci-
mens within minutes. However, several limitations still exist. 
Photons traveling through samples (cleared or uncleared) are 
absorbed or scattered by interaction with the tissue, resulting in 
attenuation of both excitation and emission light12,13. Relatively 
thick light sheets (thickness ≥ 4 µm) are used to image volumes 
larger than a few hundred micrometers14. These light sheets 
are generated by cylindrical lenses and have Gaussian profiles; 
shrinkage-mediated imaging of entire organs and 
organisms using udisco
Chenchen Pan1,2,6, Ruiyao Cai1,2,6, Francesca Paola Quacquarelli1,6, Alireza Ghasemigharagoz1,  
Athanasios Lourbopoulos1, Paweł Matryba1,5, Nikolaus Plesnila1–3, Martin Dichgans1–4, Farida Hellal1,3 & Ali Ertürk1–3
thinnest widths, which provide the best resolution, occur only at 
the beam waist. Thus, the volume of sample that can be imaged at 
the highest resolution is limited to the central region of the light 
sheet. Finally, both small imaging chambers and the short work-
ing distance (WD ≤8 mm) of high numerical aperture (NA ≥ 0.9) 
objectives pose additional challenges. Thus, 3D reconstruction 
of neuronal connections over 5–8 mm (the approximate size of a 
mouse brain) has remained a challenging task.
Organic-solvent-based clearing methods, such as 3DISCO, 
achieve the highest level of transparency and size reduction 
among all clearing approaches11,15. 3DISCO has been used to 
study immune cells16, stem cells17, cancer cells18, and transdiffer-
entiating lung cells19; and it has been combined with deep-tissue 
antibody labeling and automated activity mapping20–22. However, 
3DISCO quickly quenches endogenously expressed fluorescent 
proteins (with a half-life of a few days)6, which has limited the 
applicability of 3DISCO. Here, we developed uDISCO, a method 
that revealed and preserved the signal of endogenous fluores-
cence over months while retaining the advantageous size reduc-
tion. Thus, uDISCO allows subcellular imaging of 2× to 3× larger 
volumes in a single scan and avoids or reduces artifacts of physical 
sectioning and mosaic imaging. Using uDISCO, we imaged entire 
bodies of adult rodents to determine long-distance neuronal 
and vascular projections and spatial information on stem cell 
transplants (which have previously been difficult to study) at 
single-cell resolution.
results
udisco preserves endogenous signal and reduces volume 
by 65%
We reasoned that 3DISCO-induced shrinkage could be promising 
for imaging whole rodent bodies. However, 3DISCO resulted in 
a fast decline of endogenous fluorescence signal during whole-
body clearing, where longer treatments with clearing solutions 
are required (Supplementary Figs. 1 and 2). To overcome this, 
we searched for organic compounds that preserved fluores-
cence while providing a potent tissue-clearing effect. Our screen 
1Institute for Stroke and Dementia Research, Klinikum der Universität Mu¨nchen, Ludwig Maximilians University of Munich (LMU), Munich, Germany. 
2Graduate School of Systemic Neurosciences (GSN), Munich, Germany. 3Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. 4German Center 
for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany. 5Current address: Department of Molecular and Cellular Neurobiology, Nencki Institute of 
Experimental Biology of Polish Academy of Sciences, Warsaw, Poland. 6These authors contributed equally to this work. Correspondence should be addressed  
to A.E. (ali.ertuerk@med.uni-muenchen.de).
Received 1 MaRch; accepted 26 July; published online 22 august 2016; doi:10.1038/nMeth.3964
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resulted in a tissue-clearing method (uDISCO) based on diphe-
nyl ether (DPE), an organic solvent with a refractive index of 
1.579 (Supplementary Fig. 3). uDISCO reveals fluorescence 
notably better and maintains it several weeks longer within 
Thy1–GFP-M mouse brains (expressing GFP in a sparse neu-
ronal population23) compared with 3DISCO and water-based 
ScaleS protocols (Fig. 1a,b, Supplementary Figs. 4–6, and 
Supplementary Video 1). As DPE has a melting point of 26 °C, 
we mixed it with benzyl alcohol (−15 °C melting point) and benzyl 
benzoate (18 °C melting point) to obtain a mixture that is liquid 
at room temperature, which we named BABB-D (Supplementary 
Table 1 and Supplementary Protocol). Additionally, uDISCO 
utilizes both the antioxidant α-tocopherol (Vitamin E) to scav-
enge peroxides and tert-butanol24, a dehydrating reagent that is 
more stable than tetrahydrofuran (THF) used in 3DISCO. With 
the resulting protocol, the fine structures of labeled neurons in 
the lipid-dense brain and spinal cord can be detected over 
weeks to months.
uDISCO effectively cleared internal organs (Supplementary 
Fig. 7) and hard tissues, including calcified bones (Supplementary 
Figs. 8–10; Supplementary Videos 2 and 3), without any addi-
tional treatment, such as decalcification with EDTA25. Bones are 
heavily mineralized, allowing only minimal exchange of clearing 
solutions. Therefore, bone clearing requires clearing solutions 
with similar refractive index (RI) to reduce the clearing duration 
and light scattering. The RI of bones has been estimated as 1.555–
1.564 (refs. 26 and 27), which is very similar to the RI of BABB-D, 
the final clearing agent in uDISCO.
We measured the size-reduction capability of uDISCO com-
pared with existing whole-body clearing techniques. We found 
that whole-body clearing by uDISCO reduced the volume of mice 
(~42%), while both CUBIC (clear, unobstructed brain imaging 
cocktails and computational analysis) and PARS (perfusion-
assisted agent release in situ) whole-body clearing methods 
enlarged it (Fig. 1c and Supplementary Fig. 11). We also tested 
the size reduction on dissected organs and found that uDISCO 
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Figure  | Development and principles of uDISCO. (a) Preservation of GFP (Thy1–GFP-M brain) after uDISCO, assessed by light-sheet microscopy.  
(b) Fluorescence-level quantifications in the GFP-M brains after uDISCO, ScaleS, and 3DISCO over time (n = 3, 3, and 4 mice, respectively; a.u., arbitrary 
unit). (c) Volume changes of 4-month-old GFP-M mice after CUBIC, PARS, and uDISCO whole-body clearing (n = 5, 3, and 7 mice, respectively).  
(d) Volume changes of dissected brains from 6-month-old mice after CUBIC, PACT, and uDISCO passive clearing (n = 4, 4, and 3 mice, respectively).  
(e) Illustration of the advantages and disadvantages of tissue shrinkage versus expansion during imaging. (f) Mouse brains (GFP-M, 4 months old): 
uncleared (left), after uDISCO (middle), and after CUBIC (right) whole-body clearing. (g) Light-sheet microscopy imaging of cortical neurons in GFP-M 
brains with shrinkage (uDISCO) and expansion (PACT and CUBIC) after clearing. (h) Imaging depth quantifications on brains after CUBIC, PARS, and 
uDISCO whole-body clearing (n = 4, 4, and 3 mice, respectively). (i) Imaging depth quantifications on brains after CUBIC, PACT, and uDISCO passive 
clearing of dissected brains (n = 4, 3, and 3 mice (6 months old), respectively). All values are mean ± s.d.; statistical significance in b–d, h, and i  
(*, P < 0.05; **, P < 0.01; and ***, P < 0.001) was assessed by one-way ANOVA followed by Dunnett’s post hoc test.
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reduced the size of adult mouse brains up to 55%, in contrast to 
CUBIC and PACT (passive CLARITY technique), both of which 
enlarged mouse brains (Fig. 1d and Supplementary Fig. 11). This 
size reduction, together with uDISCO’s preservation of fluorescent 
proteins, resulted in a substantial advantage for imaging larger 
volumes compared with other tissue-clearing methods (Fig. 1e,f). 
Using light-sheet microscopy, we found that the maximum portion 
of a cleared tissue that can be imaged at once increased 2× to 4× with 
uDISCO compared with PARS or PACT and CUBIC (Fig. 1g–i). 
To test whether the shrinkage was isotropic, we compared images 
before and after clearing. We found that brain tissues such as the 
cortex and hippocampal layers shrank homogenously, ~30% in 
each dimension at macroscopic scale (Supplementary Fig. 12). 
In addition, the shrinkage of different cell types (neurons, glia, 
etc.) and vasculature in the same brain region was homogenous 
in all dimensions (Supplementary Fig. 13). Finally, we found that 
individual cell and vascular morphologies were preserved in brain 
tissue after uDISCO clearing (Supplementary Fig. 14).
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Figure  | Whole-body clearing and imaging of adult mouse with uDISCO. (a–c) Adult GFP-M mouse (3 months old) was transcardially perfused (a), 
cleared with uDISCO (b) and imaged by fluorescence stereomicroscope at cellular resolution (c). Insets show higher-magnification images of the brain 
(magenta rectangle), spinal cord (cyan rectangle), and sciatic nerve (yellow rectangle). (d) Whole-body light-sheet imaging of intact GFP-M mouse  
(4 weeks old). (e–g) High-magnification images of the boxed regions in d. Colored rectangles show high-magnification images from the indicated regions 
in the brain (e), spinal cord (f), and sciatic nerve (g). (h) 3D visualization of the intact head from Thy1–YFP-H mouse (4 months old) after whole-body 
uDISCO clearing, indicating the detailed structure of optic nerve (i) and nerves at the base of the whiskers (j). The arrowheads in i and j mark some of 
the individual axons. The composites in c, d, and h were obtained via tile imaging.
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udisco enables micrometer-resolution whole-body imaging
We used uDISCO on whole rodent bodies for system-level inter-
rogation. We cleared the whole body of an adult Thy1–GFP-M 
mouse within 3–4 d (Fig. 2a,b; 3-month-old mouse; the skin 
was removed before clearing). We first imaged the whole trans-
parent mouse with a standard fluorescence stereomicroscope 
(Fig. 2c; the skull and vertebra were removed for epifluorescence 
imaging). We readily identified the individual neurons and 
their extensions throughout the brain, spinal cord, and limbs 
in the intact mouse (Fig. 2c). To accommodate the entire trans-
parent mouse into the imaging chamber of a standard light-
sheet microscope, we constructed sample holders to keep the 
cleared specimens in place within the imaging chamber for 
automated tile scans without obstructing the excitation light 
2 cm 2 cm
5 mm 5 mm
j
d
f
e
k
l
2 cm
200 µm
200 µm
200 µm
500 µm 500 µm 500 µm
1 cm
a b c d
e
f
g h
i
j k l
Figure  | Whole-body clearing and imaging of rats with uDISCO. (a–c) A young adult female rat (4 weeks old) was injected with Texas Red Dextran  
to label the vasculature. The rat was transcardially perfused (a), cleared with uDISCO (b) 20 min after the dextran injection, and imaged with a 
fluorescence stereomicroscope (c). (d–f) High-magnification images of the boxed regions in c, such as the brain (d), spinal cord (e), and hindlimb (f). 
(g–i) Adult rat (10 weeks old) CNS (brain and spinal cord) before (g) and after (h) uDISCO clearing. (i–l) 3D visualization of vasculature via light- 
sheet imaging throughout the entire CNS from the adult rat (i). The vasculature in the cortex (j) (yellow arrowhead shows the right middle cerebral 
artery), brainstem (k) (yellow arrowheads show the two vertebral arteries, and purple arrowhead shows the basilar artery), and lumbar spinal cord 
(l) (yellow arrowheads show the spinal vessels, and purple arrowheads show their small s ulcal branches) are shown. The composites in c and i were 
obtained via tile imaging.
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(Supplementary Figs. 15 and 16). Upon shrinkage, the width of 
the largest body region (torso) was reduced from 2.24 ± 0.052 cm 
to 2.0 ± 0.048 cm (mean ± s.e.m., n = 7 mice), allowing us to 
complete 10-mm depth scans from dorsal and ventral sides of 
the mouse (Supplementary Fig. 17). Subsequently, we imaged 
the entire transparent mouse using light-sheet microscopy to 
detect neuronal structures throughout the intact mouse body 
at ~0.5- to 2-µm lateral and ~4-µm axial resolution (Fig. 2d). 
Subcellular details of neuronal projections in the whole body 
were visible throughout the animal with light-sheet microscopy 
(Fig. 2e–g). In addition, large body regions such as the head, 
torso, and whole limbs could be studied in detail. For example, 
when we imaged the entire head from an adult Thy1–YFP-H 
mouse23, we observed the projections of optic nerves and inner-
vation of whiskers (Fig. 2h–j).
uDISCO is also applicable to larger rodents. Rats (Rattus nor-
vegicus) are valuable experimental models in toxicology and 
neurological studies because, compared with those of mice, 
rat physiology and behavior more closely resemble those of 
humans. uDISCO successfully cleared whole rats (Fig. 3a,b and 
Supplementary Fig. 18). We could observe the details of Texas 
Red–dextran-labeled vasculature in the brain, brainstem, and 
limbs using a standard fluorescence stereomicroscope in the 
intact 4-week-old rats (Fig. 3c–f). In addition, uDISCO achieved 
uniform clearing and over 60% tissue shrinkage of the intact cen-
tral nervous system (CNS) in adult rats (10 weeks old, n = 4 rats; 
Fig. 3g,h). Subsequently, we obtained light-sheet microscopy 
images of the vasculature in the intact CNS over 13 cm (Fig. 3i 
and Supplementary Video 4). We identified vascular structures 
such as the right middle cerebral artery (Fig. 3j); the two vertebral 
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Figure  | Projections throughout the entire adult mouse CNS (whole brain and spinal cord). (a) The intact CNS from a GFP-M mouse (4 months old) 
after uDISCO clearing and light-sheet microscopy imaging. (b) Image of the brain in a showing the transparency after uDISCO. (c) Details of neuronal 
structures in the entire brain in a. (d–f) High-magnification images of boxed regions in c, showing the neuronal structures at subcellular resolution in 
the cortex (d), in the hippocampus (e), and projecting to the midbrain (f). (g) After uDISCO, imaging of dendritic spines with light-sheet microscopy. 
The composites in a and c were obtained via tile imaging.
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arteries, which merge to form the basilar artery (Fig. 3k); and the 
spinal vessels and their small sulcal branches (Fig. 3l).
udisco allows tracing of the intact central nervous system
Since we could image the intact CNS of rodents with light-sheet 
microscopy at subcellular resolution, we used uDISCO to trace 
neuronal structures from head to toe in the entire CNS (brain 
and spinal cord) of 3- to 5-month-old Thy1–GFP-M adult mice. 
We could trace individual axons in the intact CNS over several 
centimeters in these scans (Fig. 4a; Supplementary Videos 5 
and 6). Focusing on the brain, we observed the details of neuronal 
structures in the cortex, the hippocampus, and fine axonal projec-
tions to the midbrain (Fig. 4b–f and Supplementary Video 7). 
PACT1 and CUBIC8 reported visualization of dendritic spines 
using confocal or two-photon microscopy. For the first time for 
an organic-solvent-based clearing method in intact adult mouse 
brain, uDISCO achieved dendritic-spine resolution using light-
sheet microscopy (Fig. 4g and Supplementary Video 8).
udisco allows interrogation of Bmscs in the entire mouse
Bone marrow stem cells (BMSCs) are widely used for neuropro-
tection, regeneration, immunomodulation, and localized drug 
delivery studies28,29. So far, assessment of their distribution and 
densities has relied on methods such as histology, biolumines-
cence, or radiolabeling30. These approaches are time consuming 
and lack the sensitivity to detect sparsely localized cells or unex-
pected sites of grafting31. We used uDISCO whole-body clearing 
for an unbiased screen of transplanted syngeneic mouse BMSCs 
in the entire body at single-cell resolution. We collected BMSCs 
from β-actin EGFP mice as described previously32 and labeled 
them with quantum dots (Qdots) (Supplementary Fig. 19). Cells 
easily incorporate Qdots, which do not interfere with cell func-
tionality or migration capacities and therefore Qdots are widely 
used for cell tracking33. Subsequently, we injected the cells either 
intravenously (IV) or intraperitoneally (IP) into host C57BL/6N 
mice (Fig. 5a). Control animals were injected with vehicle 
(PBS) only. At 3 h after injection, we euthanized the animals for 
whole-body clearing. We first imaged whole mouse bodies using 
a fluorescence stereomicroscope to determine sites of grafted 
BMSCs (Supplementary Fig. 20). Subsequently, we performed 
high-resolution light-sheet microscopy on body parts and organs 
that hosted BMSCs. As expected, the majority of BMSCs were 
trapped in the first-passage, low-flow organs such as the lungs, liver, 
and spleen after IV injection (Fig. 5b,c, Supplementary Figs. 20–22, 
and Supplementary Video 9)31,34. Moreover, we detected sparsely 
distributed BSMCs in organs such as kidneys, bone marrow, and 
intestines (Fig. 5b,c; Supplementary Figs. 21 and 22). The locali-
zations in bone marrow and intestines are of high interest because 
they were previously difficult to investigate despite their impor-
tance for hematopoietic cell populations or immune reactions31. 
As reported35, we did not observe any BMSCs in the intact healthy 
CNS (Fig. 5b,c). Overall, our data demonstrate that uDISCO 
whole-body clearing can be used to study density and distribution 
of fluorescently labeled transplanted cells throughout the entire 
host body at single-cell resolution in an unbiased way, combining 
both high speed and resolution for transplantation studies.
udisco is compatible with virus labeling and immunostaining
Most animal models used in the laboratory, as well as human 
clinical samples, do not express fluorescent proteins. Hence, we 
sought to test alternative methods to label tissues for uDISCO. To 
this end, we used adeno-associated virus (AVV) tracing to label 
neurons in the CNS of mice. We transduced the right motor cor-
tex of mice with AAV2–Syn–EGFP and the left motor cortex with 
AAV2–Syn–RFP (Fig. 6a). 4 weeks after transduction, we per-
formed whole-body uDISCO clearing. Fluorescence expression 
of the virally delivered proteins was detectable in the brain and 
throughout the intact spinal cord (Fig. 6b–f and Supplementary 
Fig. 23). The pyramidal decussation of descending motor axons 
was clearly visible (Fig. 6c). We detected both bundles of axons as 
well as individual axons in the brain and spinal cord over several 
centimeters (Fig. 6d–f).
Antibody staining is a valuable approach for labeling molecules 
of interest without the need for fluorescent tagging. Deep- 
tissue antibody-labeling methods20,21 were recently combined with 
3DISCO. To test these methods with uDISCO, we cut 1-mm-thick 
tissue sections of mouse brains and labeled them with antibodies 
against glial fibrillary acidic protein (GFAP) and ionized calcium 
binding adaptor molecule 1 (Iba1) as well as with a DNA-specific dye 
(Fig. 6g). After uDISCO, the slices shrank more than 60% in volume. 
We found that the signals from GFAP (astrocytes), Iba1 (micro-
glia and macrophages), and TO-PRO-3 (DNA dye) were visible 
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Figure 5 | Distribution of mouse BMSCs after transplantation. (a) Illustration of the experimental design. (b) Images of liver, lung, limb, and head 
(brain) from host mice in control, IP, and IV groups assessed by light-sheet imaging. The composites of individual organs were obtained via tile imaging. 
The background autofluorescence signal outlines the overall morphology of the organs. Some Qdots-positive BMSCs are indicated by red arrowheads.  
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throughout the tissue, indicating compatibility of uDISCO with 
deep-tissue labeling (Fig. 6h–l and Supplementary Fig. 24).
Human clinical tissue samples are typically stored in 4% forma-
lin over extended periods of time. To determine whether uDISCO 
could be applied to such specimens, we immunostained 1-mm-
thick human samples (archived for either 1 month or 14 months) for 
GFAP and TO-PRO-3 or Iba1 and TO-PRO-3. We measured shrink-
age of 52% and 46% in samples stored for 1 month or 14 months, 
l
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Figure 6 | uDISCO is compatible with AVV neuron tracing and immunolabeling. (a) Experimental design for AAV–Syn–RFP and AAV–Syn–GFP injections. 
(b,c) Maximum-intensity projections of the entire brain (b,c) and CNS (b) after whole-body uDISCO clearing. Arrowheads in c indicate decussation of 
the descending motor axons. (d–f) Details of neuronal extensions of boxed regions in (b): the thalamus and midbrain (d), cervical (e), and thoracic (f) 
spinal cord regions. Colored rectangles show the enlarged views from the respective images. (g) Immunolabeling workflow. (h–l) GFAP and TO-PRO-3 
labeling of coronal sections. 3D reconstructions show labeling of astrocytes (h) and cell nuclei (i) stained by GFAP antibody and TO-PRO-3, respectively. 
(j) Merged image of h and i. (k,l) Maximum-intensity projections of the z-positions marked by purple boxes in j; nuclei are shown in cyan and astrocytes 
in red. (m,n) 14-month fixed human tissue before (m) and after (n) uDISCO. (o–r) GFAP and TO-PRO-3 labeling of 14-month fixed human cortical tissue. 
Astrocytes (o) and nuclei (p) are labeled. (q) Merged image of o and p. (r) Maximum-intensity projection of the z-position marked by the purple box in q;  
nuclei are shown in cyan and astrocytes in red. All values are mean ± s.d. The composites in b and c were obtained via tile imaging.
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respectively (Fig. 6m,n). uDISCO allowed successful clearing, 
signal preservation, and imaging of human tissues stored in for-
malin more than a year (Fig. 6o–r and Supplementary Fig. 25), 
although the image quality was better for shorter storage periods 
(Supplementary Fig. 25i). Importantly, the combination of 
uDISCO and deep-tissue antibody labeling did not require addi-
tional antigen retrieval steps. Overall, these results demonstrate 
that uDISCO is a versatile method that can be used to clear and 
image different types of tissues with various labeling methods.
discussion
uDISCO achieved whole-body clearing and imaging because of 
sample-size reduction and preservation of fluorescent proteins. 
Another major advantage of organic-solvent-based clearing meth-
ods is the easy handling of cleared tissues; specimens become 
hard because of dehydration, yet are flexible enough for versatile 
positioning of long samples, such as the entire spinal cord of adult 
rats. In contrast, concentrated glycerol and sugar solutions used 
in various clearing methods are difficult to work with because of 
their high viscosity, the resulting gel-like texture of the cleared 
tissue, and the air bubbles generated during the refractive-index 
matching procedures and imaging11.
Recently, tissue expansion was used to obtain super-resolution 
images of small volumes (expansion microscopy)36–38. Treweek 
et al.25,39 used a similar concept (expansion (e) PACT) for high-
resolution imaging. While expansion provides more resolution, 
tissue shrinkage, in theory, decreases resolution (30% in one 
dimension for uDISCO). However, uDISCO resulted in high-
quality images (Supplementary Fig. 26), allowing the visu-
alization of dendritic spines and individual axons over several 
centimeters in the intact CNS of adult mice. This high image 
quality could result from a larger proportion of shrunken samples 
(compared with nonshrinking samples) fitting into the optimal 
imaging region of the light sheet. Hence, shrinkage allows imag-
ing of 2× to 3× larger volumes in the same setup without apparent 
loss of resolution. Importantly, uDISCO did not alter the struc-
tural integrity of the brain either at macroscopic (e.g., cortex and 
hippocampus structures) or microscopic scales (e.g., individual 
cells). However, isotropic shrinkage remains to be confirmed for 
other tissues such as muscle or fat. In addition, uDISCO can be 
combined with microscopy techniques that deliver even higher 
resolution and/or faster scanning, such as confocal, two-photon, 
and lattice light-sheet microscopy40. We demonstrated that high 
numerical aperture (NA), long working distance objectives such 
as Zeiss CLARITY 20× and Olympus 25× are compatible with 
uDISCO (Supplementary Fig. 27).
Acute injuries in the CNS might affect not only the injury site 
but also uninjured distal parts of the CNS41,42. Thus, repair strate-
gies after CNS traumas need to be evaluated throughout the entire 
CNS. The uDISCO approach enables the assessment of long-range 
axonal projections and individual cells throughout entire organisms. 
Hence, this approach can help to reduce (1) the bias of analyzing only 
selected organs; (2) the time needed to prepare and screen individual 
organs and body parts of a complete mouse43; and (3) by generating 
whole mouse atlases and databases it can reduce the resources and 
number of animals needed in experimental research.
Whole-body clearing of diverse tissues, and the compatibility of 
this method with different imaging techniques, may have broad 
applications in the biomedical sciences. Whole-body clearing 
approaches could facilitate the assessment of neurodegeneration 
in diseases that affect both the central and peripheral nerves such 
as in amyotrophic lateral sclerosis (ALS), inflammation that may 
extend from gut to brain, stem cell transplantation studies, or even 
3D mapping of the cellular structures in larger brain volumes, 
possibly even the whole human brain.
methods
Methods and any associated references are available in the online 
version of the paper.
 Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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A step-by-step protocol for uDISCO is available as Supplementary 
Protocol (and ref. 44).
Animals. We used the following animals in the study: 1- to 
6-months-old, mixed gender 27 (15 male and 12 female) C57BL/
6N (Charles Rivers Laboratories), 57 (28 male and 29 female) 
Thy1–GFP mice (line GFP-M), 5 (2 male and 3 female) Thy1–YFP 
mice (line YFP-H)23, 32 (13 male and 19 female) CX3CR1–GFP 
mice (B6.129P-Cx3cr1tm1Litt/J, Jackson Laboratory strain code: 
005582), 6 (3 male and 3 female) β-actin EGFP mice (C57BL/ 
6-Tg(CAG–EGFP); 131Osb/LeySopJ, Jackson Laboratory strain 
code: 006567), and four rats (4 female) (CD IGS Rat strain 001). 
Sample sizes were chosen based on preliminary experiments. 
Sample sizes are specified in figure legends. The animals used 
in this study were selected for each experiment based on their 
genetic background (wild type or fluorescent transgenes), and 
animals that resulted fluorescent-protein negative by genotyp-
ing were excluded from the study. Within each strain, animals 
were randomly selected; different stages of experiments (clearing, 
imaging, and data analysis) were carried out by different opera-
tors. Animals were housed in our animal facility under a 12/12 h 
light/dark cycle and were provided food and water ad libitum. 
Experiments were conducted according to institutional guidelines 
of the Ludwig Maximilian University of Munich after approval of 
the Ethical Review Board of the Government of Upper Bavaria 
(Regierung von Oberbayern, Munich, Germany). All data are 
reported according to the ARRIVE criteria45.
Human tissue. Human tissues used for this study were obtained 
from five donors of 64–89 years old (1 male and 4 females). 
Human tissue donors gave their informed and written consent to 
the donation of their bodies for teaching and research purposes 
regulated by the Saxonian Death and Funeral Act of 1994 (third 
section, paragraph 18 item 8).
Perfusion and tissue preparation. Animals were deeply anes-
thetized by intraperitoneal injection with the triple combination 
of midazolam/medetomidine/fentanyl (MMF) (1 ml per 100 g of 
body mass for mice) before intracardial perfusion. Subsequently, 
animals were perfused transcardially (100–125 mm Hg pressure on 
Leica perfusion one system) with heparinized 0.1 M PBS (10 U/ml 
of heparin, Ratiopharm) for 5–10 min at room temperature until 
the blood was washed out and with 4% paraformaldehyde in 
0.1 M PBS (pH 7.4; Morphisto, 11762.01000) for 20 min using 
100–125 mm Hg pressure. The dissected tissue samples (whole 
brain, spinal cord, whole brain with the spinal cord, and femurs) 
were postfixed in 4% paraformaldehyde for 1–2 d at 4 °C. Then, 
tissues were washed once in PBS for 5 min; meninges were 
removed; and bent samples, such as spinal cords, were kept 
straight for the clearing procedure.
For cut bone clearing, femurs dissected from CX3CR1–GFP 
mice were fixed in cold 4% PFA for 24 h. Afterwards, the bones 
were washed with PBS and incubated in 30% sucrose PBS solution 
overnight at 4 °C. For longitudinal dissection, a Leica cryostat 
(Leica, CM3050S) was used to cut the bones embedded in opti-
mum cutting temperature (O.C.T.) formulation (SAKURA, 4583). 
The section thickness was set at 30 µm, and the serial section-
ing was performed until the entire bone marrow appeared. The 
remaining intact half bones were collected and washed with PBS 
to remove OCT and then processed for immunostaining and 
respective clearing46.
For whole-body clearing, after the mouse body was well perfused 
and fixed, the skin was separated from the body while avoiding 
adhesion of pelage. The skull and vertebra were carefully opened, 
avoiding any damage such as puncturing and squeezing of the 
tissue. Whole-body tissue clearing was started immediately.
Immunostaining. The following antibodies and dyes were used in 
this study: Iba1 (Wako, 019-19741, dilution 1:350), GFAP (Dako, 
Z033401-2, dilution 1:350), Collagen 4 (SouthernBiotech, 1340-01, 
dilution 1:650), AlexaFluor 647 conjugated anti-GFP rabbit 
polyclonal antibody (Life Technology, A31852, dilution 1:500), 
TO-PRO-3 iodide (642/661) (Life Technologies, T3605, dilu-
tion 1:500), AlexaFluor 568 goat anti-rabbit IgG (H+L) (Life 
Technologies, A-11036, dilution 8 µg/mL), AlexaFluor 647 goat anti-
rabbit IgG (H+L) (Life Technologies, A-21245, dilution 8 µg/mL), 
and Cy3 AffiniPure donkey anti-goat IgG (H+L) (Jackson, 705-
165-147, dilution 1:300).
For immunostaining, the tissues (mouse brains or human tissue) 
were cut into 1 mm slices using a vibratome (Leica, VT1200S). 
Mouse sections were immunostained using iDISCO20 or Belle 
et al.21 protocols. We used the following iDISCO protocol. The 
sections were initially pretreated: first, they were washed in 0.1 M 
PBS for 50 min two times, then they were incubated in 50% and 
80% methanol (in 0.1 M PBS) for 50 min at each step and then in 
100% methanol for 1 h two times. Sections were bleached with 
ice-cold 5% H2O2 (Sigma, D216763) and 20% DMSO (Sigma 
D8418)/methanol (AppliChem, 141091.1211) at 4 °C overnight. 
After bleaching, sections were washed in methanol for 45 min 
three times; then in 20% DMSO/methanol for 45 min two times; 
then in 80% and 50% methanol for 45 min each step; then in 0.1 M 
PBS for 45 min two times; and finally in PBS/0.2% Triton X-100 
(Sigma, T8787) for 45 min two times. For the immunostaining 
step, pretreated sections were incubated in PBS–0.2% Triton 
X-100–20% DMSO–0.3 M glycine (Sigma, G8898) at 37 °C overnight, 
then blocked in PBS–0.2% Triton X-100–10% DMSO–6% goat 
serum at 37 °C for 1 d, washed in PBS–0.2% Tween-20 (Sigma, 
P9416) with 10 mg/ml heparin (PTwH) overnight and then incu-
bated with primary antibody dilutions in PTwH–5% DMSO–3% 
goat serum at 37 °C with gentle shaking on an oscillator for 6–8 d, 
refreshing the primary antibodies once after 3–4 d. Sections were 
then washed for 1 h with PTwH four times and then incubated 
with secondary antibodies diluted in PTwH–3% goat serum at 
37 C° with gentle shaking on an oscillator for 3–4 d, refreshing 
once after 2 d. Sections were finally washed in PTwH 30 min five 
times and incubated with TO-PRO-3 iodide (642w/661) (dilution 
1:750) in PTwH for 5 h at room temperature with gentle oscil-
lation, washed again for 1 h four times with PTwH, and stored 
at 4 °C in 0.1 M PBS until clearing.
Human sections were immunostained using a modification of 
the protocol from Belle et al.21; briefly, 1 mm thick brain sections 
were incubated on a rocker (IKA, 2D digital) at room tempera-
ture in PBSGT solution, which consists of 0.1 M PBS with 0.2% 
porcine skin gelatin (Sigma, G2500), 0.5% Triton X-100, and 
0.05% sodium azide (Sigma, 71290) for 24 h. Next, PBSGT was 
exchanged with PBSGT + 1% goat serum containing the primary 
antibodies and left in incubation at 37 °C with gentle shaking on 
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an oscillator (IKA, MS 3 basic) for 8–9 d. The primary antibod-
ies were refreshed once after 4–5 d. Then, samples were washed 
for 30 min with PBSGT five times at room temperature and incu-
bated with secondary antibodies, diluted in PBSGT + 1% goat 
serum at 37 °C with gentle shaking on an oscillator for 4–5 d. 
The secondary antibody was refreshed once after 2 d. Finally, 
samples were washed for 30 min three times with PBSGT, incu-
bated with TO-PRO-3 in PBSGT for 5 h at room temperature with 
gentle oscillation, washed again for 1 h four times with PBSGT 
and stored at 4 °C in 0.1 M PBS until clearing.
For cut bone immunostaining, collected half bones were pre-
treated with 5 d of PBSGT incubation at room temperature. Then, 
the tissue was incubated in PBSGT with 1% goat serum and 
AlexaFluor 647 conjugated anti-GFP antibody (dilution 1:500) 
at 37 °C for 10 d, refreshing once after 5 d, and finally washed five 
times with PBSGT for 10 min.
Preparation of uDISCO solutions. Dehydrating solutions were 
prepared by mixing tert-butanol (Sigma, 360538) and distilled 
water in the following concentrations: 30 vol% tert-butanol, 
50 vol% tert-butanol, 70 vol% tert-butanol, 80 vol% tert-butanol, 
90 vol% tert-butanol, 96 vol% tert-butanol. Pure (100%) tert- 
butanol has a melting point between 23 °C and 26 °C; therefore. we 
recommend keeping it above the melting temperature before use. 
Delipidation solution dichloromethane (DCM) (Sigma, 270997) 
was used as a pure solution. Three refractive index matching solu-
tions were used: BABB-D4, prepared by mixing BABB (benzyl 
alcohol + benzyl benzoate 1:2, Sigma, 24122 and W213802) with 
diphenyl ether (DPE) (Alfa Aesar, A15791) at a ratio of 4:1 and 
adding 0.4% vol DL-alpha-tocopherol (Vitamin E) (Alfa Aesar, 
A17039); BABB-D10, prepared by mixing BABB with DPE at a 
ratio of 10:1 and adding 0.4% vol vitamin E; BABB-D15, prepared 
by mixing BABB with DPE at a ratio of 15:1 and adding 0.4% vol 
vitamin E. In passive clearing, BABB-D4 preserved the fluores-
cence signal better, while BABB-D15 gave better transparency. 
BABB-D10 was used for whole-body tissue clearing. The ratio of 
DPE to BABB can be adjusted to achieve either better preservation 
of fluorescence or more tissue transparency.
uDISCO passive clearing procedure. All incubation steps were 
performed in a fume hood with gentle rotation or shaking using 
5 ml tubes (Eppendorf, 0030 119.401) for whole mouse brain or 
smaller samples, or steps were performed using glass chambers 
(Omnilab, 5163279) for bigger samples such as rat tissues or whole 
brain and spinal cord. The samples were covered with aluminum 
foil to keep them in dark.
The clearing consisted of serial incubations of the fixed samples 
in 5–80 ml of 30 vol%, 50 vol%, 70 vol%, 80 vol%, 90 vol%, 96 vol% 
and 100% tert-butanol at 34–35 °C to dehydrate the tissue, fol-
lowed by immersion in DCM for 45–60 min at room temperature 
to remove the lipids. Eventually, they were incubated in BABB-
D at room temperature for at least 2 h until samples became 
transparent. The requirement of DCM step and the incubation 
time of each step in tert-butanol solutions depended on sample 
size. For instance, small tissues such as mouse spinal cord or 
1-mm-thick coronal slices did not need DCM step and required 
short incubation times (2–4 h) per each tert-butanol step com-
pared with thicker or mineralized tissues such as whole brain 
and intact bones (12 h). Details of each protocol are showed in 
Supplementary Table 1. Samples could be stored in BABB-D 
at room temperature in dark for weeks.
All other clearing methods, including PACT, CUBIC, 3DISCO, 
1-propanol BABB, ScaleS, SeeDB and Murray’s clear (Fig. 1; 
Supplementary Figs. 5,6, and 9–11), the clearing protocols were 
performed following the original publications1,2,6,9,10,14,24,25,47.
uDISCO whole-body clearing procedure. We established a 
transcardial circulatory system comprised of a peristaltic pump 
(Gilson, Peristaltic Pump MINIPULS 3; Supplementary Fig. 28; 
see also the step-by-step protocol of uDISCO in Supplementary 
Protocol). In principle, two channels from the pump were 
required for circulation. The first channel pumped the clearing 
solution through the mouse body, and the second channel col-
lected the solution exiting the mouse body and recirculated it 
back to the original bottle. Since clearing solutions are corrosive, 
Viton reference tubing was chosen (Gilson, F1817745) because 
it is resistant to clearing chemicals. First, the reference tubing 
was set up following the instructions, and each end of the tubing 
was connected to a tubing connector (Omnilab, 5434482). Next, 
the tubing connectors were linked with additional PVC tubing 
(Omnilab, 5437920). For the outflow tubing of the first channel, 
which injected the solution into the heart, the head part cut from 
a 1 ml syringe (Braun, 9166017V) was inserted as the connec-
tor of the perfusion needle and fixed with a mouse transcardiac 
perfusion needle (Leica, 39471024). Meanwhile, the inflow tubing 
of the second channel, which recirculated solution, was fixed to 
the glass chamber containing the mouse body. Eventually, the 
inflow tubing of the first channel was kept below the surface of 
the solution, and the circulation was started until air bubbles were 
pushed out from the tubing system.
All clearing steps should be performed in a fume hood. First, 
the mouse body was put in a glass chamber, and the perfusion 
needle was set into the heart through the same pinhole made 
during tissue preparation in the perfusion setup. Next, the 
chamber was covered with aluminum foil, and the transcardial 
circulation was started. Each gradient of dehydration solution was 
circulated at 8–10 ml/min for 10–12 h. As the melting point of 
tert-butanol is 23 to 26 °C (close to room temperature), a heating 
plate with 35–40 °C was used for the two rounds of 100% tert-
butanol circulation to prevent the solution from solidification. 
The final step of tissue clearing could normally be achieved by 
circulating BABB-D10 with the same injection rate for 6–12 h. 
The transparency of the mouse body was checked by eye during 
clearing. Bubbles were carefully prevented from forming, 
especially in the first channel, at every step. For rat whole-body 
clearing, a thicker perfusion needle (Leica, 39471022) without 
rubber head was used, and each step of circulation was prolonged 
to 24 h with a flowing rate of 15–20 ml/min. A passive incubation 
step of DCM for 6–8 h with gentle shaking was included before 
performing BABB-D10 circulation. Supplementary Table 1 sum-
marizes the incubation times and temperatures of each clearing 
solution for whole-body clearing.
As a final note, the amount of solutions for circulation depends 
on the capacity of the clearing chamber. For mice whole-body 
clearing, if the maximum volume of the glass chamber is 400 ml, 
300 ml of volume of solution was used for circulation. For rat 
whole-body clearing, a 1,000 ml capacity glass chamber with 
800 ml working clearing solution would be sufficient.
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PARS and CUBIC whole-body clearing methods (Fig. 1  
and Supplementary Fig. 11) were performed following the 
original papers10,25.
Vasculature labeling with Texas Red Dextran. Texas Red Dextran 
(70,000 MW, Lysine Fixable, Invitrogen) was diluted in saline with 
a concentration of 15 mg/ml for mouse (0.1 ml per animal) and 
8 mg/ml for rat (1 ml per animal). A pulled tubing (nonsterile 
polythene tubing, ID 0.86 mm, OD 1.27 mm, Harvard Apparatus) 
was attached to the syringe needle to achieve sharp ending thinner 
than femoral vein. For dextran injection, animals were anesthe-
tized (MMF triple combination, 8 ml/kg, i.p.) and placed ventral 
side up. The right femoral vein was identified and exposed by 
surgical dissection in the inguinal region. The sharp ending of the 
tubing was inserted into the venous sinus of femoral vein, and the 
dextran was injected at a rate of 0.3–0.4 ml/min. After injection, 
the tubing was retreated and the wound was sealed by surgical 
suture. Then, the animals were placed in a warm cage for 15–20 min 
before proceeding with the standard perfusion and tissue prepara-
tion procedure. We experienced that skipping heparin in the pre-
washing step of the perfusion (and using only 0.1 M PBS instead) 
resulted in better labeling of the vasculature.
Neuronal tracing by AAV virus. AAVs expressed EGFP (AAV2–
Syn–EGFP) and RFP (AAV2–Syn–RFP) under the promoter of 
human Synapsin (Vector Core, University of North Carolina). 
The final titers were around 2×109 GC (Genome Copy) per µl. 
For the virus injection, 3- to 4-month-old female C57BL/6N mice 
were anesthetized (MMF triple combination, 8 ml/kg, i.p.) and 
placed in a stereotaxic frame. To expose the motor cortex targeted 
for tracing axons into spinal cords, two cranial windows on each 
side of the skull were created within the area: 1.0 mm and 2.0 mm 
lateral; 0.5 mm anterior and 1.5 mm posterior to bregma. AAVs 
were injected into the cortex using a custom-established injector 
fixed with a pulled glass pipette. First, ten independent injection 
sites were targeted with the following coordinates: 1.2 mm and 
1.8 mm lateral; 1.0 mm deep; 0.3 mm anterior to bregma, 0.1 mm, 
0.5 mm, 0.9 mm, and 1.3 mm posterior to bregma. Next, 400 nl 
virus was injected at a rate of approximately 200 nl/min for 
every injection site. The glass pipette was kept in situ for 1 min 
before moving to the next site. After finishing all the injections, 
the cranial windows were covered by absorbable gelatin sponge 
(GELITA-SPON, GS-110), and the incision was closed by wound 
clips (CellPoint Scientific, part no. 203-1000). The animal was 
placed in a warm cage for waking up and then transferred into a 
regular keeping room. Carprofen (0.2 ml per injection, 1 mg/ml, 
i.p.) was given 3 times per d for 3 d. The animal survived for 
4 weeks post virus injection before performing uDISCO.
Culture and characterization of mouse BMSCs. Mouse BMSCs 
were collected and cultured from β-actin EGFP mice as described 
previously32,48. Briefly, femur and tibia from 8- to 12-week-old 
mice (4–5 mice per culture) were removed under sterile condi-
tions, and bone marrow was flushed out using a 20 gauge needle 
syringe. After mechanical dissociation with repeated flow of the 
bone marrow through needles of progressively smaller diameter, 
the cell suspension was filtered through a sterile 40 µm nylon 
cell strainer mesh. Cells were resuspended in a final density 
of 20 × 106 cells per ml of medium and were plated in T25 
flasks (5 ml per flask) at 37 °C with 5% CO2. Culture medium 
was composed of aMEM, 10% lot-selected mesenchymal- 
stem-cell-qualified fetal bovine serum (FBS), 1% L-glutamine, 
1% penicillin–streptomycin, and medium was stored at 4 °C for 
1–3 weeks until usage. The medium was changed on day 2 (half 
of medium) and day 7 (complete change), followed by a complete 
change of medium every 3–5 d. Cells were passaged for the first 
time when 70–80% confluent using 0.05% trypsin–EDTA, and 
they were split at a 1:3 ratio.
Characterization of mix BMSCs was done with flow cytometry 
(FACS) and differentiation assays on passage 3. For FACS analysis 
the following primary antibodies were used in two different 
staining panels: CD11b-eFluor450 (eBiosciences 48-0112, clone 
M1/70, dilution 1:400), CD45.2-PE (eBiosciences 12-0454, clone 
104, dilution 1:400), CD34-eFluor450 (eBiosciences 48-0341, 
clone RAM34, dilution 1:100), Sca1-APC (eBiosciences 17-5981, 
clone D7, dilution 1:200), CD29-PE (eBiosciences 12-0291, clone 
HMb1-1, dilution 1:200), and CD44-APC (eBiosciences 17-0441, 
clone IM7, dilution 1:200). Briefly, cells were harvested by trypsini-
zation with 0.05% trypsin, washed with ice-cold PBS, centrifuged 
at 1,500 r.p.m. for 8 min at 4 °C, resuspended at a concentration 
of 1–5 × 106 cells/ml, and stained with the primary antibodies for 
45 min at 4 °C in the dark. Following washing with ice-cold PBS 
three times, cells were immediately read at a flow cytometer (BD 
Biosciences, FACS Verse). Unstained cells and cells stained with 
the corresponding isotypic controls were used as negative controls 
for FSC, SSC, and autofluorescence adjustments.
Osteogenic and adipogenic differentiation capacity of BMSCs 
was tested on cells of passage 3 as previously detailed47. Bone min-
eralization and fat droplets after osteo- and adipo-differentiation 
were detected using alizarin red and oil red O staining assays, 
respectively, according to standard protocols. Chondrogenic dif-
ferentiation capacity of mBMSCs was studied using the StemPro 
chondrogenesis differentiation kit (Gibco A10071-01) accord-
ing to manufacturer instructions; proteoglycans produced 
by chondrocytes were stained with 1% alcian blue solution 
according to a standard protocol. Characterization of the trans-
planted EGFP+ mBMSCs is shown in Supplementary Fig. 19. 
Approximately 30% of the transplanted cells were EGFP+, and 
60% were loaded with quantum dots.
Labeling of cells with Qdots. The EGFP+ BMSCs were cultured 
for 30–45 d until reaching passage 4 or 5. 1 d before transplantation, 
EGFP+ BMSCs were labeled with fluorescent carboxyl quantum 
dot nanoparticles (Qtracker Qdots, Invitrogen, emission at 655 
nm or 800 nm). The nanoparticles were aseptically reconstituted 
according to manufacturer’s instructions (20 µl of component A 
and 20 µl of B), allowed to sit at room temperature for 5 min, 
vortexed for 30 s, mixed with full BMSC medium up to a volume 
of 400 µl, and then added to the flasks (200 µl per 1 T75 flask with 
confluent BMSCs). Labeling of the EGFP+ BMSCs with Qdots 655 
was checked 24 h later with microscopy and FACS analysis before 
transplantation. The efficiency of the labeling and the presence of 
any remaining free Qdots was also checked by sequential transfer-
ring of the Qdots-containing medium to a new flask with BMSCs, 
which did not produce any further cell labeling.
Transplantation procedures. Transplantation of the EGFP+ 
BMSCs, EGFP+/Qdot-labeled BMSCs, or vehicle (PBS) was 
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performed via tail vein intravenous (IV) or intraperitoneal (IP) 
injections. The injections were performed in C57BL/6N mice. All 
animals were food-starved overnight before the transplantation 
to clear the intestines for visualization.
For IV transplantation, animals were shortly anesthetized with 
2% isoflurane. To achieve maximum vein dilation for successful 
infusion, the tail was shortly dipped and gently massaged in warm 
water (35–38 °C, for 10 s) and was then immediately placed for 
5 min between a prewarmed (38 °C) heating pad and warm wet 
gauzes. The suspension of 1 × 106 BMSCs in 300 µl was injected 
IV at once using a 30-gauge needle attached to a 1 ml syringe. 
The injection caused a short heart arrest (approximately 10 s) in 
some animals that recovered either spontaneously or after short 
thoracic massaging. For IP transplantations, animals were briefly 
(30–60 s) anesthetized with isoflurane just before the injection 
and then received IP injection of 1 × 106 BMSCs in 300µl of PBS 
at once. Following successful injections, animals recovered from 
anesthesia in a heat chamber (set at 30–31 °C) for approximately 
30 min before returning to their home cage. The control animals 
were injected with PBS. 3 h after injection, we euthanized the 
animals for uDISCO.
Imaging setup, light-sheet microscopy. We used LaVision 
BioTec Ultramicroscope II light-sheet microscope (Supplementary 
Table 2). The axial resolution of the Ultramicroscope is 4 µm, and 
the lateral resolution is 0.5–2 µm, depending on the objective 
used (details are in Supplementary Table 2). We used exposure 
times of 250 ms to 50 ms, laser power of 1 to 3mW (25% to 70% 
of the power level at a given wavelength, mostly centered around 
470 nm, 545 nm, or 640 nm), distributed across a Gaussian light 
sheet of variable width and NA; according to the manufacturer 
specifications, the light sheet has a thickness of 4.5 µm at its waist 
at 488 nm. A typical width spanning between 0.5 mm and 0.3 mm 
was chosen to adjust the illumination extent to the field of view of 
the objective used. The excitation branch of the imaging setup was 
used as provided, without further calibration. The microscope 
features a zoom body (Olympus revolving zoom unit U-TV, 1×, 
2×, and 4×) equipped with an automated filter box for 25 mm 
mounted filters. An enhanced fluorescence acquisition branch 
consists of refractive-index-corrected long working distance 
objectives (Clear4brain, Munich): Olympus 2×/0.15 NA (WD 
10 mm), Olympus 4×/0.28 NA (WD 10 mm) and Olympus 
20×/0.45 NA (WD 5 mm). Making use of the entire scanning 
area, defined by the built-in scanner capabilities, we acquired tile 
scans to cover the entire specimens.
Imaging setup, laser-scanning confocal microscopy. Cleared 
specimens such as brain slices or whole organs were incubated in 
BABB-D solution for a minimum of 2 h. Samples were mounted 
on histological glasses using transparent silicone gel (OBI, 
4799656): a pool on glass was created with the glass as the bottom 
surface and silicone as walls, then samples were put into the pool 
filled with BABB-D. Eventually, glass coverslips were used 
to seal the pool, creating a closed chamber to prevent leakage 
of BABB-D.
Regions of brain slices were imaged with an inverted laser- 
scanning confocal microscopy system (Zeiss, LSM 880) using 
a 25× water-immersion long working distance objective lens 
(Leica, 0.95 NA, WD = 2.5 mm) mounted on a custom mounting 
thread. The z-step size was 3–5 µm, and whole stacks of the slices 
were acquired (Supplementary Table 2).
Imaging setup, fluorescence stereomicroscopy. Cleared and 
uncleared specimens such as brain slices, whole bodies, or organs 
were immersed either in BABB-D or in PBS, respectively, and 
imaged with Zeiss AxioZoom EMS3/SyCoP3 fluorescence ster-
eomicroscope using a 1× long working distance air objective lens 
(Plan Z 1×, 0.25 NA, WD = 56 mm; Supplementary Table 2).
Image processing. Processing and 3D rendering was executed 
by HP workstation with 8 core Xeon processor, 196 GB RAM, 
and Nvidia Quadro k5000 graphics card. We used Imaris, Amira, 
and Fiji (ImageJ2) for 3D and 2D image visualization. Stitching 
of tile scans was done via Fiji’s stitching plugin49. Stitched images 
were saved in tiff format to enable fast processing using different 
software. We removed acquisition errors using Fiji’s TrakEM2 
plugin and Imglib2 (ref. 50) library.
Image processing consists of three main steps: error correction, 
image quality enhancement, and quantification.
Error correction. (e.g., Fig. 3j) Errors in image acquisition and 
following steps may occur for various reasons, such as physical 
interference with the microscope during image acquisition or 
miscalibration of a dynamic plate of the microscope, resulting 
in unwanted shifting of tiles or drifting effects between different 
slices of the same image series.
Quality enhancement. (e.g., Fig. 5b) We used filtering tech-
niques (such as Gaussian, median, and anisotropic diffusion fil-
tering) in the spatial domain for noise reduction. Morphological 
filters were used to correct the artifacts based on their shapes. 
Owing to the big size of data sets, filtering in the frequency 
domain is not feasible. Image intensity manipulation and equali-
zation employed local (CLAHE in Fiji) and pseudo flat-field 
correction in Fiji (Supplementary Video 1).
Quantification. (e.g., Fig. 5c) To quantify the density of 
Qdot-positive BMSCs, we developed a simple workflow based 
on Fiji (Supplementary Figure 29).
Quantifications. Normalized fluorescence signal profile plots and 
total signal intensity.
Normalized signal profiles demonstrate the quality of the sig-
nal over the background, which defines the ability to trace the 
individual cellular structures in the scans (e.g., axon tracing in 
Supplementary Video 6). We calculated the total signal intensity 
to compare the remaining fluorescence signal after each clearing 
method. We presented details of these calculations with example 
images in Supplementary Figure 30.
For normalized signal profile measurement, a straight line 
was drawn across the specific area, which includes signal and 
background, and plotted via Fiji’s ‘plot profile’ option. To cal-
culate the mean background intensity, we chose another line 
adjacent to the profile line with no intersection to any specific 
signal. Subsequently, the profile plot was normalized by dividing 
the profile data over the calculated mean background intensity. 
Normalized profile of each sample was shown in the representa-
tive line chart (Supplementary Figs. 2,5,6 and 10).
For total signal intensity quantification, we selected a rectangu-
lar area covering the signal (several cellular structures), and mea-
sured the integrated density as the representative of the total signal 
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intensity of selected area. To calculate the mean background, a 
straight line was drawn across the area. Eventually, the total sum 
of the signal intensity in the sample area was determined as:
Sum of background intensity =  Number of background pixels 
+ Mean background value
Sum signal intensity =  Total sum of intensity of the area − Sum 
of background intensity
We calculated the average total signal intensity by dividing 
the sum of the signal intensity over the pixel number of the 
rectangular selection (Supplementary Figs. 2,5,6,9 and 10).
Signal-to-noise ratio (SNR). A small part of the image was 
selected, and pixels belonging to a specific signal were separated 
from the background by thresholding the input image, f, and 
applying the binary image as the mask to the same image. 
f n m S o p X i j( , ) ( , ) ( , )= +  
o i p j≠ ≠,
S is the image that contains only the specific signal, and X is the 
background image. SNR was calculated based on Jahr et al.51 
SNR Mean Std= ( )/ ( )S X
Peak signal-to-noise ratio (PSNR). PSNR was calculated as previ-
ously described52. In brief, we used a mean square error (MSE) cal-
culation between the sample image and a reference image. We took 
the average intensity of the background pixels as the reference image 
without the noise. Then, we calculated the MSE and PSNR as: 
MSE
N M
X i j Y i j
j
M
i
N
= −
=
−
=
−
∑∑1 2
0
1
0
1
*
[ ( , ) ( , )]
Y is the reference image with N × M dimension. 
PSNR
MAX
MSE
= 

20 10* log
MAX represents the maximum intensity of the input image f in 
the selected neighborhood.
RMSE calculation. The root mean square (RMS) of the morphol-
ogy deformation error at single-cell scale was used as a quantification 
factor for isotropy. RMSE calculation includes three steps: 1) 
Postclearing and preclearing images of a single cell were regis-
tered by similarity transformation in Fiji’s TrakEM2 plugin. To 
achieve perfect overlay, output images from step 1 were registered 
with nonrigid transformations using Fiji’s bUnwrapj plugin53. 2) 
The deformation parameter for preclearing image pixels was 
masked with a skeletonized preclearing image to remove irrel-
evant deformation parameters. 3) RMS of the deformation error 
with respect to the distance from the center of the cell or vessel 
(constant point) was calculated37.
Fluorescence level. Fluorescence level quantification was 
expressed as a signal-to-background ratio and was calculated 
using Fiji at the following timepoints after clearing: 0, 4, 7, 19, 
and 37 d (Fig. 1b). From each brain scan, a z-projection of three 
consecutive images in Tiff format was made at the same anatomic 
region for all the samples. The mean value of the background 
for each z-projection was obtained by averaging the background 
values of 15–20 regions from equally sized areas of the projection 
without signal. To calculate the mean value of the signal of each 
z-projection, we used the threshold function of the software; the 
threshold was adjusted to consider the fluorescence signal visible 
in the projection. After adjusting the threshold, only the sharp 
signal from specific cellular structures was analyzed per each 
z-projection. To this end, we used Fiji’s “analyze particles” to 
measure the signal intensity only of particles sized between 10 
and 150 pixels (visible fluorescent cells), and we calculated the 
mean value from all the particles. Next, this value was divided by 
the mean value of the background of the respective projection, 
obtaining the fluorescence level on the background.
Imaging depth quantification. To assess the imaging depth between 
different clearing methods (CUBIC, PARS, PACT, and uDISCO), 
the tile scans of three whole brains per clearing method were 
taken with a light-sheet microscope with 4 µm z step (in Fig. 1h,i, 
and Supplementary Fig. 11). 3D reconstructions at the same 
anatomic level (from the surface of the brain to the center of 
the brain, including the region of the hippocampus) of each 
sample were shown in the coronal view using Imaris. Next, the 
images of the 3D reconstructions were analyzed in Fiji. Using 
the scale bar provided by Imaris, the distance of imaging depth 
was measured from the surface (where the signal was sharp) 
to the inner part of the brain until the last identifiable signal 
over the background coming from cell body or cellular structure 
(e.g., axons or dendrites) was detected.
Statistical analysis. Data are presented as mean ± s.d. in Figures 
1b–d,h,i;3i;6h,n and in Supplementary Figures 4,7b,8c,11b,12e, 
13s,25i,26. Data are presented as mean ± s.e.m. in Figure 5c and 
in Supplementary Figures 2c,5h,6h,9g,10h. The data distribution 
in each experiment was checked for normality using Shapiro–Wilk 
test in IBM SPSS statistics software. P values were calculated using 
unpaired t-test to compare data between two groups (Supplementary 
Figs. 2c,4,8c,25i). One-way ANOVA was used to compare more 
than two groups of data (Fig. 1b–d,h,i; and Supplementary 
Figs. 5h,6h,9g,10h,11b,12e,13s); if ANOVA was significant, it 
was followed by post hoc Dunnett’s test for multiple comparisons 
(Figs. 1b–d,h,i and Supplementary Figs. 5h,6h,9g,10h,11b).
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 Supplementary Figure 1: Whole-body clearing and imaging of adult mice with 3DISCO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Whole-bodies of adult GFP-M mice (3 months old) were cleared with 3DISCO (same protocol as used in uDISCO). 
Before (a) and after (b) 3DISCO whole-body clearing images of a representative mouse body. 3DISCO whole-body 
clearing provided a comparable optical transparency to uDISCO (see Fig. 2b). (c-g) In contrast, preservation of 
endogenous GFP signal was weak after 3DISCO whole-body clearing. (c) Fluorescence stereomicroscope acquisition 
could not detect any identifiable neuronal structures unlike the uDISCO sample (see Fig. 2c). (d-g) Light-sheet 
microscopy of entire GFP-M mouse brain after 3DISCO whole-body clearing. While a weak GFP signal remained in 
some cell bodies, neuronal projections were completely undetectable due to diminished signal after 3DISCO whole-body 
clearing (see Fig. 4c-f). 
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 Supplementary Figure 2: Fluorescence signal quality comparison after whole body uDISCO and 3DISCO clearing  
 
Representative light-sheet microscopy images of GFP-M brains at 2.5 mm depth from the dorsal surface after whole-body 
uDISCO (a) or 3DISCO (b) clearing. (c) Signal intensity (calculations are explained in Methods and Supplementary Fig. 
30) comparison after whole-body uDISCO and 3DISCO clearing. Statistical significance (***P < 0.001) was assessed by 
unpaired t-test at each brain region. Values are mean ± s.e.m.; n=3 brains for each group (3 months old GFP-M mice). (d) 
Normalized signal profiles (calculations are explained in Methods and Supplementary Fig. 30) after whole body uDISCO 
and 3DISCO clearing at different depths (distance from brain surface) to compare the fluorescence signal: cortex (0.5 
mm), hippocampus (1.2 mm), corpus callosum (2.5 mm) and midbrain (4.0 mm); n=3 brains for each group plotted (each 
magenta or green line profile represents one brain). 
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Supplementary Figure 3: The details of chemicals used in 3DISCO and uDISCO  
 
Tetrahydrofuran (THF) used in dehydration step of 3DISCO has an ether functionality, which is prone to oxidation and 
further reactions. In contrast, tert-butanol used in uDISCO is a tertiary alcohol and more stable to oxidation and less 
reactive. 3DISCO utilizes dibenzyl ether (DBE) or BABB (benzyl alcohol and benzyl benzoate) in refractive index 
matching step. Both of these chemicals have reactive benzylic C-H and C-O bonds, hence, they can form peroxidase and 
quench the fluorescence signal. To reduce chemical interactions that could diminish the endogenous fluorescence signal in 
uDISCO, 1) we performed refractive index matching in the presence of diphenyl ether (DPE): DPE does not have reactive 
benzylic C-H and C-O bonds, therefore, it is less prone to radical and other oxidative reactions; 2) we used antioxidant 
vitamin E to scavenge further the peroxides that can destroy the fluorescent proteins. 
  
Nature Methods: doi:10.1038/nmeth.3964
 Supplementary Figure 4: Endogenous fluorescent signal stabilization in uDISCO  
 
 
We measured the fluorescence signal of the same uDISCO and 3DISCO samples presented in Fig. 1b, 3 months after the 
clearing. We observed some decrease in signal level within the first few weeks (most probably due to the further 
dehydration of tissues in final clearing solutions), which got stabilized after about a month. At all-time points the level of 
fluorescence after uDISCO was higher compared with the level of fluorescence after 3DISCO. Values are mean ± s.d.; 
n=3 and 4 mice for uDISCO and 3DISCO, respectively. Statistical significance (*P < 0.05, **P < 0.01, ***P < 0.001) 
was assessed by unpaired t-test. 
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 Supplementary Figure 5: Fluorescence signal quality comparison after uDISCO, 3DISCO, 1-proponal BABB, 
PACT, CUBIC, ScaleS and SeeDB clearing in Thy1-GFP-M mice 
Representative images of normalized signal profiles at 0.5 mm and 2.5 mm depth from the dorsal surface after uDISCO 
(a), PACT (b), CUBIC (c), 3DISCO (d), 1-proponal BABB (e), ScaleS (f) and SeeDB (g) clearing of GFP-M brains. 
Normalized signal profile for each sample demonstrates the dynamic range of the obtained signal, which is the primary 
parameter for the tracing of imaged structures (separation of specific signal from the background). (h) Quantification of 
total signal intensity on specific cellular structures (cell bodies) at different depths (0.5 mm and 2.5 mm) of the samples 
after respective clearing (see the Methods and Supplementary Fig. 30). uDISCO cleared brains resulted in greater signal 
intensity compared with other methods. Statistical significance (***P < 0.001) was assessed by one-way ANOVA 
followed by Dunnet’s post-hoc test. Values are mean ± s.e.m.; n=3 brains for each group (3 months old GFP-M mice). 
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 Supplementary Figure 6: Fluorescence signal quality comparison after uDISCO, 3DISCO, 1-proponal-BABB, 
PACT, CUBIC, ScaleS and SeeDB clearing in CX3CR1-GFP mice  
Representative images and normalized signal profiles at 0.5 mm and 2.5 mm depth from the dorsal surface after uDISCO 
(a), PACT (b), CUBIC (c), 3DISCO (d), 1-propanol BABB (e), ScaleS (f) and SeeDB (g) clearing of CX3CR1-GFP 
brains. In all cases, regions at the same depth and anatomical locations were quantified. Note that tissue shrinkage by 
uDISCO allowed visualization of larger volumes with the same imaging parameters, while tissue expansion e.g. by PACT 
allowed visualization of more details as cells appear larger. (h) Signal intensity quantifications at different depths of the 
samples after respective clearing. While uDISCO showed comparable results to PACT and CUBIC clearing, it has 
outperformed 3DISCO, 1-propanol BABB, ScaleS and SeeDB at deeper brain regions (2.5 mm depth). Statistical 
significance (*P < 0.05, **P < 0.01) was assessed by one-way ANOVA followed by Dunnett’s post-hoc test. Values are 
mean ± s.e.m.; n=6 brains for uDISCO group, n=3 brains for each other group (3 months old CX3CR1-GFP mice). See 
also Supplementary Video 1.   
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 Supplementary Figure 7: Clearing performance of uDISCO for dissected organs and shrinkage quantifications  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Individual organs before and after uDISCO clearing. They became optically transparent after uDISCO clearing. The 
redness after the clearing is due to the residual blood, which did not impede the imaging of fluorescent structures as 
shown in Fig. 5 and Supplementary Fig. 22. (b) Volume quantifications of individual organs, showing that brain, spinal 
cord, heart, lungs, kidneys, gut, liver and bones shrank in average 50.54%, 45.92%, 30.22%, 46.85%, 64.94%, 53.44%, 
51.76% and 8.08%, respectively. Values are mean ± s.d.; n=4 mice (5 months old) for each organ. 
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 Supplementary Figure 8: uDISCO clearing resulted in similar shrinkage of hard bone and bone marrow 
 
(a) Femurs from 6 months old CX3CR1-GFP mice were cut into half for visualization of hard bone (red arrowheads) and 
bone marrow regions (purple arrowheads). (b) Same bones are shown after uDISCO clearing. (c) Quantification of 
diameter change before and after uDISCO clearing: the shrinkage rate was slightly higher for bone marrow regions, even 
though it did not reach statistical significance (unpaired t-test, n.s. = P > 0.05). Values are mean ± s.d.; n=3 bones. (d) 
Illustration of how the quantification is performed: 1) the bone images before and after clearing were overlapped with 
each other, 2) 3 lines were drawn at different positions along the bone, and 3) the diameter change of the same hard bone 
(white line) and bone marrow (red line) regions were calculated at these three different axes using ImageJ. 
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 Supplementary Figure 9: Different clearing protocols on intact bones: assessment of endogenous GFP signal in 
CX3CR1-GFP mice 
The bones from CX3CR1-GFP transgenic mice were cleared by uDISCO, Murray’s clear and CUBIC methods. Maximum 
intensity projections at 0.4 mm and 0.66 mm depth from the bone surface for uDISCO (a,b), Murray’s clear (c,d), and 
CUBIC (e,f) protocols are shown. (g) Quantification of total signal intensity through the bones; statistical significance 
(***P < 0.001) was assessed by one-way ANOVA followed by Dunnett’s post-hoc test; values are mean ± s.e.m.; n=8 
ROI in uDISCO bones, n=5 ROI in Murray’s clear and CUBIC bones (5 months old CX3CR1-GFP mice).  
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 Supplementary Figure 10: Test of IHC with different bone clearing protocols  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3D reconstruction of CX3CR1-GFP mice bones after (a) uDISCO, (b) Murray’s clear and (c) CUBIC clearing. The bones 
were immunolabeled with AlexaFluor-647 conjugated anti-GFP rabbit polyclonal antibody before clearing. (d-f) 
Projections at 0.66 mm depth (~half-way through the cut bone) showing the signal quality after respective clearing. (g) 
Normalized signal profile plots of AlexaFluor-647 positive cells in uDISCO (magenta line), Murray’s clear (green line) 
and CUBIC (blue line) cleared cut bones. (h) Quantification of signal intensity of antibody labeling in the bones after 
respective clearing. Statistical significance (***P < 0.001) was assessed by one-way ANOVA followed by Dunnett’s 
post-hoc test. Values are mean ± s.e.m.; n=8 ROI in uDISCO and Murray’s clear cut bones; n=5 ROI in CUBIC cut bone 
(5 months old CX3CR1-GFP mice). 
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 Supplementary Figure 11: CUBIC PARS/PACT uDISCO size and imaging comparison 
 
(a) 3D reconstruction of brains after CUBIC, PARS and uDISCO whole-body clearing. Imaging depth quantifications on 
brains in (a) are shown in Fig. 1h. (b) Volume changes of brains of 4 months old GFP-M mice after CUBIC, PARS and 
uDISCO whole-body tissue clearing methods. The final brain volume after uDISCO was significantly lower than after 
CUBIC and PARS whole-body clearing. Statistical significance (***P < 0.001) was assessed by one-way ANOVA 
followed by Dunnett’s post-hoc test. Values are mean ± s.d.; n=4, 3, 3 GFP-M mice for CUBIC, PARS and uDISCO, 
respectively. (c) 3D reconstruction of brains after CUBIC, PACT and uDISCO passive tissue clearing of dissected brains. 
Imaging depth quantifications on brains in (c) are shown in Fig. 1i. With the same imaging settings at a single scan, more 
neurons can be imaged with uDISCO (owing to shrinkage) while more detailed structures of individual neurons can be 
resolved by PACT and CUBIC (owing to expansion) (see also Fig. 1g). 
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 Supplementary Figure 12: Comparison of gross tissue structures before and after uDISCO clearing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 mm coronal brains slices from GFP-M mice (5 months old) at different levels were imaged with a fluorescence 
stereomicroscope before (a) and after (b) uDISCO clearing. The borders of main structures before and after clearing are 
highlighted in orange and blue, respectively. (c) The overlay of borders by ratio-metric enlargement of shrunken tissue 
shows a substantial overlap. (d) To quantify the proportions of size change on same the slice, we assessed the width of 
different brain regions (indicated by numbered lines) before and after clearing. (e) The quantifications showed that 
different tissue regions shrank at a similar rate (~30%) in length after clearing (one-way ANOVA, n.s. = P > 0.05). Values 
are mean ± s.d.; n=4, 4, 3, 4, 4 for regions 1, 2, 3, 4, 5, respectively.  
  
Nature Methods: doi:10.1038/nmeth.3964
 Supplementary Figure 13: Microscale changes of different cells and tissues before and after uDISCO clearing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To assess the uniformity of shrinkage on different types of cells and tissues, we measured shrinkage of neurons, microglia 
and vessels with respect to each other. To this end, we immunolabeled 1 mm thick GFP-M brain slices (from 2 months old 
mice) with Iba1 (microglia) and Collagen4 (vessels) and acquired confocal images before and after uDISCO clearing. (a-
i) Single channel views from the same tissue location containing neurons (a-c), microglia (d-f) and vessels (g-i). Overlay 
channels show a substantial overlap of before and after images. (j-r) Double channel views from the same tissue location 
demonstrating neurons-microglia (j-l), neurons-vessels (m-o) and microglia-vessels (p-r) together. To simplify the 
interpretation of overlay channels, we used only two colors (red and cyan) and swapped the colors before and after 
clearing channels, resulting in white color for overlay of tissue components. (s) The distances between neurons-neurons, 
microglia-microglia, vessels-vessels, neurons-microglia, neurons-vessels and microglia-vessels were measured before and 
after uDISCO and normalized to the rate of gross shrinkage of the slice (n=7 per each tissue structure/cell type from at 
least 3 different slices). The quantification showed that the relative distances between the structures and cells were not 
significantly changed after clearing (one-way ANOVA, n.s. = P > 0.05). Values are mean ± s.d. 
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 Supplementary Figure 14: Comparison of single cells and vessels before and after uDISCO clearing 
Confocal images of 1 mm coronal brains slices from GFP-M mouse (2 months old) before and after uDISCO clearing, 
showing individual neurons (a), Iba1 stained microglia (b), and Collagen4 stained vessels (c). The overlay after ratio-
metric enlargement of shrunken cells and vessels shows a substantial overlap suggesting that individual cell morphology 
is preserved after uDISCO clearing. Note that more structures are visible after clearing (cyan in “after” and “overlay” 
images). (d) Quantifications of RMSE to evaluate the degree of morphological deformations for neurons (left), microglia 
(middle) and vessels (right). After defining a center of a cell or a structure as the constant point, displacements of cellular 
and vascular structures before and after clearing have been plotted with regular intervals from the center point. The degree 
and direction of regional deformations are shown with arrows in overlay images (n ≥ 6 cells from at least 3 different slices 
and n ≥ 3 vessel structures from at least 3 different slices). Values are mean ± s.e.m. 
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 Supplementary Figure 15: Details of light-sheet microscope and sample holders for whole mouse body imaging 
 
(a) LaVision Biotec light-sheet ultramicroscope featuring: (1) Andor Neo 5.5 sCMOS camera; (2) Olympus U-TVCAC 
revolving zoom unit enabling 1x, 2x, 4x additional magnification with a fourth slot for a shutter plate; (3) LaVision 
autofocusing unit for automatic focus correction at different wavelengths; (4) filter box with 8 slots for 25 mm mounted 
filters; (5) BABB corrected Olympus objective; (6) imaging chamber, where LaVision Biotec suspension trays for sample 
holders are placed; (7) fiber coupled laser outlet for supercontinuum laser (SuperK EXTREME EXW 9 - 450-1000); (8-9) 
beam profile generation units. (b) Half of the central part of the commercial sample holder suspension (LaVision Biotec) 
is cut to make space, which allows flexible positioning of the mouse body at the center of the imaging beam. Silver plated 
copper wires are used to secure the mouse (c) to the branches of the suspension by its fore- and hind-limb (green 
arrowheads). (d) View of cleared adult mouse body immersed in the imaging chamber. Note that there is a large space left 
from the sleek immersion objective (Olympus air immersion corrected for RI 1.56), which facilitates the repositioning of 
the mouse in the chamber. (e) Demonstration of laser light sheets crossing the cleared mouse body. After imaging a region 
(f), the mouse is repositioned (g) so that next body part is now in the center of imaging area (purple rectangles). 
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 Supplementary Figure 16: Details of customized sample holders for individual brain and other organs 
(a) To allow maximum flexibility, we used 0.33 mm thick fine needles (BD Micro-Fine Ultra, 325118) in combination 
with commercially available sample suspension (Lavision Biotec). The plastic cup is trimmed (b, arrow) to avoid contact 
with the bottom of the imaging chamber. The needle is inserted into the hole of sample holder and bent as shown (b, 
arrowheads). (c) An example of an uDISCO-cleared brain secured to the fine needle: the resinous consistency of uDISCO 
cleared brains allows a clean piercing that is not visible in the sample once imaged, owing to the multiple sheets coming 
from different angles and compensating for cast shadows. (d-f) Variation of customized sample holders for long 
specimens, such as entire CNS (brain and spinal cord together). To this end, in addition to the fine needle holding the 
brain, we used a cooper wire to stabilize the long spinal cord. The copper wire is prepared as follows: first, we inserted it 
into a Pasteur pipette tube (d, arrowheads) and into the hole of suspension. Finally, we looped the ends as shown (e, 
arrows). The brain is imaged first while the spinal cord lies in a loop of the wire to keep it at a suitable height. After 
imaging, the sample is swept along its axis (f, arrow), so that a different part of the unsectioned CNS can be imaged, until 
completion. (g-i) Customized sample holders for specimen clarified with water-based clearing methods. If the samples 
have jelly-like textures, they cannot be held in place with fine needles. Instead, we trimmed a plastic Pasteur pipette as 
shown (g, arrowhead) and glued the specimens on top (h,i, arrows). A mounted CUBIC brain is shown from the side (h) 
and bottom (i). 
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 Supplementary Figure 17: 10 mm depth z-scan across rodent body parts after uDISCO clearing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3D Volren surface reconstructions (red-orange) of 10 mm z-scans obtained by light-sheet microscopy. An ortho-slice 
(black-white) is shown in the corner-cut view (Amira software) to demonstrate the details throughout the scans. (a-c) 
Different body parts of the whole-body light-sheet microscopy scanned mouse in Fig. 2d: the pelvic area (a), hindlimb (b) 
and the head (c); voxel size: 1.625 x 1.625 x 6 µm. (d) A 10 mm z-scan through vasculature labeled (FITC-lectin) mouse 
brain; voxel size: 1.625 x 1.625 x 4 µm3. (e) 10 mm z-scan through the shoulder of a vasculature labeled (Texas Red) 
adult rat. Vessels and fine structure are well defined. 
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 Supplementary Figure 18: Rat organs after uDISCO clearing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Grid images of individual organs from rat after whole-body uDISCO clearing, showing that the heart, liver, kidney, lung 
and intestine were rendered optically transparent. The redness after the clearing in liver and kidney images is due to the 
residual blood. 
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 Supplementary Figure 19: BMSCs characterization 
 
Characterization of β-actin EGFP BMSCs loaded with Qdots. (a) Representative picture of BMSCs (passage 4-5) that 
were harvested for IV transplantation (arrowheads mark some of the BMSCs). The purple insert shows the EGFP+ cells 
(superimposed image of wide-field and GFP channels). (b-d) The osteogenic (b), chondrogenic (c) and adipogenic (d) 
potential of the BMSCs confirms their mesenchymal origin. (e) BMSCs loaded with Qdots, shown as red cytoplasmic 
aggregates (superimposed image of wide-field and Qdot channels). (f) FACS characterization of the EGFP+ and Qdot+ 
BMSCs before their harvest for transplantation. (g) BMSCs were sca1+, CD34-, CD45- and CD11b- while expressing 
medium levels of CD105 and CD90.2 as characterized by FACS; the population only contained a small fracture of 
CD11b+ and CD45+ monocytes, as expected. (h,i) Colocalization of GFP and Qdot signals in cleared lungs from animals 
injected with BMSCs, imaged by confocal microscopy. White and magenta rectangles show high-magnification single 
channel images (EGFP (green), Qdot (magenta)) of dashed marked regions in the same images. 
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 Supplementary Figure 20: Whole-body clearing and imaging of mouse after BMSCs transplantation 
 
BMSCs were collected and labeled with Qdots, then transplanted into 2 months old C57BL/6N mice through IV injection. 
The mice were transcardially perfused and cleared with uDISCO. The intact mouse bodies could readily be screened by 
fluorescent stereomicroscope (a-c). (d) Whole-body stereomicroscope imaging of intact host mouse body. The individual 
cells were identifiable throughout the body, e.g. in the lung (e), liver (f) and bone marrow (g). No BMSCs were detected 
in the brain as expected (h).   
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 Supplementary Figure 21: 3D reconstruction of internal organs from intact mouse transplanted with Qdot labeled 
BMSCs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Light-sheet microscopy images from intact mice, which were transplanted with Qdot loaded BMSCs. (a) Lungs, liver 
layers, right kidney and part of the intestine shown in 3D surface rendering view. (b-d) The projection images of regions 
marked in (a): lung (b), upper liver layer (c) and intestine (d). (e) 3D surface reconstruction of lungs from another mouse. 
(f) The projection image of region marked in (e). 
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 Supplementary Figure 22: Distribution of mouse BMSCs in kidney, spleen and intestine 
 
Images of kidney, spleen and intestine from host mice in control, IP and IV groups. We found a sparse distribution of 
Qdot positive BMSCs throughout the kidney, spleen and intestine in both IP and IV groups  
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 Supplementary Figure 23: AVV tracing of whole adult mouse CNS 
 
 
Individual channels of traced adult mouse CNS (a) shown in Fig. 6. AAV-syn-GFP signal in the entire CNS is shown in 
(b), AAV-syn-RFP signal in (c). 
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 Supplementary Figure 24: Microglia/macrophage IHC on mouse brain 
 
Iba1 and TO-PRO-3 labeling of coronal sections from the cortex of 4 months old mouse brain. (a-c) 3D reconstructions 
showing the homogeneous labeling of microglia and cell nuclei stained with Iba1 antibody (a) and TO-PRO-3 (b) and 
their merge (c). (d,e) Maximum intensity projections of the z-positions marked by purple boxes in (c); microglia are 
shown in red and TO-PRO-3 staining in cyan. 
  
Nature Methods: doi:10.1038/nmeth.3964
 Supplementary Figure 25: Microglia/macrophage IHC on short and long-term formalin-fixed human clinical tissue 
slices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iba1 and TO-PRO-3 labeling of short-term (1-month) (a-d) and long-term (14-months) stored (e-h) clinical cortical tissue 
samples of human brains. 3D reconstructions showing the homogeneous labeling of microglia (Iba1) (a,e) and cell nuclei 
(TO-PRO-3) (b,f) and their merge (c,g) throughout the 1 mm human tissue samples stored short-term (a-c) or long-term 
(e-g). (d,h) Maximum intensity projections of the z-position marked by the purple box in (c,g), respectively. Nuclei are 
shown in cyan, microglia and their processes are in red. All the images were taken by confocal microscopy with 3-4 µm z-
steps. (i) Fluorescence level quantification. Antibody (microglia) and dye (cell nuclei) labelings were complete and 
specific on both short-term and long-term stored human clinical tissue samples even though the fluorescence level was 
significantly lower in long-term stored tissues, mostly owing to the increased background in long-term storage. Note that 
the 1-month fixed sample was obtained from an individual without any obvious brain pathology reported vs. the 14-
months fixed sample from an individual who suffers from obesity. Values are mean ± s.d.; n=6, 4 slices for short-term 
fixed samples and long-term fixed samples, respectively. Statistical significance (**P < 0.01) was assessed by unpaired t-
test. 
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 Supplementary Figure 26: SNR and PSNR in uDISCO cleared samples 
 
 
Signal-to-noise ratio (SNR) (a) and peak signal-to-noise ratio (PSNR) (b) range at different depths for uDISCO clearing 
as assessed on 3 months old GFP-M mice. Lines represent mean ± s.d.; n=3 brains for each group. The exact formulas and 
more details are given in the Methods part.  
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 Supplementary Figure 27: Different objectives in BABB-D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The quality comparison of four commercially available objectives (as indicated in the respective images) in BABB-D (RI 
1.56) after uDISCO clearing of GFP-M brains. All images were generated using light-sheet microscopy at 1.5 mm depth 
from the cortex surface. It is worth mentioning that the water (a) and CLARITY (b) corrected objectives (therefore not 
corrected for BABB-D refractive index) generated comparable quality images to BABB corrected objectives (c,d). NA = 
numerical aperture, WD = working distance, RI = refractive index. 
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 Supplementary Figure 28: The transcardiac circulatory system for uDISCO whole body tissue clearing 
 
(a) Components of the circulation loop: 2x Viton reference tubing (Gilson, F1817745) (blue arrow), 4x tubing connectors 
(Omnilab, 5434482) (red arrow), 4x PVC tubing for extension (Omnilab, 5437920) (orange arrow), 1x transcardiac 
perfusion needle (Leica, 39471024) (green arrow), 1x needle connector cut from 1 ml syringe (Braun, 9166017V) (black 
arrow). The red box shows the connection of each Viton tubing ending indicated in (b). (b) A completed setup of the 
transcardiac circulatory system. Green dash highlights the first channel for pumping the clearing solution through whole 
mouse body. The yellow dash shows the second channel for collecting and recirculating the solution back to the original 
bottle. (c) Insert the cutting connector (black arrow) into the outflow tubing of the pumping channel (orange arrow) and 
fix it with a transcardiac perfusion needle (green arrow). After pushing the air bubble out of the tubing system, the animal 
is placed in the glass clearing chamber and the perfusion needle is inserted into the left ventricle of the heart. 
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 Supplementary Figure 29: Workflow for cell counting 
 
To count the number of bone marrow stem cells (BMSCs), we used publicly available ImageJ and its plugins as detailed 
below. Here we showed each step of the analysis on a sample image (a single optical section from a liver scan at 1.62 
x1.62 x 12 µm voxel size). 1) To improve the background, we used convoluted median background subtraction option in 
BioVoxxel plugin. This plugin works fast, and removes the background smoothly in our samples because of low artifacts. 
2) Median filtering was performed to remove artifacts coming from background subtraction. In this filtering, the radius is 
equal to the smallest object to be maintained (4 µm in our example). 3) Unsharpen mask was used when the signal-to-
background ratio was lower than 2. In this mask, R stands for the average radius of the cells (6 um in our example). 4) To 
remove all the artifacts smaller than the cells, we used Grayscale opening morphological filter option in MorpholibJ 
plugin. In this filter, R is the radius of the biggest object to be removed (3 µm in our example) and disk option was used as 
structuring elements. 5) To decrease complexity of the quantification, we converted processed images to binary images by 
thresholding. To perform automatic thresholding, we used Otsu Limited function in DeadEasy plugin, which can perform 
multi-level thresholding. In addition, watershed can be used to separate the connected cells in densely labeled samples 
(this step was not performed in the example above because of sparse distribution). 6) Finally, detected cells were overlaid 
with the original data to check accuracy of the cell detection.   
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 Supplementary Figure 30: Methods for normalized signal profile and intensity quantifications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Fiji (ImageJ2) software, a straight line was drawn across the specific signal spots and the plot profile of the signal was 
measured (a). Another straight line was drawn across the background area close to the specific signal spot to measure the 
mean value of the background (red box) (b). Next, the profile was divided by the selected background value and 
normalized profile of each sample was shown in the representative line chart (Supplementary Figs. 2, 5, 6, and 10). For 
signal intensity quantification, a rectangular selection covering the signal spot (a specific cellular structure) was made 
within the defined region and the integrated density of the signal was recorded (purple box) (c). A straight line was drawn 
across the background area close to the signal spot and the mean gray value of the background was measured (blue box) 
(d). (e) Formula for the signal intensity: 1) the total mean value of the background of the rectangular selection was 
subtracted from the integrated density of the signal to get the total signal density in the rectangular selection, and 2) the 
average intensity of the signal without background was calculated by dividing the total signal density with the pixel 
number of the rectangular selection (green box) (Supplementary Figs. 2, 5, 6, 9 and 10). 
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Supplementary Protocol 
Perfusion and tissue preparation 
Before intracardial perfusion, anesthetize the animals deeply with a combination of anesthetics, such as 
midazolam/medetomidine/fentanyl (MMF) (1ml/100g of body mass for mice).  
1. Transcardially perfuse the animals (e.g. using Leica perfusion one system at 100-125 mmHg pressure) 
first with heparinized (10U/ml of Heparin, ratiopharm GmbH, N68542.03) 0.1 M PBS for 5-10 minutes 
then with 4% paraformaldehyde (PFA, Morphisto, 11762.01000) in 0.1 M PBS for 20 minutes at room 
temperature.  
TIP: Skipping the Heparin when vasculature is labeled can increase the quality of labeling. For all 
perfusion steps, the needle should be placed and kept in the left ventricle of the heart and should not 
cross to the right side of the heart.  
2. For whole-body clearing, remove the skin and carefully open the skull and vertebra without damaging 
the CNS tissue. At this point, the whole body clearing can be performed immediately, or the mouse body 
can be stored in 0.1M PBS at 4 °C up to 4 weeks. For clearing dissected organ, collect the tissues directly 
and post-fix them in 4% PFA for 1-2 days at 4°C. Wash the samples once in 0.1M PBS for 5 min before 
clearing. 
 
Preparation of uDISCO solutions  
1. Prepare tert-butanol (Sigma, 360538) solutions with distilled water at 30 Vol%, 50 Vol%, 70 Vol%, 80 
Vol%, 90 Vol%, 96 Vol% and 100 Vol% for gradient dehydration.  
2. Use Dichloromethane (DCM) (Sigma, 270997) as a pure solution, for delipidation step.  
3. Prepare refractive index matching solutions by mixing BABB (benzyl alcohol + benzyl benzoate 1:2, 
Sigma, 24122 and Sigma, W213802, respectively) and diphenyl ether (DPE) (Alfa Aesar, A15791) at 
following ratio: BABB-D4, BABB:DPE at a ratio 4:1 (Vol/Vol); BABB-D10, BABB:DPE at a ratio 10:1 
(Vol/Vol); BABB-D15, BABB:DPE at a ratio 15:1 (Vol/Vol). Add 0.4% Vol vitamin E (Alfa Aesar, 
A17039) into BABB-D solutions to scavenge the peroxides. 
Tert-butanol is flammable, DCM is toxic and BABB-D components can cause skin irritation, therefore they 
should be handled carefully. Waste should be treated and discarded accordingly. 
 
uDISCO passive clearing procedure for dissected organs 
All incubation steps are performed in a fume hood with gentle rotation or shaking using 5 ml tubes (Eppendorf, 
0030 119.401) for whole mouse brain or smaller samples, or using 80 ml glass chambers (omnilab, 5163279) 
for bigger samples such as rat tissues or whole brain + spinal cord. The samples are covered with aluminum foil 
to keep them in dark.  
1. Incubate the fixed samples in 30 Vol%, 50 Vol%, 70 Vol%, 80 Vol%, 90 Vol%, 96 Vol% and 100% 
tert-butanol for 2-12 hours at 34-35°C (Supplementary Table 1).  
2. Incubate in DCM for 45-60 minutes at room temperature (small tissues such as mouse spinal cord or 1 
mm thick coronal slices can skip this step). 
3. Incubate in BABB-D for 2-6 hours until the samples become optically transparent. 
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TIP: The higher amount of DPE in BABB yields better signal preservation (e.g. BABB-D15), while the 
lower amount of DPE in BABB results in higher transparency (e.g. BABB-D4). We recommend to use 
BABB-D4 for small tissues e.g. spinal cord or tissue slices, and BABB-D15 for large tissues e.g. for rat 
brain clearing. For whole-body clearing with perfusion system, use BABB-D10.  
4. Samples can be stored in BABB-D at room temperature in the dark for several weeks. TIP: It is 
recommended to image sample as soon as possible to yield the best outcome.  
 
uDISCO whole-body clearing procedure with perfusion system 
Establish the transcardial-circulatory system as in Supplementary Fig. 28. Here, we used a peristaltic pump 
(Gilson, Peristaltic Pump MINIPULS 3) with one pumping channel (green dash line) and one recirculating 
channel (yellow dash line). All steps should be performed in a fume hood. 
1. Connect the Viton reference tubing to the peristaltic pump.  
TIP: As the clearing solutions can be corrosive to various tubing material, we recommend usage of 
Viton tubing (Gilson, F1817745).  
2. Insert the tubing connectors (Omnilab, 5434482) (red arrow) at each end of the Viton tubing (blue 
arrow). 
3. Connect the tubing connectors (red arrow) with additional PVC tubing (Omnilab, 5437920) for 
extension (orange arrow).  
TIP: Transparent PVC tubing, which is compatible with clearing solutions, helps for checking unwanted 
air bubbles in the tubing system. 
4. Cut the head part of the 1 ml syringe (Braun, 9166017V) as a connector (black arrow) and insert it into 
the outflow tubing of the pumping channel (orange arrow).  
5. Connect the transcardiac perfusion needle (Leica, 39471024) (green arrow) for mouse or the thinnest 
perfusion needle (Leica, 39471022) without rubber head for rat with this connector. Subsequently, fix 
the inflow tubing of the recirculating channel in the glass chamber containing animal body ready for 
clearing.  
TIP: Fix the tubing with tapes (any kind). Keep a certain height between the inflow tubing head and 
bottom of the glass chamber to ensure that the sample is covered by clearing solutions during clearing at 
all times. 
6. Keep the inflow tubing of the pumping channel beneath the surface of the clearing solution and start the 
circulation until air bubbles are pushed out from the tubing system. 
TIP: Avoid pumping air bubbles by keeping the tubing always immersed into solution while pumping.  
7. Set the perfusion needle into the heart of the animal through the same pinhole made during perfusion 
and circulate the clearing solutions one by one as indicated in Supplementary Table 1.  
TIP 1: When starting the circulation, it might be visible that some ripples occur beside the right atrial 
appendage because the PBS in the sample is pushed into 30 Vol% tert-butanol solutions. This would be 
a good signal that the pumping is working appropriately. If not, try to change the angle of the perfusion 
needle to reach the best position and fix it with tapes. Because of the shrinkage during dehydration, the 
needle should stay in the heart without slipping out. 
TIP 2: Stop the pump temporarily when changing the clearing solutions between steps. Collect the last 
solution back to the bottle by using a serological pipette and fill the glass chamber with the next solution 
quickly to minimize exposure to air. Because serological pipettes are not stable in BABB-D, use them 
only in the prior steps. Hold the inflow tubing ending of the pumping channel carefully to avoid any air 
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bubble and put it beneath the surface of next solution. If there are large air bubbles within the tubing, 
they can be eliminated by a brief run of the pump in the reverse direction.  
TIP 3: As the melting point of tert-butanol is between 23 and 26 °C (close to room temperature), use a 
heating plate at 35-40 °C for 100% tert-butanol circulation steps to prevent the solution from 
solidification. 
TIP 4: The amount of solutions for circulation depends on the capacity of the clearing chamber and the 
size of the animal that is being cleared. For example, for mice, a 400 ml capacity glass chamber with 
300 ml working clearing solution and for rats, a 1000 ml capacity glass chamber with 800 ml working 
clearing solution would be sufficient. 
TIP 5: For rat clearing, because PVC tubing is not resistant to DCM, the DCM step can be performed 
with gentle shaking to increase the efficiency. 
TIP 6: The flowing rate was set at 8-10 ml/min for mouse clearing and 15-20 ml/min for rat clearing. 
8. At the final step, circulate BABB-D10 until full transparency is achieved (about 6-12 hours for mouse 
and ~24 hours for rat). 
TIP: It is recommended to image sample as soon as possible to yield the best outcome. 
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 Supplementary Table 1: Notes for clearing steps 
 
Times for each experiment step can be shortened (e.g to half) or extended (e.g. to double) depending on tissue size to 
improve antibody penetration or clearing performance. To preserve the signal better in low fluorescence conditions, 
dehydration can be ceased at 90% or 96% and proceed to the BABB-D step. We found that active (perfusion mediated) 
whole-body clearing provided superior transparency compared to passive clearing of dissected organs e.g. the brain. 
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                                     Supplementary Table 2: Imaging specifications 
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4.2 Panoptic imaging of transparent mice reveals whole-body 
neuronal projections and skull-meninges connections 
The possibility to clear and analyze entire transparent rodent bodies would allow the study of physiological 
and pathological events with a holistic approach.  
Recent papers (including our uDISCO paper) have already introduced the clearing and imaging of whole 
organisms, yet, reliable detection and quantification of the fluorescence signal in such thick tissues have 
remained a challenge because of several reasons: (i) most of the applications of tissue clearing are based on 
the detection of endogenous fluorescent proteins whose signal is often strongly reduced by the clearing 
process, (ii) these proteins are generally less bright than synthetic fluorescent dyes (for examples the ones 
conjugated to secondary antibodies), (iii) they emit light in the visible spectrum, a range where muscles and 
tissues are characterized by an obstructive autofluorescence.  
To overcome the above mentioned limitations, in this article we developed a new method called vDISCO. 
vDISCO is the first method achieving whole-body immunolabeling and clearing, exploiting the small size of 
nanobodies- variable domain of heavy chain antibodies- (instead of using conventional antibodies) and 
boosting the signal of fluorescent proteins up to 2 orders of magnitude while maintaining it for years. In this 
way vDISCO allows light-sheet imaging of whole transparent bodies (panoptic imaging) through tissues, 
bones and skin, and the quantification of subcellular details. With vDISCO, we visualized and reconstructed 
the first map of neuronal projections embedded in muscles and bones of an adult mouse at subcellular 
resolution. Thanks to panoptic imaging, we were able to detect whole-body neuronal changes triggered by 
traumatic brain injury, to observe inflammatory events after stroke in the whole head and also to reveal short 
vascular connections –named short skull-meninges connections (SMCs)– between the skull marrow and brain 
meninges which represent a possible new route of immune cell invasion under pathological conditions such as 
stroke. 
Taken together, vDISCO opens a new way to study the biological phenomena in an unbiased and 
comprehensive manner. 
Contribution of R.C. to this work: equal contribution to the development of the method with C.P.; moreover, I performed: characterization of the 
method: preservation of the fluorescent signal,  fluorescent signal analysis, imaging penetration, deep tissue staining efficiency, comparison with other 
immunostaining methods (passive and active), pressure experiment; performing the experiments, analyzing the data and  interpretation of the results 
for the followings: whole-body neuronal map experiments, skin cleared Thy1-GFPM animal, TBI experiments, NeuroGPS-Tree experiments, whole-
body and whole-brain CX3CR1-GFP experiments,  ClearMap experiments, vimentin nanobody experiments, SCI preliminary experiments; writing the 
manuscript with equal contribution from C.P. (please see section 12 for further details) 
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Most diseases, even when arising in a specific site, eventually affect the entire organism. Histological techniques devel-oped in the last century have been the standard procedure 
for charting pathology, yet a more complete understanding of bio-
logical mechanisms requires an unbiased exploration of the whole 
organism, not just pre-defined tissues.
However, mammalian tissues are naturally opaque, hindering 
high-resolution imaging in any tissue deeper than a few hundred 
micrometers, a major reason why sectioning is needed for histo-
logical examination of target organs1. Recent innovations in tissue 
clearing technology now allow three-dimensional (3D) histologi-
cal examination of intact organs2–12. Tissue clearing is a chemical 
process aiming to match refractive indices throughout intact tis-
sues, thus rendering them transparent and allowing deep-tissue 
fluorescent microscope imaging. Most initial applications of tis-
sue clearing relied on the assessment of endogenous fluorescent 
proteins expressed in the mouse CNS. More recently, deep-tissue 
immunolabeling methods have enhanced the quality of imaging 
for whole rodent organs as well as human embryos thanks to the 
conjugation of bright fluorescent dyes with secondary antibod-
ies4,13,14. A few studies have even rendered entire adult mouse bodies 
transparent after removal of the skin3,15–18 and allowed head-to-toe 
light-sheet microscopy imaging of intact adult mice17,18. All whole-
body clearing and imaging methods to date rely on transgenic 
expression of fluorescent proteins such as enhanced green fluores-
cent protein (EGFP), enhanced yellow fluorescent protein (EYFP) 
and mCherry17,18. While these fluorescent proteins emit light in the 
visible spectrum, skeletal muscles and other bodily tissues possess 
obstructive autofluorescence in this range19. In addition, fluores-
cent proteins are often less bright compared with many synthetic 
fluorophores, and their signal intensity is further attenuated dur-
ing the clearing and imaging procedure. Together, these bottlenecks 
hinder reliable detection and quantification of subcellular details in 
centimeters-thick transparent mice and therefore require reliance 
on imaging of dissected organs for quantifications, compromising 
the benefits of whole-body transparency.
Here we developed a whole-body immunolabeling method, 
named vDISCO (nanobody(VHH)-boosted 3D imaging of solvent-
cleared organs), to boost the signal of fluorescent proteins using 
nanobodies, which consist of the variable domain of heavy chain 
antibodies (VHH)20. This technology can enhance fluorescent sig-
nals more than 100 times and thereby allows head-to-toe light sheet 
microscopy scanning of transparent mice (panoptic imaging) and 
quantification of subcellular details. We used this technology to 
construct the first neuronal projection map of an adult mouse and 
to reveal far-reaching changes in neuronal projections and inflam-
matory processes following acute CNS injuries. Panoptic imaging 
also revealed short vascular connections between the skull marrow 
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Analysis of entire transparent rodent bodies after clearing could provide holistic biological information in health and disease, 
but reliable imaging and quantification of fluorescent protein signals deep inside the tissues has remained a challenge. Here, we 
developed vDISCO, a pressure-driven, nanobody-based whole-body immunolabeling technology to enhance the signal of fluo-
rescent proteins by up to two orders of magnitude. This allowed us to image and quantify subcellular details through bones, skin 
and highly autofluorescent tissues of intact transparent mice. For the first time, we visualized whole-body neuronal projections 
in adult mice. We assessed CNS trauma effects in the whole body and found degeneration of peripheral nerve terminals in the 
torso. Furthermore, vDISCO revealed short vascular connections between skull marrow and brain meninges, which were filled 
with immune cells upon stroke. Thus, our new approach enables unbiased comprehensive studies of the interactions between 
the nervous system and the rest of the body.
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and meninges (both at the brain surface and sagittal sinus), which 
may serve as immune gateways following stroke.
Results
vDISCO principles and signal enhancement. Quantitative assess-
ments of intact transparent mouse bodies remained a major chal-
lenge impeding the study of neurological diseases at the whole-body 
scale. We reasoned that fluorescent proteins such as EGFP and red 
fluorescent protein (RFP) are relatively dim compared with bright 
fluorochromes (for example, Alexa and Atto dyes) after tissue clear-
ing, making them difficult to detect in centimeters-thick mouse 
bodies, especially through intact thick bones (for example, skull and 
vertebrae) and skin. Therefore, we set out to enhance the signal of 
fluorescent proteins via whole-body immunolabeling with brighter 
and more stable fluorescent dyes to provide a much higher contrast 
(signal-to-background ratio) in cleared mice. Furthermore, using 
fluorescent dyes in the far-red spectrum could help to overcome tis-
sue autofluorescence, thus allowing reliable detection of subcellular 
details in all tissues4,19 (Supplementary Fig. 1). We reasoned that 
nanobodies are particularly suited to achieve thorough immunola-
beling throughout entire adult mouse bodies because of their small 
molecular weight (12–15 kDa) compared with that of conventional 
antibodies (~150 kDa)3,20. Indeed, nanobodies were more efficient 
for labeling large tissues compared with conventional antibodies 
(Supplementary Figs. 2 and 3).
First, we tested the signal quality of nanobody labeling in dis-
sected mouse brains from Thy1-GFP-M mice, in which a subset of 
neurons express EGFP21. Following the nanoboosting, the tissues 
were cleared using organic solvents6,7. We found that nanoboosting 
enhanced the signal intensity by one to two orders of magnitude 
compared with direct imaging of fluorescent proteins (Fig. 1a–i). 
In the nanoboosted samples, fine details of neurons were evident 
even in the deep brain regions of Thy1-GFP-M mice (compare 
Fig. 1b,c with Fig. 1e,f). We also obtained a similar signal intensity 
increase in the cerebellum of Thy1-GFP-M brains (compare Fig. 1g 
with Fig. 1h), which is notoriously difficult to clear due to the 
high lipid content.
A major aim of tissue clearing approaches is to perform auto-
mated quantifications in large imaging datasets in an unbiased and 
timely way. Towards this goal, we used the NeuroGPS-Tree algo-
rithm, a robust, automated neuron-tracing tool that was recently 
developed for tracing neurons in scans of cortical regions obtained 
by high-resolution confocal microscopy22. We found that virtu-
ally all of the neuronal cell bodies and neurites were detected and 
linked to each other as complete neurons upon vDISCO nanoboost-
ing in light-sheet microscopy scans (Supplementary Figs. 4 and 5). 
In contrast, in unboosted samples or in standard immunoglobu-
lin G antibody-boosted samples, many fine extensions of neurons 
were not identified or not connected to somas and neuronal trees 
(Supplementary Fig. 4). Nanoboosting allowed imaging not only of 
neuronal details but also of smaller individual cells such as microg-
lia cells and immune cells (Fig. 1j–m and Supplementary Fig. 6). 
Compared with unboosted samples, we could resolve fine details 
of microglia cells in intact transparent brains of CX3CR1GFP/+ 
mice using light-sheet microscopy (Fig. 1j–m and Supplementary 
Video 1). Nanoboosting also enabled automated quantification of 
CX3CR1 GFP+ cells using the ClearMap algorithms23: we found 
approximately 2.3 million microglia cells in the adult mouse 
brain (Supplementary Fig. 7a). We also automatically quantified 
microglia in all brain regions annotated by the Allen Brain Atlas. 
Thereby we found, for example, ~150,000 microglia in the hippo-
campus and ~50,000 in the thalamus of adult mice (Supplementary 
Fig. 7b–k). Furthermore, we found no significant decrease in signal 
intensity over time of the same samples, suggesting that vDISCO 
nanoboosting stabilizes the fluorescent signal (Fig. 1n,o), allowing 
long-term preservation and re-imaging of the samples. Thus, owing 
to the enormous enhancement and stabilization of fluorescent sig-
nals using nanobodies, we could use available computational tools 
to automatically trace neurons and count cell numbers in images 
acquired by light-sheet microscopy.
vDISCO allows panoptic imaging of intact adult mouse bodies. 
To apply whole-body clearing technology at the systems level, it is 
critical to obtain information not only from dissected organs but 
also from intact transparent bodies. Towards this goal, we aimed 
at establishing an approach to achieve nanoboosting in the entire 
mouse body. We reasoned that vDISCO amplification of the fluo-
rescent signals would allow reliable quantification of cells through 
intact thick bones and highly autofluorescent muscles. To ensure 
homogeneous delivery of nanobodies into all body regions, we 
used high-pressure cardiac perfusion with two- to three-fold 
increased pressure compared with standard perfusion protocols 
(160–230 mmHg compared with 70–110 mmHg (ref. 24)). We also 
illustrated the effect of high-pressure delivery compared with 
standard pressure using methylene blue. This novel high-pressure 
delivery approach facilitated a consistent distribution of the dye 
into deep tissues (Supplementary Fig. 8). Assessing the tissue integ-
rity upon high-pressure delivery, we did not observe any structural 
changes (Supplementary Fig. 9). Furthermore, we used a permea-
bilization solution containing Triton X-100, methyl-β -cyclodextrin 
(to extract the cholesterol from membranes) and trans-1-acetyl-
4-hydroxy-l-proline (to loosen the collagen network)12. To further 
reduce the background signal caused by the residual blood and to 
decalcify the bones, we treated whole mouse bodies with aminoal-
cohols5,15 and EDTA25 before the whole-body immunolabeling step. 
Combination of these diverse improvements allowed us to achieve 
whole-body immunolabeling in adult mice with a high degree of 
transparency (Fig. 2a and Supplementary Fig. 10) and to obtain 
quantitative information on single cells in deep brain regions 
through the intact skull3,15–18,23 (Supplementary Figs. 11 and 12). 
Here, we used anti-XFP nanobodies conjugated with bright Atto 
dyes (called nanoboosters) to boost the fluorescent protein signal 
in transparent mice. Moreover, we used anti-vimentin nanobodies 
to label activated glia cells in the brain upon trauma, demonstrat-
ing that our approach also works with nanobodies targeting endog-
enously expressed proteins (Supplementary Fig. 13).
In addition to the specific boosted signal, we also visualized and 
segmented other major tissues in the transparent body: muscles by 
their autofluorescence within the blue–green spectrum, and bones 
and internal organs by propidium iodide (PI) labeling (Fig. 2b,c and 
Supplementary Fig. 14a–d). Usage of organic solvents, which induce 
isotropic tissue shrinkage17, allowed us to perform head-to-toe pan-
optic imaging of entire mice by light-sheet microscopy.
Being able to image subcellular details of neurons through intact 
bones and highly autofluorescent muscles in the whole mouse body 
using vDISCO panoptic imaging, we constructed the first whole-
body neuronal projection map of a Thy1-GFP-M transgenic mouse 
(Fig. 2d,e, Supplementary Fig. 14 and Supplementary Video 2). We 
noticed that in the peripheral nervous system, mainly axons inner-
vating muscles were labeled in this mouse line, which enabled us to 
investigate the neuromuscular junctions in greater detail. We also 
observed fluorescent labeling of the internal organs, such as kidneys 
of Thy1-YFP-H mice21 (Supplementary Fig. 15). Owing to the great 
increase in signal-to-background ratio by vDISCO, we could read-
ily visualize axonal projections from the spinal cord through intact 
vertebrae to their terminals into the muscles, even in very remote 
locations such as toes (Fig. 2f–i and Supplementary Videos 3 and 4). 
Panoptic imaging of individual neuronal projections through 
intact bones can now provide more details on neuroanatomy. For 
example, how axons coming from consecutive roots enter the spinal 
cord—that is, in an overlapping or non-overlapping manner—has 
been unclear26. Using our technology, we observed that in mice, the 
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Fig. 1 | Enhancement and permanent preservation of the fluorescence signal with vDISCo. a–f, Signal quality comparison between vDISCO-boosted 
(a) and unboosted (d) half-brain samples coming from the same 11-month-old Thy1-GFP-M mouse. To achieve the best comparison between the two 
procedures, we divided the mouse brains in two halves for light-sheet microscopy imaging (one hemisphere boosted and imaged in the far-red channel, 
the other hemisphere unboosted and imaged in the green channel for endogenous EGFP). The boosted hemisphere showed highly distinguishable cellular 
details (b,c) such as axonal projections not visible in the unboosted hemisphere (e,f), especially in the regions with dim GFP labeling in Thy1-GFP-M 
mice, such as mid-brain (b,e) and cerebellum (c,f) (representative images, repeated at least on 3 different samples). g,h, Comparison of signal quality in 
cerebellum from the boosted (g) and unboosted (h) samples (repeated with at least 3 mice per group). i, Plots of signal intensity profiles from boosted 
samples (left) versus unboosted samples (right) along the blue and orange lines in g and h, respectively; n =  3 brains for each group (2- to 6-month-old 
Thy1-GFP-M mice). j–m, Light-sheet microscopy images (× 4 and × 25 magnification) of the microglia from CX3CR1GFP/+ mice in boosted (j,k) versus 
unboosted samples (l,m) showing the fine details of microglia ramifications obtained with vDISCO boosting (similar results repeated with at least 3 mice 
per group). n, Representative light-sheet microscopy images of 1 of 3 CX3CR1GFP/+ mouse brains at 0, 2, 12 and 18 months after boosting, showing the 
preservation of the fluorescence signal over 18 months. o, Fluorescence level quantifications, in arbitrary units (a.u.), in CX3CR1GFP/+ brains after boosting 
at different time points postclearing (n =  3 mice, 2–6 months old).
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axonal bundles coming from different roots enter the spinal cord 
at non-overlapping territories (Supplementary Fig. 16). Thus, the 
vDISCO approach provides a holistic view of the intact mouse, 
which should lead to novel discoveries on how interconnected 
organ systems function in health and what happens during their 
perturbation in disease.
Clearing of the whole body without removal of the skin. The skin 
is the largest organ, forming ~15–20% of the body. Among many 
other components, it consists of nerve endings, glands, immune 
cells, blood and lymphatic vessels, signifying its diverse biological 
roles in addition to being a physical barrier against the external envi-
ronment27. However, clearing and imaging whole mice with skin has 
not been reported. Towards this goal, we adopted the vDISCO pro-
tocol to clear and image mice with skin. We observed that vDISCO 
could efficiently clear whole nude mice without removal of the skin 
(Fig. 3a,b). In addition, we cleared C57BL/6J (BL6) background mice 
after shaving the fur. In CX3CR1GFP/+ mice, we could readily image 
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Fig. 2 | vDISCo panoptic imaging uncovers neuronal projections in intact mice. a, An example of a transparent 6-week-old mouse generated by vDISCO 
(similar results were observed from at least 20 independent mice). b–e, Three-dimensional reconstruction of complete neuronal projections of a 6-week-
old Thy1-GFP-M mouse obtained by light-sheet microscopy imaging (similar labeling and imaging results were achieved at least in 5 different mice; whole-
body reconstruction was performed on 2 mice). vDISCO boosted GFP+ neuronal structures are shown in green, bones and internal organs are prominent 
with PI labeling in white, and the muscles visualized by autofluorescence background imaging are in red (b–d). The depth color-coding shows the neuronal 
projections at different z levels in the 2.5-cm-thick whole mouse body (e). f,g, High-resolution 3D reconstruction views of the left torso and forelimb from 
the same animal as in b–e. Details of innervation throughout muscles and bones are evident. h,i, Surface reconstruction of the paw (h) and its nerves (i) 
from the boxed region in f. See also Supplementary Videos 2–4.
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Fig. 3 | vDISCo panoptic imaging on mice with the intact skin. a,b, Adult NMRI nu/nu nude mouse, 3–4 months old (a), cleared with the vDISCO method 
(b): the insets show close-up views of the cleared lungs (magenta) and skin (cyan) in b (similar results were observed from 3 independent NMRI nu/nu 
mice). c–h, vDISCO on 6-week-old CX3CR1GFP/+ mouse with intact skin. c, Cleared body, with the inset (cyan) showing visible inguinal lymph nodes (black 
arrowhead) through the transparent skin. d, Light-sheet images of CX3CR1GFP/+ mouse boosted with anti-GFP 647-nanobooster (cyan) and labeled with PI 
(magenta), showing CX3CR1 GFP+ cells (cyan) densely located in the lymph node and sparsely located in and under the skin, such as around hair follicles 
(magenta). e–h, Confocal 1-mm z-scan of the skin and lymph node in d with visible CX3CR1 GFP+ cells (cyan) and nuclei (magenta). e, Three-dimensional 
rendering of the stack showing the skin and the lymph node beneath. f, Two-dimensional image at the level of the skin with individual CX3CR1 GFP+ cells 
in the tissue and in the hair follicles (yellow arrowheads). g, The fine details of the ramifications of the immune cells at the surface of the skin are visible 
(green arrowheads). h, Two-dimensional image of the lymph node with visible immune cells (yellow arrowheads) in the organ. See also Supplementary 
Video 5. i–k, vDISCO on 2-month-old Thy1-GFP-M mouse with intact skin. i, Cleared body, with the inset (magenta) showing a visible inguinal lymph node 
through the skin. j, Light-sheet images of Thy1-GFP-M mouse boosted with anti-GFP 647-nanobooster (green) and labeled with PI (magenta), showing 
Thy1-GFP-expressing immune cells (white arrowheads) and neuronal projections coming from the spinal cord and projecting to the rest of the body, 
including the skin (green); the insets show close-up details of a neuronal projection (green fibers and yellow arrowheads) projecting into the skin. k, High-
magnification confocal image of the region in j (yellow dashed rectangle) showing details of the immune cells (white arrowheads) and neuronal projections 
(green and yellow arrowheads) into the skin of the animal. All the results from c to k were similarly observed in 2 independent mice for each mouse line.
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immune cells through the intact skin owing to the increase of fluo-
rescent signal by vDISCO (Fig. 3c–h and Supplementary Video 5). 
In Thy1-GFP-M mice, we observed the axonal innervations in the 
skin in addition to Thy1 GFP+ immune cells28 located under the skin 
(Fig. 3i–k). These results demonstrate that vDISCO allows detailed 
imaging of intact mice with skin, which may be of great value for 
studying skin-related pathologies.
Degeneration of peripheral nerve terminals after brain injury. 
Traumatic brain injury (TBI) is a major cause of death and dis-
ability, and currently there is no disease-modifying treatment 
available to combat especially chronic sequelae. In addition to its 
acute consequences, TBI often leads to chronic focal and global 
neurological impairments, such as dementia, epilepsy, progres-
sive motor decline, peripheral neuropathy and dystonia29,30. These 
impairments could be due to degeneration of the corresponding 
brain regions and/or the dysfunction of nerves outside of the brain. 
However, so far, the impact of TBI on long-range neuronal pro-
jections outside of the brain has not been assessed. For example, 
while TBI-induced sensory-motor dysfunction has been observed 
in both animal models and human pathologies31–34, the underly-
ing mechanisms remain unknown, hampering the development of 
effective therapeutic approaches. Here, imaging the whole CNS, we 
found extensive neurodegeneration of the descending motor axons 
in the brainstem and spinal cord upon TBI over the right somato-
sensory and motor cortices (Supplementary Fig. 17). However, 
how TBI alters neuronal projections in the peripheral nervous 
system remains elusive. We used panoptic imaging to examine 
neuronal changes throughout the body more than a month after 
the brain injury (chronic stage) in comparison with control ani-
mals. As mainly axons innervating muscles are labelled in Thy1-
GFP-M mice, we primarily focused on these nerve terminals. Our 
quantifications conducted in intact cleared mouse bodies demon-
strated that the complexity of nerve terminals at the neuromuscu-
lar junctions was reduced after TBI, especially in the upper torso, 
compared with unlesioned control mice (Fig. 4a–d). We observed 
that nerve endings were reduced in complexity at the contralateral 
body regions, with fewer axonal ramifications left, implying partial 
degeneration of these axon terminals (Fig. 4e,f). Interestingly, we 
also observed changes at the ipsilateral axons, albeit to a smaller 
degree with respect to the contralateral body region (Fig. 4e). 
Overall, these data demonstrate that light-sheet microscopy imag-
ing of entire transparent mouse bodies by vDISCO holds great 
promise for discovering hitherto unknown biological and patho-
physiological processes.
Visualizing new routes for immune cell trafficking in the brain 
and spinal cord. The lymphatic system, which connects various 
lymphatic organs in the body, is crucial for immune responses. Until 
recently, the brain was considered to be devoid of any lymphatic 
vessels. In recent years, brain lymphatic vessels were re-discovered 
and are considered to play critical roles in brain pathologies35–38. 
As these lymphatic vessels are located between the brain and the 
skull39, their connections are largely destroyed when the brain is 
harvested for standard histology.
We utilized panoptic imaging to overcome this hurdle and 
imaged details of meningeal vessels in intact transparent mice. We 
used Prox1-EGFP reporter mice, in which lymphatic endothelial 
cells express EGFP40. We readily observed previously described 
brain lymphatic structures, particularly along the sagittal sinus, 
pterygopalatine artery and transverse sinus (Fig. 5a–e and 
Supplementary Fig. 18) in addition to many other body regions 
(Supplementary Fig. 19 and Supplementary Video 6). Next, we 
imaged multiple subtypes of immune cells within and outside the 
meningeal vessels using the CX3CR1GFP/+ × CCR2RFP/+ mice by mul-
tiplexing with two different nanoboosters (anti-GFP conjugated 
to Atto-647N and anti-RFP conjugated to Atto-594N). The 
CX3CR1 GFP+ microglia cells in the brain parenchyma (Fig. 5f,g) 
and CCR2 RFP+ peripheral immune cells in the meningeal vessels 
were clearly identifiable (Fig. 5g,h and Supplementary Video 7). 
As expected, we also observed CX3CR1 GFP+ immune cells in 
meningeal vessels, which likely represent meningeal monocytes 
and macrophages (Fig. 5h). It remains unclear how the immune 
cells within meningeal vessels contribute to the pathology of acute 
brain injuries, as they may be in an advantageous position to 
invade the brain. To start addressing this query, we used the mid-
dle cerebral artery occlusion (MCAO) model of stroke, which was 
performed in LysM-EGFP mice, a transgenic mouse line express-
ing EGFP in myeloid cells (mainly in neutrophils and monocytes) 
but not in microglial cells41. The mice with MCAO showed an inva-
sion of LysM GFP+ cells into the brain parenchyma, especially in 
the peri-infarct region, compared with sham-operated controls 
(Fig. 5i,j). Numbers of LysM GFP+ cells also increased in the men-
ingeal structures after MCAO (Fig. 5i), suggesting that the menin-
ges might play a role as entry and/or exit routes of the brain in 
addition to the disrupted blood–brain barrier and the choroid 
plexus42. Thus, vDISCO panoptic imaging of transparent mice is 
a powerful tool to study the anatomy and cellular repertoire of 
meningeal vessels in health and disease.
Next, we aimed at investigating vascular connections between 
the skull and the meninges in greater detail. Towards this goal, we 
injected a cerebrospinal fluid (CSF) tracer (fluorophore-conjugated 
ovalbumin) into the cisterna magna in VEGFR3-YFP mice, another 
commonly used reporter line for meningeal vessels. We observed 
that the CSF tracer was quickly transported into the VEGFR3+ 
meningeal vessels (Fig. 6a–d). Interestingly, we also observed that 
the tracer-labeled vessels extended into the skull (Fig. 6b,c). We fur-
ther investigated the details of these new connections using lectin, 
another vessel tracer binding to endothelial cells. We found that 
these vascular connections are mostly located between the skull 
marrow and the outer surface of the meninges (both at the brain 
and sagittal sinus interfaces; Fig. 6e,f, Supplementary Fig. 20 and 
Supplementary Videos 8 and 9). We measured that they have an 
average size of 46.9 ± 5.8 µ m in length and 19.2 ± 2.5 µ m in width at 
the brain interface and of 83.7 ± 0.3 µ m in length and 28.5 ± 1.8 µ m 
in width at the sagittal sinus interface (mean ± s.e.m., n = 3 mice; 
Supplementary Fig. 20); therefore, we named them as short skull–
meninges connections (SMCs). They also occasionally contain cells 
(Fig. 6e,f and Supplementary Fig. 20). To address whether the SMCs 
might play a role in neuropathological conditions, we studied the 
distribution of LysM GFP+ immune cells in these connections after 
MCAO. The mice with MCAO showed significantly more LysM 
GFP+ cells in the SMCs compared with sham-operated controls 
(Fig. 6g–i and Supplementary Video 10), suggesting that they might 
represent an entry route for myeloid cells from the skull marrow 
to the meningeal compartments after brain injury. Thus, vDISCO 
imaging revealed connections between skull and meninges, which 
might be important for immune cell trafficking, especially during 
brain pathologies.
Finally, we explored the immune cell trafficking after spinal cord 
injury using vDISCO panoptic imaging. To this end, we induced 
a spinal cord injury in CD68-EGFP transgenic mice expressing 
EGFP in monocytes and macrophages43. Upon spinal cord injury, 
we observed an influx of CD68 GFP+ cells at the lesion site as well as 
a rather widespread increase in CD68 GFP+ cells around the spinal 
cord (Supplementary Fig. 21 and Supplementary Video 11). Indeed, 
only 3.5% of these phagocytes were seen in the injured spinal cord, 
while ~96.5% of the CD68 GFP+ cells were located in the surround-
ing tissues of the spinal cord including adjacent muscles, spinal cord 
roots and meningeal vessels, similar to sham mice (Supplementary 
Fig. 22). Thus, vDISCO is a powerful tool to image and quantify the 
trafficking of immune cells to and within the injured CNS.
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Discussion
Panoptic imaging of transparent adult mouse bodies from head 
to toe holds the promise of providing an unbiased and highly 
resolved view of entire organ systems in health and disease. Here, 
we developed a new whole-body nanobody labeling method in 
conjunction with whole-body tissue clearing, enabling a reliable 
visualization and quantification of subcellular details through-
out centimeters-thick tissues of intact mouse bodies. This new 
panoptic imaging technology is straightforward in application 
and is suitable for systemic analysis of a vast range of biomedi-
cal inquires, as demonstrated here in visualization of the neuronal 
projections in whole mouse bodies, the description of vascular 
pathways between the skull and meninges, and the visualization of 
remote neuronal and immune consequences of acute CNS injury 
models. While we developed vDISCO for panoptic imaging of the 
whole mouse body, it is readily applicable for individual organs, 
using a simplified protocol to drastically increase and stabilize the 
signal contrast, as we show for mouse brains imaged more than 
a year after boosting and clearing (Supplementary Video 12 and 
Supplementary Table 1).
The panoptic imaging of nervous and immune systems in intact 
mouse bodies was achieved owing to the massive enhancement of 
the signal intensity by one to two orders of magnitude via whole-
body immunolabeling employing nanobodies conjugated to bright 
dyes in the far-red spectrum. Therefore, the strong autofluorescence 
of tissues in shorter-wavelength spectra, in which traditional fluo-
rescent proteins such as GFP are excited and imaged, is avoided. 
Here, we primarily used Atto dyes at 647 nm, and additional Atto 
594 nm for multiplexing two different cell types. In the future, usage 
of nanobodies conjugated to dyes that emit in the near-infrared 
range44 can further facilitate multiplexed detection of more than two 
targets. While the number of commercially available nanobodies is 
still limited, the nanoboosters used in this study can stain a broad 
selection of 21 different fluorescent proteins including EGFP, YFP, 
Venus, mCherry, and mRFP. Our method can also be used with 
nanobodies against endogenous proteins, as we demonstrated using 
anti-vimentin nanobodies labeling activated glia cells in the brain 
upon trauma45,46. Currently, nanobodies are developed mainly for 
in vivo applications due to their small size (for example, for crossing 
the blood–brain barrier)47; therefore, they are mostly selected for 
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Fig. 4 | TBI-induced peripheral nerve degeneration revealed by vDISCo panoptic imaging. a,b, Background-equalized light-sheet microscopy 
maximum intensity projections of the torso from TBI-induced (a) vs. unlesioned control (b) Thy1-GFP-M mice. c,d, High-magnification views of marked 
regions in a and b, showing the left thoracic peripheral nerve projections in the TBI (c) vs. control animal (d); the color-code indicates the z-depth of 
anatomical regions as given in the scale bars. The colored rectangles show the high-magnification images of the marked regions in c and d, respectively, 
demonstrating fewer intact peripheral nerve endings in TBI mice compared with controls (similar results were observed from 6 independent mice per 
group). e, Quantification of axonal projection complexity expressed as number of peripheral nerve endings over length of axonal ramifications in TBI versus 
control mice (3–5 months old) at the level of the contralateral side (left) and ipsilateral side (right) (mean ±  s.d.; for the contralateral side, n =  6 animals 
per group; for the ipsilateral side, n =  6 mice for the TBI group and 5 mice for the unlesioned group, respectively; statistical significance (**P =  0.003, 
*P =  0.03) was assessed by two-tailed t test). f, Representative illustration showing the peripheral nerve ending morphology in TBI versus control mice.
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in vivo epitopes but not for fixed tissues. We believe that our study 
will encourage the production of diverse nanobodies for deep-tissue 
immunolabeling.
Here, we used transgenic mice endogenously expressing fluo-
rescent proteins; however, the labeling can also be achieved by 
rabies virus retrograde tracing, systemic adeno-associated virus 
injections48 or transplantation of genetically engineered cells (such 
as stem cells or adoptive transfer of immune cells). Another key 
advantage of vDISCO panoptic imaging is that upon staining with 
Atto dyes through nanoboosting, the signal becomes permanent, 
permitting long-term imaging sessions and future re-analysis of the 
same sample if needed. This also enables high-resolution imaging 
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in red and nucleus labeling by PI in cyan. Immune cells in the meningeal vessels of the injured mice were observed (yellow arrowheads). All images were 
obtained by light-sheet microscopy.
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of desired body parts by confocal or two-photon microscopy. 
Indeed, the samples from this study are available to the scientific 
community upon request for further studies. We believe making 
vDISCO-treated samples accessible to other labs for further studies 
can save time and resources, reduce the number of mice used in 
experimental research and create more powerful datasets by allow-
ing direct correlation of various inquiries by multiple studies from 
the same animals.
A current limitation is the absence of light-sheet microscope sys-
tems that could image the entire body of a mouse in one session 
without any displacement and turning of the sample. Construction 
of such new light-sheet microscopes should further decrease the 
time needed for data acquisition and simplify data processing for 
3D reconstruction. In fact, as shown here, optics and light sources of 
current commercial light-sheet microscopes are sufficient to image 
intact mouse bodies at subcellular resolution, although the whole 
body has to be manually moved in the imaging chamber to achieve 
the scanning of different body regions. In addition, development 
of machine learning-based (artificial intelligence) algorithms to 
automatically identify and quantify cellular changes on the whole-
organism scale will be important to further scale up this technology 
in the future.
Using panoptic imaging, we constructed a neuronal projec-
tion map for the Thy1-GFP-M transgenic line, showing subcel-
lular details of long-range neuronal connections from the CNS to 
the distal extremities. Here, we visualized neuronal details in Thy1-
GFP-M mice, in which only a subset of CNS neurons and peripheral 
nervous system neurons innervating skeletal muscles are labeled. 
In the future, panoptic imaging of other transgenic lines labeling a 
greater and more diverse subset of neurons will allow the explora-
tion of other biological systems such as the autonomic innervation 
of internal organs.
In recent years, researchers have been providing more evidence 
on post-TBI changes that seem to form the basis of chronic com-
plications, such as epilepsy, neuropsychiatric disorders, dementia 
and progressive motor decline29. However, the effects of a localized 
brain lesion on the rest of the body have been poorly understood, 
mainly due to the technical challenges in studying long-range neu-
ronal projections. Because vDISCO fluorescent signal boosting 
allows both imaging and quantifications of light-sheet microscopy 
images of transparent mouse bodies, we identified TBI-induced 
changes at the peripheral axonal projections innervating the skel-
etal musculature of the torso. These data are in line with recent 
work by others and us demonstrating the functional deficits in fine 
motor movements in mice and the presence of sensory-motor dys-
functions in TBI patients29,30,33. Our data provide a possible cellular 
mechanism for these functional impairments, suggesting that they 
could arise due to degeneration of long-range axons throughout the 
spinal cord and peripheral nervous system. This discovery opens 
alternate avenues for the identification of therapeutic targets. For 
instance, recent literature showed that microtubule stabilization is a 
powerful way to block degeneration of axons in spinal cord injury49. 
In this regard, it would be important to assess whether microtu-
bule stabilization would also counteract axon degeneration outside 
of the brain and circumvent the development of chronic sensory-
motor dysfunctions. Here, we also demonstrated that meningeal 
vessels extending between the cranium and CNS tissue and their 
cellular content can readily be imaged by vDISCO panoptic imag-
ing in naïve animals and acute CNS injury models. Importantly, we 
observed short vascular connections between the skull and menin-
ges both at the brain interface (recently seen also by others50) and 
at the sagittal sinus, which were filled with immune cells follow-
ing ischemic stroke injury. Most of the SMCs seem to be open both 
at the skull marrow and meningeal ends without being connected 
to the vascular system of the brain/head (Supplementary Video 9). 
In the future, it will be important to identify to which meningeal 
compartment or compartments (subdura, subarachnoid or sub-
pial) the SMCs are connected. In addition, due to the present lack 
of appropriate reporter mice, it was not possible to distinguish the 
type of SMCs (blood or lymphatic vessels) with increased LysM+ 
cells after stroke. In the future, vDISCO imaging of immune cells 
in a lymphatic vessel reporter mouse line with different fluorescent 
proteins (for example, LysM-EGFP + Prox1-RFP double reporter) 
could reveal more details of this new route for immune cell infil-
tration. As neuroinflammation is a major determinant of neuronal 
function and survival following CNS injuries of various etiolo-
gies, our technology should accelerate investigation of these novel 
immune cell infiltration routes in various CNS pathologies.
In conclusion, vDISCO enhancement and stabilization of fluo-
rescent proteins combined with signal acquisition in far-red spec-
tra should facilitate discovery of previously inaccessible biological 
information. For example, imaging and quantification of neuronal 
projections, vascular organizations and immune cell populations in 
the entire mouse body should contribute to a more comprehensive 
understanding of the initiation, progression and extent of neuro-
logical conditions.
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Methods
Animals. We used the following mixed-gender animals in the study: CX3CR1GFP/+ 
(B6.129P-Cx3cr1tm1Litt/J; Jackson Laboratory strain code 005582)51, Thy1-GFP-M 
and Thy1-YFP-H21, Prox1-EGFP (Tg(Prox1-EGFP)KY221Gsat/Mmucd; Mutant 
Mouse Resource and Research Centers strain code 031006-UCD), VEGFR3-YFP, 
CX3CR1GFP/+ × CCR2RFP/+ (B6.129(Cg)-Ccr2tm2.1Ifc/J; Jackson Laboratory strain 
code 017586), LysM-EGFP (Lyz2tm1.1Graf, Mouse Genome Informatics strain code 
2654931), CD68-EGFP (C57BL/6-Tg(CD68-EGFP)1Drg/j; Jackson Laboratory 
strain code 026827), C57BL/6J, and NMRI nu/nu mice. The animals were housed 
under a 12/12 h light/dark cycle. The animal experiments were conducted 
according to institutional guidelines (Klinikum der Universität München/Ludwig 
Maximilian University of Munich), after approval of the ethical review board of 
the government of Upper Bavaria (Regierung von Oberbayern, Munich, Germany) 
and the Animal Experiments Council under the Danish Ministry of Environment 
and Food (2015-15-0201-00535), and in accordance with the European directive 
2010/63/EU for animal research. Ages of the animals are indicated in the figure 
legends. All data are reported according to the Animal Research: Reporting of In 
Vivo Experiments (ARRIVE) criteria. Sample sizes were chosen on the basis of 
prior experience with similar models and are specified in figure legends. Within 
each strain, animals were randomly selected. Animals that resulted negative for the 
expression of fluorescent proteins by genotyping were excluded from the study. No 
statistical methods were used to pre-determine sample sizes, but our sample sizes 
are similar to those reported in previous publications17.
TBI. TBI was performed using a controlled cortical impact device (Leica 
Benchmark Stereotaxic Impactor, 39463923). At 30 min before surgery, 
we administered carprofen (4 mg per kg body weight) and buprenorphin 
(0.05 mg per kg) to the animals via subcutaneous injection. Then, anesthesia was 
induced in animals with 4% isoflurane in a N2O/O2 (70%/30%) mixture and 
afterwards maintained with 1.5% isoflurane in the same mixture for the whole 
surgery. As soon as the animals did not show any pedal reflex, they were placed in 
the associated stereotaxic apparatus, and their body temperature was kept at 37 °C 
using a heating pad for the whole surgery procedure. Next, the scalp of the animals 
was shaved, aseptically prepared by wiping with Octenisept (Schülke, 22580-A) 
as disinfectant and the skin of the scalp was incised longitudinally between the 
occiput and forehead. We identified the target area of the injury, which was the 
right somatosensory cortex extending to the motor cortex, using the stereotaxic 
frame (bregma coordinates: 2 mm posterior, 5 mm right lateral). The injury 
was then triggered via controlled cortical impact machine using the following 
parameters: impact speed, 6.9 m s−1; impact duration, 400 ms; impact depth, 2 mm. 
With these parameters, the resulting injury was severe, with cracks in the skull, 
bleeding and exposed brain tissue. After the impact, the skin was sutured with 
metallic wound closure clips (VWR, 203-1000), and the animals were kept at 31 °C 
in a recovery chamber (Mediheat, 34-0516) for at least 30 min until they recovered 
from the anesthesia. In the following days, animals were subcutaneously injected 
with carprofen (4 mg per kg) once per day for 4 d and sacrificed at > 1 month post-
injury by transcardial perfusion according to the ‘Perfusion and tissue preparation’ 
section below.
MCAO model. Experimental stroke was induced using the intraluminal filament 
model of MCAO (fMCAO) for transient, focal brain ischemia. Mice were 
anesthetized with isoflurane delivered in a mixture of 30% O2 and 70% N2O. 
A heat-blunted nylon suture (6/0) was inserted into the external carotid artery 
and advanced until it obstructed the middle cerebral artery together with the 
ligation of the common carotid artery for 30 min. Regional cerebral blood flow 
(bregma coordinates: 2 mm posterior, 5 mm lateral) was continuously recorded by 
transcranial laser Doppler flowmetry from the induction of ischemia until 10 min 
after reperfusion. Following fMCAO, mice were placed in temperature-controlled 
recovery cages for 2 h to prevent post-surgery hypothermia. For the survival period 
(3 d), the mice were kept in their home cage with facilitated access to water and 
food. Sham-operated mice received the same surgical procedure without insertion 
of the filament. Body temperature was maintained throughout surgery using 
a feedback-controlled heating pad and kept constant (37.0 ± 0.5 °C). Exclusion 
criteria were as follows: insufficient MCAO (a reduction in blood flow to 15% of 
the baseline value) and blood flow recovery > 80% within 10 min of reperfusion. 
Mice were sacrificed at 3 d post-injury by transcardial perfusion according to the 
‘Perfusion and tissue preparation’ section below.
Cisterna magna injection for meningeal vessel labeling. For the cisterna 
magna injections, mice (VEGFR3-YFP; 6 months old) were anesthetized with a 
mixture of ketamine and xylazine (100 mg per kg and 10 mg per kg, respectively) 
via intraperitoneal injection. After toe pinch reflexes ceased, mice were fixed in 
a stereotaxic frame by the zygomatic arch, with the head slightly tilted to form 
an angle of 120° in relation to the body. The head and neck regions were shaved 
to expose the neck muscles, which were bluntly dissected to expose the cisterna 
magna. Cannulas composed of a dental needle (SOPIRA Carpule 30 G 0.3 × 12 mm; 
Kulzer, AA001) and polyethylene tubing (0.024 in OD (outside diameter) × 0.011 
in ID (interior diameter); Scandidact, PE10-CL-500) were used to perform the 
cisterna magna injections. A cannula filled with CSF tracer (2% ovalbumin 45 kDa 
conjugated to Alexa Fluor 647 (Thermo Fisher Scientific, O34784), diluted in 
artificial CSF (126 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 2 mM Mg2SO4, 
2 mM CaCl2, 10 mM glucose, 26 mM NaHCO3; pH 7.4 when gassed with 95% O2 
and 5% CO2)) was inserted into the cisterna magna. With the aid of an injection 
pump (LEGATO 130 Syringe pump; KD Scientific, 788130), 10 µ l of CSF tracer was 
injected into the cisterna magna at a rate of 1 µ l min−1. At the end of the injection, 
CSF tracer was allowed to circulate in the subarachnoid and paravascular spaces 
for 1 h. Mice were then transcardially perfused according to the ‘Perfusion and 
tissue preparation’ section below.
Spinal cord injury model. Mice were deeply anesthetized by intraperitoneal 
injection of a combination of midazolam (5 mg per kg), medetomidine 
(0.5 mg per kg) and fentanyl (0.05 mg per kg). The mid-thoracic spinal cord of 
anesthetized CD68-EGFP mice was surgically exposed by a dorsal laminectomy 
as previously described52. A hemisection of the spinal cord was performed using 
fine-tip surgical scissors (Fine Science Tools 15000-08 spring scissor, 2.5 mm 
cutting edge). For sham surgery, the dorsal laminae of mid-thoracic vertebrae were 
surgically exposed in anesthetized CD68-EGFP mice. After spinal cord injury or 
sham surgery, muscle tissue and skin were sutured with a surgical thread (Ethilon 
suture 6-0, 667 H) and animals were allowed to recover on a heating pad. After 
48 h, mice were transcardially perfused according to the ‘Perfusion and tissue 
preparation’ section below.
Perfusion and tissue preparation. Mice were deeply anesthetized using a 
combination of midazolam, medetomidine and fentanyl (MMF; 1 ml per 100 g body 
mass for mice; intraperitoneal). As soon as the animals did not show any pedal 
reflex, they were intracardially perfused with heparinized 0.1 M PBS (10 U ml−1 of 
heparin, Ratiopharm; ~110 mmHg pressure using a Leica Perfusion One system) 
for 5–10 min at room temperature until the blood was washed out, followed by 
4% paraformaldehyde (PFA) in 0.1 M PBS (pH 7.4; Morphisto, 11762.01000) for 
10–20 min. Next, optionally, skin and eyes as well as premaxilla and maxilla bones 
were carefully removed, the palate of the animal was opened (without damaging 
the tissue beneath), and the feces were gently washed out from the intestine with 
0.1 M PBS through small cuts using a syringe. For the animals cleared with skin, 
the skin was not removed from the bodies, and in case of BL6 background animals, 
the fur was shaved off using a razor blade (Personna, 604305-001001). Then, the 
bodies were post-fixed in 4% PFA for 1 d at 4 °C and later washed with 0.1 M PBS 
for 10 min 3 times at room temperature. Either the whole-body nanoboosting 
procedure was started immediately or whole mouse bodies were stored in PBS at 
4 °C for up to 4 weeks or in PBS containing 0.05% sodium azide (Sigma-Aldrich, 
71290) for up to 6 months.
For the collection of dissected tissues such as brains, mice were perfused 
with PBS and PFA as described above. Subsequently, the organs of interest were 
dissected out and post-fixed in 4% PFA overnight at 4 °C, washed with 0.1 M PBS 
for 10 min 3 times at room temperature and kept in PBS plus 0.05% sodium azide 
for up to 3 weeks.
Clearing of unboosted samples. For the quantification of fluorescence signal 
after clearing, without boosting, we followed the uDISCO passive clearing 
protocol as described by Pan et al.17. In brief, dissected brains were placed in 5 ml 
tubes (Eppendorf, 0030 119.401) and covered with 4.5 ml of clearing solution. 
All incubation steps were performed in a fume hood with gentle shaking or 
rotation, with the samples covered with aluminum foil to keep them in dark. 
To clear the samples, we incubated them in a gradient of tert-butanol (Sigma-
Aldrich, 360538): 30 vol%, 50 vol%, 70 vol%, 80 vol%, 90 vol%, 96 vol% (in distilled 
water), and 100 vol% twice at 35 °C for 12 h each step followed by immersion in 
dichloromethane (Sigma-Aldrich, 270997) for 45–60 min at room temperature 
and finally incubation with the refractive index matching solution BABB-D15, 
containing 15 parts BABB (benzyl alcohol + benzyl benzoate 1:2; Sigma-Aldrich, 
24122 and W213802), 1 part diphenyl ether (Alfa Aesar, A15791) and 0.4 
vol% vitamin E (dl-α -tocopherol; Alfa Aesar, A17039), for at least 6 h at room 
temperature until transparency was achieved.
Nanobodies, antibodies and fluorescent dyes used in this study. The nanobodies, 
antibodies and fluorescent dyes used in this study are as follows: Atto594-
conjugated anti-RFP nanobooster (Chromotek, rba594-100), Atto647N-conjugated 
anti-GFP nanobooster (Chromotek, gba647n-100), Atto488-conjugated anti-
GFP nanobooster (Chromotek, gba488-100), Atto488-conjugated anti-vimentin 
nanobooster (Vimentin-Label_Atto488; Chromotek, vba488-100), Alexa647-
conjugated anti-GFP antibody (Invitrogen, A31852), and PI (Sigma-Aldrich, 
P4864). For the nanobody and antibody validation information, see the Life 
Sciences Reporting Summary.
Validation of nanoboosters for vDISCO. Post-fixed brains from fluorescent protein-
expressing mice (for example, Thy1-GFP-M) were cut into 400 µ m slices using a 
vibratome (Leica, VT1200S). The slices were imaged before staining with a Zeiss 
AxioZoom EMS3/SyCoP3 fluorescence stereomicroscope to make sure that the 
samples have fluorescent protein expression. All the following steps were done with 
gentle shaking. The slices were first incubated for 3 h in a 24 multiwell (Falcon, 
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353504) at 37 °C with 1 ml of permeabilization solution containing 1.5% goat 
serum (Gibco, 16210072), 0.5% Triton X-100 (AppliChem, A4975,1000), 0.5 mM  
of methyl-β -cyclodextrin (Sigma-Aldrich, 332615), 0.2% trans-1-acetyl-4-hydroxy-
l-proline (Sigma-Aldrich, 441562) and 0.05% sodium azide (Sigma-Aldrich, 
71290) in 0.1 M PBS. Subsequently, they were incubated overnight at 37 °C with  
the same permeabilization solution, and the nanobooster of interest was  
added with dilution 1:500 considering final volume = 500 µ l. The multiwell was 
covered with aluminium foil to keep the slices in dark and was sealed well with 
parafilm (Bemis, PM-992) to prevent the solution from drying out. One slice was 
kept as negative control where there was no adding of nanobooster. After the 
incubation, slices were washed with the washing solution (1.5% goat serum, 0.5% 
Triton X-100, 0.05% sodium azide in 0.1 M PBS) at room temperature for 15 min 
4 times and then washed with 0.1 M PBS at room temperature for 10 min 3 times. 
Then the slices were imaged again after staining with the AxioZoom microscope 
to check whether the staining worked. In the end, slices were moved to 5 ml 
Eppendorf tubes wrapped with aluminium foil to keep them in dark and cleared 
with 3DISCO protocol: first they were incubated at room temperature in the 
following gradient of tetrahydrofuran (THF; Sigma-Aldrich, 186562) in distilled 
water (45 min for each step): 50 vol% THF, 70 vol% THF, 80 vol% THF, 100 vol% 
THF and 1 h 100 vol% THF; after dehydration, samples were incubated for 15 min 
in dichloromethane, and finally in BABB until transparency. Finally, the slices 
were imaged again with the AxioZoom microscope to make sure that the staining 
worked even after clearing. For more details of the AxioZoom imaging setup, see 
the ‘Fluorescence stereomicroscopy imaging’ section below.
vDISCO whole-body immunostaining, PI labeling and clearing. In order to 
remove remaining blood and heme after PFA perfusion, and to decalcify the 
bones, the animals were subjected to perfusion with decolorization solution and 
decalcification solution before immunostaining. The decolorization solution was 
made with 25–30 vol% dilution of CUBIC reagent 15 in 0.1 M PBS. CUBIC  
reagent 1 was prepared with 25 wt% urea (Carl Roth, 3941.3), 25 wt% N,N,N′ , 
N′-tetrakis (2-hydroxypropyl)ethylenediamine (Sigma-Aldrich, 122262) and 
15 wt% Triton X-100 in 0.1 M PBS. The decalcification solution consisted of  
10 wt/vol% EDTA (Carl Roth, 1702922685) in 0.1 M PBS, adjusting the pH to  
8–9 with sodium hydroxide (Sigma-Aldrich, 71687).
The solutions for the immunolabeling pipeline were pumped inside the body 
of the animal by transcardial-circulatory perfusion, exploiting the same entry point 
hole into the heart created during the PBS and PFA perfusion step (see above) and 
following the procedure described by Pan et al.17. In brief, the mouse body was 
placed in a 300 ml glass chamber (Omnilab, 5163279) filled with 250–300 ml of 
appropriate solution, which covered the body completely. Next, the transcardial-
circulatory system was established involving a peristaltic pump (ISMATEC, 
REGLO Digital MS-4/8 ISM 834; reference tubing, SC0266), keeping the pressure 
at 160–230 mmHg (45–60 r.p.m.). One channel from the pump, made by a single 
reference tube, was set for circulation of the solution through the heart into the 
vasculature: one ending of the tube was connected to the tip of a syringe (cut 
from a 1 ml syringe; Braun, 9166017V) which held the perfusion needle (Leica, 
39471024), and the other ending was immersed in the solution chamber where 
the animal was placed. The perfusion needle pumped the appropriate solution 
into the mouse body, and the other ending collected the solution exiting the 
mouse body to recirculate the solution, pumping it back into the animal. To fix the 
needle tip in place and to ensure extensive perfusion, we put a drop of superglue 
(Pattex, PSK1C) at the level of the hole where the needle was inserted inside the 
heart. Using the setting explained above, after post-fixation and PBS washing, 
the mice were first perfused with 0.1 M PBS overnight at room temperature; 
then, the animals were perfused with 250 ml of decolorization solution for 2 d at 
room temperature, exchanging with fresh decolorization solution every 6–12 h 
until the solution turned from yellowish to clear and the spleen became lighter in 
color (indicating that the blood heme was extracted). Then, they were perfused 
with 0.1 M PBS, washing for 3 h 3 times, followed by perfusion with 250 ml of 
decalcification solution for 2 d at room temperature and again perfusion/washing 
with 0.1 M PBS for 3 h 3 times. After this, the animals were perfused with 250 ml 
of permeabilization solution containing 1.5% goat serum, 0.5% Triton X-100, 
0.5 mM of methyl-β -cyclodextrin, 0.2% trans-1-acetyl-4-hydroxy-l-proline and 
0.05% sodium azide in 0.1 M PBS for half a day at room temperature. Subsequently, 
the perfusion proceeded further, through connection of a 0.20 µ m syringe filter 
(Sartorius, 16532) to the ending of the tube not holding the needle to efficiently 
prevent accumulation of dye aggregates into the sample. At the same time, from 
this step we used an infrared lamp (Beuer, IL21) directed to the chamber to heat 
up the solution to 26–28 °C. With this setting, the animals were perfused for 6 d 
with 250 ml of the same permeabilization solution containing 35 µ l of nanobooster, 
which is 20–35 µ g in 250 ml (0.08–0.14 µ g ml−1), 1:7,000 in dilution (stock 
concentration 0.5–1 mg ml−1; the amount of nanobody was adjusted depending on 
the expected presence of fluorescent protein in the mouse body) and 290 µ l of PI 
(stock concentration 1 mg ml−1). Next, we removed the animals from the chamber, 
and with fine scissors we removed a tiny piece from the back of the skull (above the 
cerebellum) at the level of the occipital bone; we then placed the bodies in a 50 ml 
tube (Falcon, 352070) filled with the same permeabilization solution containing 
an extra 5 µ l of nanobooster and incubated the tubes at 37 °C with gentle shaking 
for an additional 2–3 d of labeling. After that, the mice were placed back in the 
perfusion system, and labeling solution was washed out by perfusing with washing 
solution (1.5% goat serum, 0.5% Triton X-100, 0.05% of sodium azide in 0.1 M 
PBS) for 3 h 3 times at room temperature and 0.1 M PBS for 3 h 3 times at room 
temperature.
After the staining, the animals were cleared using a 3DISCO-based passive 
whole-body clearing protocol optimized for big samples. The mice were incubated 
at room temperature in dehydration and clearing solutions inside a 300 ml glass 
chamber, kept with gentle rotation on top of a shaking rocker (IKA, 2D digital) 
inside a fume hood. For dehydration, mice bodies were incubated in 200 ml of 
the following gradient of THF in distilled water (12 h for each step): 50 vol% THF, 
70 vol% THF, 80 vol% THF, 100 vol% THF and again 100 vol% THF, followed 
by 3 h in dichloromethane and finally in BABB. During all incubation steps, the 
glass chamber was sealed with parafilm and covered with aluminum foil. See 
Supplementary Table 1 and http://www.discotechnologies.org/vDISCO/.
vDISCO whole-mount immunolabeling of individual organs. vDISCO was 
performed on dissected organs as well: dissected brains were stained using the 
immunolabeling protocol for dissected organs. First, the post-fixed brains were 
pretreated, incubating them for 2 d at 37 °C with gentle shaking in 4.5 ml of 
same solution used at the permeabilization step (see above). Subsequently, the 
brains were incubated in 4.5 ml of this same permeabilization solution plus the 
nanobooster of interest with the concentration adjusted to expression of the 
target (for example, Atto647N-conjugated anti-GFP nanobooster dilution 1:600, 
which is ~5–8 µ g of nanobooster in 4.5 ml (1.1–1.8 µ g ml−1; stock concentration, 
0.5–1 mg ml−1) for Thy1-GFP-M brains) for 12–14 d at 37 °C with gentle shaking, 
then brains were washed for 2 h 3 times and once overnight with the washing 
solution (1.5% goat serum, 0.5% Triton X-100, 0.05% of sodium azide in 0.1 M 
PBS) at room temperature and in the end washed for 2 h 4 times with 0.1 M PBS at 
room temperature. The immunostained brains were cleared with 3DISCO clearing: 
first they were put in the Eppendorf 5 ml tubes, and then they were incubated at 
room temperature with gentle shaking in 4.5 ml of the following gradient of THF 
in distilled water (2 h for each step): 50 vol% THF, 70 vol% THF, 80 vol% THF, 
100 vol% THF and overnight ;vol% THF; after dehydration, the samples were 
incubated for 1 h in dichloromethane and finally in BABB until transparency. 
During all the clearing steps, the tubes were wrapped with aluminum foil to keep 
them in dark. See Supplementary Table 1.
For the comparison of deep-tissue staining efficiency in terms of penetration 
of the staining of nanobody versus conventional antibody (Supplementary Fig. 2), 
we followed the same protocol described above in this section for both nanobody 
and antibody experimental groups. The only exception was that for the antibody 
group, in the immunostaining step, we replaced the nanobooster with Alexa647-
conjugated anti-GFP antibody (Invitrogen, A31852) with the same concentration 
(see above).
Pumping pressure measurement. A KKmoon Digital Manometer Pressure 
Gauge Manometer (HT-1891) was used to measure the pressure. To achieve 
one additional measuring channel to connect with the manometer, a two-head 
connector (B.Braun Discofix C Dreiwegehahn, 16494C) was inserted into the 
pumping channel, and the second head was further connected to the manometer 
with extended PVC tubing. The pumping channel was set in the standard way as 
described including a transcardiac perfusion needle. First, the switch on the two-
head connector was set without connecting the measuring tubing, and pumping 
was started until all the air bubbles were excluded from the pumping channel. 
Subsequently, the switch was set to connect the measuring tubing while pumping 
was continued, and the pressure was measured when the manometer readouts 
stabilized. Three measurements were made at different time points including 
morning, afternoon and evening to exclude the variation of room temperature, and 
the data were quantified by averaging.
Comparison of high-pressure versus low-pressure perfusion with methylene 
blue. The diffusion of methylene blue (Sigma-Aldrich, M9140), perfused into the 
body of the animals, was used to compare the efficiency of high-pressure versus 
low-pressure perfusion (Supplementary Fig. 8). For this purpose, we used 3 BL6 
animals (4 months old) per experimental group: post-fixed whole bodies were 
perfused for 15 min with 0.05% methylene blue in 0.1 M PBS, at either 50 r.p.m. 
(~180 mmHg) for the high-pressure group or 25 r.p.m. (~70 mmHg) for the low-
pressure group. The same pump setting explained in the section ‘vDISCO whole-
body immunostaining, PI labeling and clearing’ was used, including the usage of 
superglue to fix the needle in place inside the hole in the heart.
iDISCO+. Antibody validation: methanol compatibility test. Before performing the 
comparison of the efficiency between vDISCO nanobody staining and iDISCO+ 
antibody staining on whole brains, we verified the compatibility of the chosen 
antibody with the iDISCO+ protocol (Supplementary Fig. 3a–d). This was done 
performing the antibody validation step, which tested the compatibility of the 
antibody with the methanol pretreatment required by iDISCO+ . To do so, we 
followed the original iDISCO+ publication23 and the latest protocol updates from 
https://idisco.info. Briefly, post-fixed brains from Thy1-GFP-M and CX3CR1GFP/+ 
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mice (2–3 months old) were cut into 600 µ m slices with a vibratome. First, the slices 
were incubated overnight in 100% methanol (Roth, 4627.6) at room temperature; 
then, after rehydrating and washing with 0.1 M PBS, the iDISCO+ immunostaining 
protocol was done as normally using 3 h as permeabilization time, 6 h as blocking 
time and overnight as immunolabeling time, adding 1:850 of Alexa647-conjugated 
anti-GFP antibody (already used in the previous section) in 500 µ l of incubation 
solution. Non-methanol-treated slices were used as positive controls. In the 
end, the slices were imaged using the Zeiss AxioZoom stereomicroscope (see 
‘Fluorescence stereomicroscopy imaging’ section below).
iDISCO+ on dissected brains. After having verified that the previously mentioned 
conventional anti-GFP antibody is compatible with iDISCO+ , we performed 
comparison of staining efficiency between vDISCO with nanobody and iDISCO+ 
with conventional antibody (Supplementary Fig. 3e–i). For this purpose, 3 
CX3CR1GFP/+ post-fixed brains (6–7 months old) were used per experimental 
group. The brains allocated into the vDISCO group were processed following  
the vDISCO protocol for dissected brains (see ‘vDISCO whole-mount 
immunolabeling of individual organs’ section), while the brains allocated into the 
iDISCO+ group were processed using 1:730 of the above-mentioned Alexa647-
conjugated anti-GFP antibody following the iDISCO+ protocol and its updates 
from https://idisco.info (ref. 23).
Different whole-body labeling protocols comparison. To show that vDISCO with 
nanobody is the only method that can efficiently boost the GFP signal in mouse 
whole bodies, we performed the following comparison using 3 GFP-M animals 
(2–3 months old) per experimental group: (1) high-pressure active perfusion 
vDISCO with nanobody, (2) passive incubation vDISCO with nanobody, (3) high-
pressure active perfusion vDISCO with conventional antibody, (4) high-pressure 
active perfusion iDISCO+ with conventional antibody, and (5) high-pressure 
active perfusion iDISCO+ with nanobody. Group 1 was processed using the above-
described vDISCO whole-body immunostaining and clearing method; the group 2 
was processed following all the steps of the vDISCO whole-body immunostaining 
and clearing protocol described above, but replacing all the original steps done in 
perfusion with passive incubation; group 3 was processed using the same vDISCO 
whole-body immunostaining and clearing protocol, but replacing the nanobooster 
with Alexa647-conjugated anti-GFP antibody at the same concentration as the 
nanobooster during the staining step; groups 4 and 5 were processed performing 
the iDISCO+ methanol pretreatment on the animals followed by sequential 
perfusion of all the iDISCO+ solutions23 (except that the clearing was done with 
passive incubation): the timing of each iDISCO+ step was adjusted considering 
the size of a whole body compared with a dissected brain (for example, during 
the methanol dehydration, each step was increased to 5 h versus 1 h for dissected 
brains). The antibody used for group 4 is the Alexa647-conjugated anti-GFP 
antibody mentioned above.
Previously published whole-body clearing methods for comparison. For PARS 
clearing, 10% EDTA adopted from Bone-CLARITY25 was transcardially perfused 
through the whole mouse bodies after PFA fixation for 5–7 d to decalcify the bones. 
Then, the standard PARS procedure was followed53. CUBIC18, uDISCO17 and 
PEGASOS16 were conducted based on the original publications. It is worth noting 
that among all the clearing methods tested, PARS, PEGASOS and vDISCO were 
characterized by a decalcification step using EDTA solutions.
Light-sheet microscopy imaging. Single-plane illuminated (light-sheet) image 
stacks were acquired using an Ultramicroscope II (LaVision BioTec), featuring an 
axial resolution of 4 μ m with the following filter sets: ex 470/40 nm, em 535/50 nm; 
ex 545/25 nm, em 605/70 nm; ex 560/30 nm, em 609/54 nm; ex 580/25 nm,  
em 625/30 nm; ex 640/40 nm, em 690/50 nm. For low-magnification whole-body 
imaging of the Thy1-GFP-M mouse, we used a × 1 Olympus air objective (Olympus 
MV PLAPO × 1/0.25 NA (WD = 65 mm)) coupled to an Olympus MVX10 zoom 
body, which provided zoom-out and zoom-in ranging from × 0.63 up to × 6.3. 
Using × 1 objective and × 0.63 of zoom, we imaged a field of view of 2 × 2.5 cm, 
covering the entire width of the mouse body. Tile scans with 60% overlap along 
the longitudinal y axis of the mouse body were obtained from ventral and dorsal 
surfaces up to 13 mm in depth, covering the entire volume of the body using a  
z-step of 8 µ m. Exposure time was 120 ms, laser power was adjusted depending on 
the intensity of the fluorescent signal (in order to never reach the saturation) and 
the light-sheet width was kept at maximum. After tile imaging of the sample within 
the entire field of view, already scanned regions were cut using a thin motorized 
dental blade (0.2 mm; Dremel 8200) for further imaging. After low-magnification 
imaging of the whole body, a forelimb of the Thy1-GFP-M animal was imaged with 
a × 2 objective (Olympus MVPLAPO2XC/0.5 NA (WD = 6 mm)) coupled with the 
same Olympus MVX10 zoom body at zoom magnification × 1.6. Moreover, the 
same × 2 objective with different zooms was used to perform high-magnification 
imaging of specific body regions (for example, the back of the animal at the level 
of lumbar vertebra, the inguinal lymph node area or the head). Individual organs 
(including brain, lungs, intestine and thymus) were imaged individually using 
high-magnification objectives: × 2 objective (Olympus MVPLAPO2XC/0.5 NA 
(WD = 6 mm)) coupled with the same Olympus MVX10 zoom body, × 4 objective 
(Olympus XLFLUOR × 4 corrected/0.28 NA (WD = 10 mm)), × 25 objective 
(Olympus XLPLN × 25/0.95 NA (WD = 4 mm)) and × 20 objective (Zeiss × 20 Clr 
Plan-Neofluar/0.1 NA (WD 5.6 = mm)) coupled to an Olympus revolving zoom 
body unit (U-TVCAC) kept at × 1. High-magnification tile scans were acquired 
using 8–30% overlap, and the light-sheet width was reduced to obtain maximum 
illumination in the field. For the specific imaging settings used in each figure panel, 
see Supplementary Table 2.
Fluorescence stereomicroscopy imaging. For images in Supplementary Fig. 3, 
brain slices were kept immersed in PBS. For nanobody validation, cleared slices 
were put on a glass lid and kept immersed in BABB. The imaging was performed 
with Zeiss AxioZoom EMS3/SyCoP3 fluorescence stereomicroscope using  
Zen 2 software (v.2.0.0.0; Carl Zeiss AG) using a × 1 long-working-distance  
air objective lens (Plan Z × 1, 0.25 NA, WD = 56 mm; Supplementary Table 2).  
For the comparison of YFP-H mouse tissues after high-pressure pumping versus 
low-pressure pumping in Supplementary Fig. 9, the mouse brains were cut into 
1 mm slices using a vibratome and imaged with magnification × 7 for overview  
and with magnification × 112 in GFP channel for their detailed cell structures.  
See Supplementary Table 2.
Laser-scanning confocal microscopy imaging. After imaging with light-sheet 
microscopy, areas of interest from the cleared specimens, such as whole heads and 
body parts, were imaged with an inverted laser-scanning confocal microscope 
(Zeiss, LSM 880) using Zen 2 software (v.10.0.4.910; Carl Zeiss AG). Before 
imaging, samples were mounted by placing them onto the glass surface of a 35 mm 
glass-bottom petri dishes (MatTek, P35G-0-14-C) and adding a few drops of BABB 
to make sure that the imaging region was immersed in BABB. Closing or sealing  
of the petri dish was not necessary because BABB has a high evaporation point  
and doesn’t dry out for several days. The only precaution taken was to check  
the resistance of the dish against BABB, by testing that the glue sealing the  
glass to the dish and the plastic parts were not dissolved after several hours of  
exposure to BABB.
The imaging was done using a × 40 oil-immersion objective lens  
(Zeiss, ECPlan-NeoFluar × 40/1.30 oil DIC M27, 1.3 NA, WD = 0.21 mm)  
and a × 25 water-immersion long-working-distance objective lens (Leica,  
0.95 NA, WD = 2.5 mm) mounted on a custom mounting thread. See 
Supplementary Table 2.
Reconstructions of whole-mouse body scans. We acquired light-sheet microscope 
stacks using ImSpector (v.5.295, LaVision BioTec) as 16-bit grayscale TIFF images 
for each channel separately. In each pair of neighboring stacks, alignment was done 
by manually selecting 3 to 4 anatomic landmarks from the overlapping regions, 
and then the stitching was done sequentially with the Scope Fusion module of the 
Vision4D (v.2.12.6 × 64, Arivis) software. Landmarks were mainly chosen from the 
skeletal bones or occasionally from the neuronal structures on the basis of visual 
inspection of the anatomical features. After completing the 3D reconstructions, the 
data visualization was done with Amira (v.6.3.0, FEI Visualization Sciences Group), 
Imaris (v.9.1, Bitplane) and Vision4D in both volumetric and maximum-intensity 
projection color mapping. Depth coding was done using the Temporal-Color Code 
plugin in Fiji (ImageJ2, v.1.51, https://fiji.sc/).
Image processing. Processing, data analysis, 3D rendering and video generation 
for the rest of the data were done on an HP workstation Z840, with 8 core Xeon 
processor, 196 GB RAM, and Nvidia Quadro k5000 graphics card and HP 
workstation Z840 dual Xeon 256 GB DDR4 RAM, nVidia Quadro M5000 8GB 
graphic card. We used Imaris, Amira and Fiji (ImageJ2) for 3D and 2D image 
visualization. Tile scans were stitched by Fiji’s stitching plugin49. Stitched images 
were saved in TIFF format and optionally compressed in LZW format to enable 
fast processing. We removed tiles with acquisition errors using Fiji’s TrakEM2 
plugin and Imglib2library. In case of tiling errors in the z dimension, we used 
TeraStitcher (v.1.10; https://abria.github.io/TeraStitcher/) with its default settings to 
globally optimize the tiled volumes and reconstruct the entire dataset. To increase 
the quality of the images, we used the following functions in Fiji: to enhance the 
contrast of microglia cells (Fig. 1n and Supplementary Fig. 2a–f), we used ‘Enhance 
Local Contrast (CLAHE)’; to equalize the images (Fig. 4a,b and Supplementary 
Fig. 2a–f), we used ‘Pseudo Flat-Field Correction’; to enhance the contrast over the 
background of the axonal terminals in Fig. 4c,d, we used the custom-made macro 
for Fiji that we utilized to generate the pre-processed data for NeuroGPS-Tree  
(see the section ‘Neuron tracing’ below).
Neuron tracing. For automated neuron tracing in our light-sheet datasets 
obtained with Zeiss × 20 Clr Plan-Neofluar/0.1 NA (WD = 5.6 mm) objective, 
we used the NeuroGPS-Tree algorithm22. NeuroGPS-Tree was developed for 
tracing relatively small volumes of confocal microscopy data; therefore, we 
initially reduced the file size to under 1 GB (approximate maximum data size 
for NeuroGPS-Tree computation) by using the Fiji scale function. Due to high 
signal intensity discrepancy between soma and neurites, we next pre-processed 
the data with a custom-made macro in Fiji (available upon request), which 
consisted of background removal, pseudo-background correction, noise filtering 
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and sharpening. Next, the pre-processed data were loaded and analyzed first in 
NeuroGPS for soma detection and later in NeuroGPS-Tree for neurite detection 
(both steps are part of the same algorithm package). The best parameters for soma 
and neurite detection were chosen following the original publication. To quantify 
the features (such as the number of neurites per cell and the number of somas with 
at least one neurite) of these detected neuronal cells, we used Amira software: we 
chose the 10 neurons with the biggest file size per group and analyzed them using 
the Spatial Graph Statistics function of the software.
Quantifications. All the details of imaging settings used to acquire the data for the 
quantifications described in this section are available in Supplementary Table 2.
Analysis of fluorescence signal profiles from light-sheet images. The fluorescence 
signal profiles from each channel (excitation 470 nm, 560 nm and 647 nm) were 
plotted in the same z-stack and normalized as percentage over the maximum peak 
using Fiji (Supplementary Fig. 1).
To compare vDISCO boosted and unboosted protocols and consequently the 
reduction of the background and the improvement of the signal over background 
ratio in the far-red channel, we analyzed neurons and axonal bundles expressing 
GFP imaged with excitation at 470 nm, and neurons and axonal bundles labeled 
with anti-GFP nanobody conjugated with Atto647N imaged with excitation at 
640 nm at the same anatomic region. First, the scans were taken with the light-
sheet microscope using the × 4 objective (Olympus XLFLUOR × 4 corrected/0.28 
NA (WD = 10 mm)). Then, the signal profiles were analyzed in Fiji and measured 
from a defined straight line covering the neuronal structure and surrounding 
tissue background, and the normalized plots of the signal profile (Fig. 1i) were 
calculated by normalizing the plots of neuronal structures obtained as described 
above over the average signal intensity of the respective surrounding background. 
Each experimental group consisted of 3 animals, and for each animal at the same 
anatomic region we plotted 3 profiles.
The same analysis of signal profile was used to compare the labeling efficiency 
of vDISCO with nanobody and iDISCO+ with antibody (Supplementary Fig. 3g–i):  
in this case the signal of interest was the one coming from microglia. Each 
experimental group consisted of 3 animals, and for each animal at the same anatomic 
region we plotted 3 profiles from 3 different microglia. The same analysis of signal 
profile was used to compare different clearing methods in Supplementary Fig. 12.
Fluorescence level. Fluorescence level quantification was expressed as a signal-
to-background ratio and was calculated using Fiji17 at the following time points: 
0, 2, 3, 4.5, 5.5, 12 and 18 months after nanoboosting (Fig. 1n,o). Each × 4 light-
sheet microscopy brain scan was taken with the same imaging parameters, and 
an image in TIFF format of the same anatomic region for all the samples was 
quantified. The mean value of the background for each image was obtained by 
averaging the background values of 12–40 regions from equally sized areas of 
the image in regions of the sample without signal. To calculate the mean value 
of the signal for each image, we used the threshold function of the software: 
the threshold was adjusted to consider the fluorescence signal visible in the 
image. After adjusting the threshold, only the sharp signal from specific cellular 
structures was analyzed per image. To this end, we used Fiji’s ‘analyze particles’ 
function to measure the signal intensity only of particles sized between 5–10 
and 100–150 pixels (visible fluorescent cells) and calculated the average value 
from all the particles. Next, this value was divided by the mean value of the 
background of the respective image, obtaining the fluorescence level over the 
background. The corresponding images, visually showing the preservation of 
signal over time in relation to the respective fluorescence levels, were processed 
using the Enhance Local Contrast (CLAHE) function in Fiji to increase the 
contrast of fluorescent cells in the tissue.
Quantification of deep-tissue staining efficiency of nanobody versus antibody. To 
quantify the depth of staining and therefore to compare whole-organ staining 
efficiency of nanobody versus antibody labeling (Supplementary Fig. 2), we 
used CX3CR1GFP/+ animals (3–7 months old), 3 whole brains per experimental 
group. The tile scans of the brains were taken with light-sheet microscopy in 
axial view using the × 4 objective (Olympus XLFLUOR × 4 corrected/0.28 NA 
(WD = 10 mm)). After stitching we chose the z-plane showing the same anatomic 
structures from all brains for comparison. These axial-view 2D images of whole 
brains were analyzed in Fiji; the distance of staining depth was quantified using the 
‘line’ function in the z-plane at the greatest width of the brain, measuring from the 
surface until the last visible boosted microglia. Then, for each image, this staining 
depth value was normalized over the total thickness of the brain at the considered 
z-level, measuring a line drawn from the same point of the surface until the axial 
middle line of the brains.
Quantification of whole-body labeling efficiency of different whole-body labeling 
protocols. To quantify the rate of staining of the different whole-body labeling 
protocols in Supplementary Fig. 11, the tile scans of 3 whole heads per method 
were taken with light-sheet microscopy in axial view using the × 2 objective 
described in the ‘Light-sheet microscopy imaging’ section above with a total 
magnification of × 1.26. For the analysis, we used Fiji to choose 3 regions in 
z in the 2D visualization, to have comparative data in 3 different depths (see 
Supplementary Fig. 2a,b). For each region, we chose the z-plane displaying the 
same anatomic structures in each sample. Next, the 2D images were opened in Fiji 
and, after adjusting the threshold to the fluorescence signal visible in the image, 
the stained area in the brain in each image was quantified using the ‘freehand 
selections’ function. Next, this stained area value was normalized over the total 
area of the brain visible in that 2D image. This total area was quantified using the 
same ‘freehand selections’ function in Fiji, following the brain outline. Statistical 
comparison was performed considering each set of corresponding regions from the 
different samples separately.
ClearMap. To quantify microglia distribution, we used ClearMap23. Since the script 
was originally developed for quantification of the cFos+ cells, to comply with the 
offered method, we did the following pre-processing steps on our microglia data 
using Fiji before ClearMap:
•	 Background equalization to homogenize intensity distribution and appearance 
of the microglia cells over different regions of the brain, using pseudo-flat-field 
correction function from Bio-Voxxel toolbox.
•	 Convoluted background removal, to remove all particles bigger than relevant 
cells. This was done with the median option in the Bio-Voxxel toolbox.
•	 Two-dimensional median filter to remove remaining noise after background 
removal. The filter radius was chosen to ensure the removal of all particles 
smaller than microglia cells.
•	 Unshapen mask to amplify the high-frequency components of a signal and 
increase overall accuracy of the cell detection algorithm of ClearMap.
After pre-processing, ClearMap was applied by following the original 
publication and considering the threshold levels that we obtained from the 
pre-processing steps. As soon as the quantification was completed, the data was 
exported as an Excel file for further analysis. For example, the cellular density per 
brain region was obtained considering the absolute number of cells detected by 
ClearMap and the volume of that specific brain region, which was calculated using 
a custom script (available upon request) based on ClearMap (Elastix registration).
Quantification of peripheral neuronal degeneration in acute brain injury. Peripheral 
neuronal degeneration in TBI animals versus unlesioned control animals was 
done in the Thy1-GFP-M line and was assessed considering the complexity of 
axonal ramifications that projected from the left (left = contralateral side) cervical 
and thoracic vertebra to the left muscles of the back at the level of the torso of 
the mouse, including the left spinotrapezius and latissimus dorsi. The complexity 
was expressed as number of axonal endpoints (nerve terminals that appear as a 
button-like shape; see Fig. 4) over the total length of axonal ramifications that were 
protruding from a main branch. To calculate this index, first a 3 × 3 tile of z-stacks 
of this anatomic region was taken from the animals by light-sheet microscopy 
using the × 2 objective described in the ‘Light-sheet microscopy imaging’ section 
with a total magnification of × 5, to have enough resolution to manually trace the 
axonal ramifications and axonal end-feet. Then, the analysis was done over the 
maximum intensity projections of the tile scans with Fiji software. To measure 
the length of the ramifications, we used the ‘free hand line’ function and the ‘ROI 
manager tool’ of Fiji to record all the traced axonal ramifications of interest, which 
were coming from a main branch; later, we calculated the sum of the length of all of 
the recorded ramifications with the ‘measure’ function of Fiji. To count the nerve 
terminals, we used the ‘point tool’ function and the same ‘ROI manager tool’ to 
record all the visible axonal endpoints protruding from the traced ramifications. 
The analysis was performed over 2–4 branches from the same anatomic region 
for each animal, in 6 animals (3–6 months old) per experimental group. The same 
quantification procedure was followed to analyze the complexity at the equivalent 
ipsilateral (right side from dorsal view) side of the animals, in 6 and 5 animals for 
the TBI and unlesioned groups, respectively.
Quantification of CD68 GFP+ cells with spinal cord injury. The spine areas of 
interest from CD68-EGFP line mice with spinal cord injury or sham surgery 
and from naïve animals were imaged with light-sheet microscopy using the × 2 
objective described in the ‘Light-sheet microscopy imaging’ section with a total 
magnification of × 3.2 and with 2 × 3 tile z-stacks. After stitching, the entire z-stacks 
of scans were loaded in Fiji software with the ‘use virtual stack’ mode. To segment 
the spinal cord tissue from surrounding tissue, including bone and muscles, and 
count the cell numbers separately, the border of the spinal cord was marked by 
using the ‘free hand line’ function in Fiji as a manual selection. These manual 
selections were done in every 6–9 image slices and were recorded by the ‘ROI 
manager tool’ function. The complete selections for the entire z-stacks were then 
achieved by using the ‘interpolate ROIs’ function and were saved as .zip files. Then, 
the entire z-stacks of scans were loaded in Fiji software again, without selecting the 
‘use virtual stack’ mode. By loading the complete selections generated from former 
steps respectively, each spinal cord was segmented by using a custom-made macro 
with the ‘clear outside’ function and saved as a new ‘image sequence’. To maintain 
the integrity of the raw data, one should not save the changes when closing the 
window after running the macro. Then, the intact original z-stacks and complete 
selections were loaded again in the same way, and surrounding tissues including 
bone and muscles were segmented by using another custom-made macro with 
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the ‘clear’ function. All the custom-made macros are available upon request. Next, 
the segmented image stacks of spinal cord or surrounding tissue were loaded with 
Imaris respectively, and the ‘surface’ function was used to segment the CD68 GFP+ 
cells. By generating the ‘surface’ selection, the ‘statistic’ function was available to 
count the number of cells in the region of interest.
Quantification of short SMCs with MCAO. The transparent skulls from LysM-EGFP 
line mice with MCAO or sham were imaged with intact heads from the sagittal 
view with light-sheet microscopy using the × 2 objective described in the ‘Light-
sheet microscopy imaging’ section with a total magnification of × 3.2 and with 
2 × 4 tile z-stacks. After stitching, the entire z-stacks of scans were loaded in Imaris, 
and the length, width and cell numbers in the SMCs were manually calculated by 
using the ‘measure-line’ function. Then, the length and width of the channels were 
corrected by a shrinkage rate of DISCO clearing17.
Statistical analysis. Data collection and analysis were not performed blind to the 
conditions of the experiments. Data distribution was assumed to be normal, but 
this was not formally tested. Data are presented as mean ± s.d. except for in Fig.6 
and Supplementary Fig. 22, where they are presented as mean ± s.e.m. Sample sizes 
are indicated in the figure legends. Statistical analysis was performed using Prism 
GraphPad software v.6 with 95% confidence interval. P values were calculated 
using two-tailed unpaired t test to compare data between two groups. P values 
were calculated using one-way ANOVA followed by Dunnett’s post hoc test to 
compare data in Supplementary Figs. 4 and 11. For CD68-EGFP quantification in 
Supplementary Fig. 22, P values were calculated using one-way ANOVA followed by 
Tukey multiple comparison test to compare data between SCI (spinal cord injury),  
sham and naïve groups. A P value of< 0.05 was considered statistically significant.  
In ANOVA analysis the reported P values are adjusted in GraphPad prism to account 
for multiple comparisons. The protocols described in this study were replicated 
successfully more than five times in independent experiments, and they were  
also reproduced at least by three different operators. See also the Life Sciences  
Reporting Summary.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Code availability. The custom codes used to analyze the data in this study are 
available from the corresponding author upon request.
Data availability
The data that support the findings of this study are available from the 
corresponding author upon reasonable request.
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main 
text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND 
variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Clearly defined error bars 
State explicitly what error bars represent (e.g. SD, SE, CI)
Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection The commercially available softwares used in this study to collect, stitch and visualize the data are: ImSpector (Version 5.295, LaVision 
BioTec GmbH), Vision4D (Version 2.12.6 x64, Arivis AG), Amira (Version 6.3.0, FEI Visualization Sciences Group), Imaris (Version 9.1, 
Bitplane AG),  Zen 2 (Version 10.0.4.910, Carl Zeiss AG),  Zen 2 (Version 2.0.0.0, Carl Zeiss AG). 
 
 
Data analysis The commercially available softwares used in this study to analyze the data are: Amira (Version 6.3.0, FEI Visualization Sciences Group), 
Imaris (Version 9.1, Bitplane AG), GraphPad Prism (Version 6, GraphPad Software Inc.). 
The already publicly or published codes/softwares used in this study to stitch and analyze the data are: Fiji (Version 1.51, https://fiji.sc/), 
TeraStitcher (Version 1.10, https://abria.github.io/TeraStitcher/), NeuroGPS-Tree (https://www.nature.com/articles/nmeth.3662), 
ClearMap (https://www.sciencedirect.com/science/article/pii/S0092867416305554). 
All the custom-made codes: the code to pre-process the data for NeuroGPS-Tree in Fiji, the custom-made macros for Fiji to remove 
region of interests in images, the custom-script to calculate the volume of specific brain regions for the cellular density are available upon 
request.  
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers 
upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The data of this study are available from the corresponding author upon reasonable request.
Field-specific reporting
Please select the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/authors/policies/ReportingSummary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample sizes were chosen based on prior experience with similar models. Sample sizes are specified in figure legends.
Data exclusions Exclusion criteria were pre-established. 
Animals that resulted negative for the expression of fluorescent proteins by genotyping were excluded from the study.  
For MCAO experiments, exclusion criteria were as follows: insufficient MCA occlusion (a reduction in blood flow to 15% of the baseline value) 
and blood flow recovery >80% within 10 min of reperfusion.
Replication The indication of how many times each experiment was repeated independently showing similar results is written in the corresponding figure 
legend. Overall, the protocols described in this study were replicated successfully more than 5 times in independent experiments and they 
were also reproduced at least by 3 different operators.
Randomization The animals used in this study were selected for each experiment based on their genetic background (wt or fluorescent transgenes). Within 
each strain, animals were randomly selected.
Blinding Littermates were housed in the same cage. The investigator was not blinded to group allocation for data analysis as this was obvious during 
the experiments (e.g. stroke vs sham or TBI vs unlesioned).
Reporting for specific materials, systems and methods
Materials & experimental systems
n/a Involved in the study
Unique biological materials
Antibodies
Eukaryotic cell lines
Palaeontology
Animals and other organisms
Human research participants
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
Antibodies
Antibodies used Atto594 conjugated anti-RFP nanobooster (Chromotek, rba594-100), Atto647N conjugated anti-GFP nanobooster (Chromotek, 
gba647n-100), Atto488N conjugated anti-GFP nanobooster (Chromotek, gba488-100), Atto488 conjugated anti-Vimentin 
nanobooster (Vimentin-Label_Atto488, Chromotek, vba488-100), Alexa647 conjugated anti-GFP antibody (Invitrogen, A31852). 
All the nanoboosters were used in dilution 1:500 to label brain slices, 1:600 to label whole brains and 1:7000 to label whole 
bodies. The antibody was used in dilution 1:850 to label brain slices, 1:730 to label whole brains and 1:7000 to label whole 
bodies.
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Validation All the nanoboosters were coming from the same company which is the manufacturer: Chromotek https://
www.chromotek.com/products/nano-boosters/. The manufacturer validated the nanoboosters and in its website (see link) they 
provide references, images of the validation from published papers and from validation experiments. We used nanobooster to 
label fluorescent proteins and vimentin expressed in mouse tissue, as indicated in example images from the manufacturer 
website. Before any deep tissue staining such as vDISCO whole body labeling, we further validated the compatibility of the 
nanoboosters with vDISCO in brain slices from transgenic animals as indicated in Method part of the manuscript. 
 
The Alexa647 conjugated anti-GFP antibody (GFP Polyclonal Antibody Alexa Fluor 647, Invitrogen, A31852) has been validated by 
the manufacturer: Invitrogen https://www.thermofisher.com/antibody/product/GFP-Antibody-Polyclonal/A-31852. In the 
manufacturer website (see link) they provide references, images of the validation from published papers and from validation 
experiments. We used this antibody to label GFP expressed in mouse tissue, and this application has already been shown by 
references indicated in the manufacturer website. We further validated the compatibility of this antibody with iDISCO+ protocol 
in Supplementary Figure 3.  
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals We used the following mixed gender animals in the study: 6 weeks-12 months old CX3CR1GFP/+ (B6.129P-Cx3cr1tm1Litt/J, 
Jackson Laboratory strain code: 005582), 6 weeks-6 months old Thy1-GFPM , 3-7 months old Thy1-YFPH, 4 weeks old Prox1-
EGFP (Tg(Prox1-EGFP)KY221Gsat/Mmucd, MMRRC strain code: 031006-UCD), 6 months old VEGFR3-YFP, 2 months old 
CX3CR1GFP/+ x CCR2RFP/+ (B6.129(Cg)-Ccr2tm2.1Ifc/J, Jackson Laboratory strain code: 017586), 6 months old LysM-EGFP 
(Lyz2tm1.1Graf, MGI: 2654931), 3 months old CD68-EGFP (C57BL/6-Tg(CD68-EGFP)1Drg/j, Jackson Laboratory strain code: 
026827), 3 weeks-4 months old C57BL/6J, 3-4 months old NMRI nu/nu mice. 
Wild animals This study does not involve wild animals 
Field-collected samples This study does not involve Field-collected samples
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5 Discussion 
5.1 Comprehensive and reasoned summary of the results 
In this project, I have developed new technologies with the aim to study biological events with the 
consideration for the whole complexity of an organism and to elucidate body-wide changes in neuronal 
pathologies. In particular, my work focused on establishing whole body tissue clearing and imaging methods 
that are able to overcome the limitations of traditional 2D histology (such as the sectioning of the samples and 
the reconstruction of 3D information from fragments), to provide quantitative data about physiological and 
pathological phenomena from a big perspective, and to discover new biological information. 
First, by an extensive chemical screen and an optimization of the protocol conditions, we established 
uDISCO, a new whole-body tissue clearing method that is able to clear in a fast and easy way whole rodent 
bodies with the highest level of transparency10. uDISCO is based on the chemical properties of tert-butanol 
and diphenyl ether to dehydrate and match the refractive indexes of biological tissues respectively. Since these 
two reagents are more chemically stable compared with previous organic-solvent-based chemicals used in 
tissue clearing, uDISCO preserves the fluorescence signal from endogenous fluorescent proteins for months 
(while previous organic-solvent-based clearings used to quench the signal in few days). Furthermore, uDISCO 
shrinks the samples (including whole rodent bodies) up to 65% in their volume; therefore, it is the first tissue 
clearing method that allowed the high resolution imaging with light-sheet microscopy of unsectioned whole 
adult rodent bodies.  
As mentioned in the introduction, the alteration of the tissue size after chemical procedures has been already 
exploited as a way to improve the imaging performance: for example, the expansion of sample sizes has been 
the basis for super-resolution imaging from expansion microscopy37,60,62,177. With uDISCO we applied this 
concept but in the other direction: we exploited the shrinkage, in order to be able to achieve the imaging of big 
samples without apparent loss of resolution. 
In fact, using uDISCO we accomplished the following results: 
 The first whole-body light-sheet imaging of a cleared adult Thy1-GFPM mouse, of which subsets of 
neurons express GFP. 
 The first light-sheet imaging at subcellular resolution of intact brain and spinal cord dissected from a 
Thy1-GFPM mouse, where we resolved dendrites, axons and dendritic spines. 
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 Imaging of the complete vasculature of the CNS and of the whole body of an adult rat for the first 
time. 
 Deep tissue staining of 1 mm thick fresh-fixed mouse and over-fixed human brain slices, showing the 
compatibility of uDISCO with standard immunohistochemistry. 
 Compatibility of uDISCO with virus tracing. 
 Application of uDISCO for unbiased detection of transplanted fluorescent stem cells at single-cell 
resolution in whole mouse bodies. We showed that our method allowed the fast screening and the 
accurate assessment of the distribution of transplanted cells. Similar results were not achievable with 
previous methods such as bioluminescence or standard histology which provides much poorer 
resolution or is very time-consuming respectively.  
Moreover, we used uDISCO as a tool that contributed to the discovery of new immune cell infiltration routes 
into the brain under pathological conditions after visualizing in 3D the specific T-cell distribution pattern in 
the brain upon stroke. With uDISCO, we could quickly assess the accumulation of lymphocytes in specific 
areas of the brain: between the lateral ventricle and the lesion site. From this first observation we discovered 
that the choroid plexus represents an important route for T-cell invasion into the infarcted brain178. 
uDISCO clearing belongs to the group of organic-solvent-based clearing methods, thereby it possesses all the 
advantages of this category: as already mentioned, it achieves a high grade of transparency, it is simple to 
perform and it physically reduces the sample size. Moreover, the cleared specimens are easy to handle: due to 
the dehydration and the chemical steps, the tissue becomes hard but flexible and easier to position in the 
imaging apparatus. In contrast, aqueous clearing methods such as the ones based on high concentration of 
sugar or the ones relying on the creation of a hydrogel scaffold are more difficult to adopt because of the jelly 
and fragile texture of the cleared brains, the high viscosity of the clearing solutions or because they are time 
consuming, requiring weeks to months to a clear whole organ 49.  
Therefore, in our research we focused on the optimization and the application of the organic-solvent-based 
methods. 
With uDISCO we paved the way for a new approach to study biological events by imaging at high resolution: 
without focusing on selected body areas only, but providing a global view of the investigated system instead. 
However, uDISCO still had many limitations: (i) the weakness of endogenous fluorescent proteins in clearing 
solutions, (ii) the strong tissue autofluorescence which can reduce the signal over background ratio6, (iii) the 
incomplete clearing of calcified tissues such as bones which limits the imaging penetration. All these factors 
prevented the possibility to reliably obtain quantitative data, especially from complex structures like neuronal 
projections, without the opening of hard tissues such as the bones enclosing the CNS. 
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Recent methods19-22 have combined immunostaining with organic-solvent-based clearing procedures, thus 
providing different advantages: the long-term stabilization of the signal and the usage of very bright 
fluorescent dyes like Alexa- or Atto-dyes to increase the signal to background ratio. 
Taken all these aspects in consideration, we next implemented a new method called “vDISCO”. Using a 
unique combination of different chemicals, we managed to develop a protocol that is able to: (i) reduce the 
autofluorescence of the tissue by removing residual heme pigment from the body, (ii) decalcify the bones to 
make them transparent for imaging, and (iii) enhance the fluorescence signal/background ratio by up to two 
orders of magnitude. Thanks to these achievements, vDISCO also gives superior imaging quality compared 
with other methods. These results were accomplished by exploiting a “high-pressure” delivery approach to 
achieve whole-body immunostaining using nanobodies—variable domain of heavy chain antibodies—which 
are ten times smaller than conventional antibodies179. Owing to their small size, the nanobodies can 
extensively reach all the epitopes in a mouse body. Moreover, since the nanobodies are conjugated to 
synthetic dyes, the fluorescent signal is (i) bright, (ii) can be shifted to the far-red spectrum, range where the 
light penetrates deeper and the autofluorescence is reduced, and (iii) can be maintained for years allowing 
repeated imaging of the same sample. This last aspect, together with the reduction of the time needed for the 
whole experimental procedure and the possibility to create high fidelity atlases and databases, also represents 
an important factor to decrease the resources and the number of animals needed in research in the future. 
Using vDISCO we achieved the following results in intact samples: 
 We obtained the imaging of cellular structures under hard tissues such as bones. In this way, it is no 
longer necessary to remove bones such as skull and vertebra from the body. 
 We created the first high resolution neuronal map of a whole adult mouse body from the Thy1-GFPM 
line, giving the possibility to trace all axonal projections in the entire body of this transgenic line. 
 We cleared mice with intact skin and imaged the cellular content of the skin beyond its surface. 
 Owing to the great enhancement of signal/background ratio of the cellular structures, we could obtain 
quantitative data about the neurodegenerative and neuroinflammatory effects of acute CNS injuries 
onto remote body parts. 
 We could image anatomic structures such as meningeal lymphatic vessels that would be normally 
damaged by conventional dissection in standard histology.  
 We also revealed short vascular connections named SMCs between the skull marrow and the 
meninges. Since we quantified an increase of the presence of immune cells in these structures in 
disease (e.g. stroke), these channels are hypothesized to be an important factor in the inflammatory 
processes involving the brain. For instance, they could work as a new route of immune cell 
trafficking. 
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Overall, we showed that the panoptic imaging of cleared whole mouse bodies represents a promising tool to 
provide an unbiased and highly resolved view of the entire organism in health and disease. 
5.2 Considerations and future perspectives about the technical 
aspects 
Both uDISCO and vDISCO are easily implementable for dissected organs: in fact, we have shown that both of 
them can be applied to process dissected brains with simplified passive versions of the protocols. Moreover, 
both methods are compatible with other staining strategies including virus labeling or fluorescent transplanted 
cells. They are also compatible with higher resolution imaging systems such as confocal and two-photon 
microscopy: for instance, we demonstrated that it is possible to dissect out parts of the body from the cleared 
animal for more detailed investigation with other microscope set-ups.  
It is noteworthy to say that since DISCO methods require steps of delipidation, the retention of the lipids and 
lipid-associated proteins in the tissue after clearing should be carefully assessed. In addition, the usage of 
organic solvents might raise concerns in terms of laboratory safety. However, these chemicals can be safely 
handled with the proper equipment such as chemical hoods which are available in most of the laboratories.  
Although causing the shrinkage, we have shown that our organic-solvent-based methods do not alter the 
proportions of the samples and their structural integrity, at least for the cerebral tissue. Further evaluation of 
other tissues is needed to confirm that the shrinkage is isotropic throughout the entire organism. 
Despite achieving 3D reconstruction of whole mouse bodies, we currently cannot perform the imaging in only 
one session due to the still big size of whole adult intact rodents. In order to image all body parts, we have to 
displace and flip the intact animal in the microscope chamber and stitch the imaged volumes together 
afterwards. In the future, the development of larger microscopes together with longer working distance 
objectives will overcome the need for manual displacement so that the whole-body information can be 
obtained in an even faster and less work intensive way.  
At the moment, the approach of panoptic imaging generates an extraordinary amount of raw data (e.g. 2-3 
terabytes for a single animal): clearly, there is need for a parallel development of more powerful hardware and 
computer tools that are able to automatically analyze this information with drastically reduced supervision and 
workload for the human operator. Efforts in this direction already resulted in informatics tools to 
automatically process big imaging datasets. For example, for one of the most popular image processing 
softwares called “ImageJ” computer scientists have written plug-ins which provide automated segmentation, 
visualization, enhancement and reconstruction of biological structures180-182. Apart from ImageJ, several 
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groups implemented their own platforms for automated data processing: Renier et al. developed “Clearmap” 
which is an algorithm that provides automatic quantification, annotation and registration of cells in whole 
cleared brains22, while Quan et al. developed “NeuroGPS-Tree” which is an algorithm that automatically 
traces neurons from confocal microscopy data of up to 1 gigabyte in size183. However, the methods available 
so far rely on traditional data analysis approaches that are based on explicit preprocessing (such as 
thresholding or normalization) and filter-based detections. This means that the parameters for the 
preprocessing and for the filters used in data analysis are hand-crafted features that need to be tailored by a 
human expert to the specifics of each individual data set, strongly limiting the flexibility of these traditional 
computer tools. For instance, if the signal intensity of a scan varies the parameters of such filter-based 
approaches, then a re-calibration of the parameters would be necessary. The rising interest in deep learning is 
promising for fully automated data analysis: in contrast to traditional detection approaches, all features are 
learnt from the data and do not need to be explicitly defined by a human expert. In addition, deep learning 
tools can process terabyte-size data and perform tasks significantly faster and with more accuracy and 
precision than a traditional method or even a human can184. In the computer vision and image analysis field, 
deep learning has been used to improve microscopy images185 or for feature and cell detection in biomedical 
images, performing significantly better than traditional methods186-188. It has been also shown that deep 
learning could work on enormous image databanks from online servers189,190 and could provide decisive 
contribution in medical assessment: for instance, Liang et al. employed deep learning to analyze massive 
electronic health records (hundreds of millions of data points from more than one million of patients) from 
entire hospital databanks to outperform the diagnosis of pediatric diseases in new patients compared with a 
single expert physician191. Thus, artificial intelligent represents a powerful solution to process whole organism 
datasets. 
As mentioned before, our latest method vDISCO has been mainly applied for the enhancement and the 
detection of transgenically expressed fluorescent proteins (putatively 21 types including cerulean fluorescent 
protein (CFP), Venus among others). This is due to the fact that there are not many commercially available 
nanobodies to be used in histology because the research efforts so far have mainly focused on the in vivo 
application of nanobodies such as therapeutic agents192. However, in this work we also demonstrated that it is 
possible to use vDISCO with other nanobodies targeting antigens of endogenous proteins (e.g vimentin). We 
believe that our data will encourage the future development of new nanobodies for immunostaining of fixed 
thick samples. For this purpose, it will be advantageous to conjugate the nanobodies with synthetic dyes that 
emit in the near-infrared spectrum in order to combine more targets and imaging channels in multiplexing 
studies and to further improve the imaging depth. 
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5.3 Considerations about the biological findings, future directions 
and applications in biomedical research 
In this project, we demonstrated that our technology represents a powerful tool for biomedical investigations. 
The phenomenon of neurodegeneration is not limited to the neurons directly harmed193. In fact, it has been 
reported that patients that have undergone different grades of brain ablation can develop diaschisis194 which is 
a change or loss of the functionality of a region of the brain connected to a distant and damaged brain area. 
Furthermore, other papers have shown that in both patients and animal models cerebral ischemia can trigger 
the atrophy of distal brain regions that are functionally connected to the ischemic site195,196.  These remote 
effects of brain insults result from the transneuronal degeneration: a biological process that describes the 
degeneration of neurons which are functionally connected with a damaged neuron and it is characterized by 
shrinkage of the cells, swelling of the mitochondria and detaching of nucleus membrane197. This kind of 
degeneration can happen retrogradely and/or anterogradely198-200 and it is caused by the fact that the loss of 
neurons creates an imbalance in the whole neuronal network193,197,201. The evaluation of the transneuronal 
degeneration has been mostly restricted to the CNS using methods such as electrophysiological recording194, 
standard histology196 or MRI202. Other studies employing optical coherence tomography focused on analyzing 
the spread of the neurodegeneration through connected synapses into the periphery, including the ones 
showing degeneration of retinal ganglion cells after visual cortex lesion203-205 or the reduction of retinal nerve 
fiber layer thickness after cerebral infarction206. However, while it has been demonstrated that stroke do not 
cause degeneration of lower motor neurons which are connected to the damaged upper motor neurons207, little 
is known about the exact locations of transneuronal changes in the PNS triggered by TBI. Through our 
vDISCO method, we have shown for the first time that TBI triggered axonal degeneration in the spinal cord 
and peripheral neurodegeneration in distal regions (in particular in the torso) of the body. This reduction of 
axonal complexity was observed more than one month after the initial injury, in the chronic stage of the 
pathology. In particular, the degeneration of axons in the spinal cord, visible as fragmentation of axonal fibers, 
was detected along the cortico-spinal tract of the animal, that is along the dorsal spinal tract which relays 
control of voluntary movements. These findings are in accordance with the disruption and degeneration of the 
descending (efferent) motor pathways that start from the injured right somato-motor cortex, and with our 
observation of the reduction of axonal complexity of the nerves innervating voluntary muscles (including the 
left spinotrapezius and latissimus dorsi) of the animals. Since the axonal tract involved belongs to the 
descending pathways we can plausibly deduce that it is anterograde transneuronal degeneration. Moreover, 
these results also account for the motor impairments evaluated by rotarod test in mice in the chronic stage of 
TBI67.  However, owing to the fact that our model of TBI does not cause a focal injury, we cannot exclude that 
other pathways might be involved in the degeneration, as well. Nevertheless, vDISCO gives the possibility to 
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quickly screen for these alternative pathways of degeneration and to follow them from the very beginning 
(brain) to the very end (peripheral nerve endfeet) along the connectivity in a whole organism. Before, this kind 
of systemic analysis on the effects of brain lesions could not be performed in an efficient way, as sectioning 
all the body parts would have been excessively time-consuming. Our TBI findings represent the first 
visualization of the alteration of the neuronal connectivity outside the CNS which may explain behavioral 
alterations which could not be explained by the CNS lesion itself (e.g. neuropathies) and present a cellular 
basis for the clinical observations of peripheral symptoms after TBI97-99. Future research efforts could be 
addressed for the followings:  
 Track in detail all the CNS and PNS regions affected by degeneration also in other TBI models. 
 Elucidate all the molecular mechanisms involved.  
 Understand the contribution of retrograde and anterograde transneuronal degeneration.  
 Evaluate if there are mechanisms of physiological regeneration occurring as well such as the one 
following Wallerian degeneration. 
 Identify new therapeutic strategies to limit the spreading of the pathology in distal sites. 
 
We showed that CNS injuries such as spinal cord injury also triggered a massive extended inflammation not 
only limited to the neuronal tissue. In fact, besides the activation of the microglia we observed that peripheral 
macrophages were also recruited from distal muscle tissues to accumulate around the lesion area, putatively 
invading the CNS through the meninges, as indicated by the presence of immune cells in the spinal meningeal 
compartment at the level of the lesion. Previously, the assessment of the inflammatory level after spinal cord 
injury has never been focused on investigating the spinal meningeal spaces in detail including their cellular 
content. In addition, the analysis of the injured tissue was done either in dissected spinal cords17, performed 
observing small areas by intravital microscopy125 or done with low resolution MRI141. Our findings show that 
it is possible to investigate (neuronal)inflammation from a broader perspective, by taking into account not 
only the CNS but also all the surrounding tissues such as muscles, bones and meninges. Future research will 
better elucidate the mechanisms behind this inflammatory process and its extent in the whole-body. Moreover, 
the fate of these recruited macrophages needs to be determined. For example, it would be interesting to 
investigate: (i) to which extent these peripheral cells infiltrate into the spinal cord and through which routes, 
(ii) if they possess a clearance activity phagocytizing cellular debris and dead cells, and (iii) whether these 
inflammatory cells belong to the myeloid-derived suppressor cell population that has been previously shown 
to prevent the autoimmune response after CNS trauma130 or whether they play a detrimental role by worsening 
the injury outcome through enhanced inflammation. 
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In the last years, tissue clearing technology has also been used to discover new anatomical structures because 
it delivers 3D information of body regions which were not accessible before by other techniques. For 
example, using a clearing method called “SimpleCLEAR”53 Gunzer´s group discovered a dense network of 
previously unknown trans-cortical blood capillaries in long bones that is connected to the cardiovascular 
system208. In our work, we demonstrated that our technology can be used to study and explore the meningeal 
content located between CNS tissue and the skull/vertebra. The investigation of this anatomic area has often 
been limited by the fact that it can either be damaged after brain harvesting or it has to be dissected out during 
histological preparations168,173. Only vDISCO could permit us to study this region in its “native” state inside 
the head of the animal. In particular, we revealed the presence of newly discovered short vascular connections 
–named SMCs– which are not part of the vascular system of the brain/head, but they directly link the skull 
marrow to the meninges. These structures might represent a direct and quick way for the brain to transfer 
information (soluble molecules, signaling factors etc…) about its state to a close hematopoietic organ and 
influence its hematopoietic activity (e.g. locally decreasing leukocyte retaining factors such as SDF-1), and to 
trigger the recruitment of spatially close skull marrow immune cells via chemokines upon pathological 
conditions. In fact, we observed that the immune cellular content of the SMCs increases in stroke and this can 
be an indication that the inflammatory signaling from the brain can directly reach the skull bone marrow and 
that these connections might work as an alternative route for cells to enter and exit the brain after cerebral 
ischemia. Interestingly, the presence of short vascular connections in the inside of the skull has also been 
recently supported by Herisson et al.209. Besides, the researchers showed that most of the peripheral immune 
cells migrating towards the dura after stroke were preferentially recruited from the skull, particularly the 
calvaria bone marrow, compared with the tibia, indicating that the access to the ischemic brain might be open 
through alternative ways which are independent from the systemic circulation. After analysing craniectomy 
specimens, they also proved in humans the existence of these short vascular structures connecting the brain 
cortex surface with skull marrow cavities. Their findings together with ours support the fact that the SMCs 
might play an important role in healthy and especially inflammatory conditions during diseases.  In fact, as 
said in the introduction, the involvement of the meninges in inflammatory responses and pathological 
conditions such as multiple sclerosis173 and Alzheimer´s disease has recently been reported175. In light of these 
results, immune cells and soluble factors which are able to exploit the SMCs as transfer channels could 
contribute to the pathogenesis of chronic neurodegenerative diseases. Future research using in vivo animal 
models and intravital microscopy or 2-photon microscopy might focus on (i) how the immune cells can 
traffick between brain and bone marrow via SMCs, (ii) how manipulating or impairing the SMCs would affect 
the outcome of brain diseases (e.g. decreasing the inflammatory response) or (iii) how it would be possible to 
exploit them as a direct and a safer means to delivery therapeutic agents against brain disorders without 
extended systemic side effects of other drugs or invasive brain parenchyma interventions. Furthermore, this 
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direct connection between brain and skull marrow may open up new diagnostic opportunities by monitoring 
changes in the skull. However, owing to the current lack of specific lymphatic transgenic reporter mice, future 
investigations are needed not only to clarify whether SMCs are lined with blood or lymphatic endothelial 
cells, but also to further characterize their anatomic features such as which layer of meninges they connect to. 
It would be also important to perform their molecular characterization via proteomics and transcriptomics 
studies in order to elucidate in what extent the skull marrow immune population trafficking in these channels 
differs from the ones originating from more distal bones (e.g tibia). In the end, it would also be interesting to 
explore whether external biological entities such as bacteria or other pathogens can hijack the SMCs to access 
to the brain and whether the functionality of the SMCs change during aging or during neurological acute and 
chronic conditions. 
There are extensive findings that suggest that the pathological effects of a cerebral ischemic stroke are not 
confined to the brain but also significantly affect other organs. In fact, it has been shown that brain ischemia 
can cause general immunodepression210, global activation of peripheral immune system211 or can induce CNS-
specific antigens including immunomodulators such as alarmins and cytokines to enter into the systemic 
circulation163,212. These are released from the damaged brain tissue and can immunomodulate213 the whole 
body by chemoattraction or interaction with various immune and no immune cell populations possibly leading 
to vascular inflammation68. At a more specific level it has been shown that stroke can deeply affect the other 
peripheral organs and viceversa: it can lead to multiple organ failure214, including heart, lung, kidney, pancreas 
and spleen. DISCO methods will help to better understand the interactions of all these organs from a global 
perspective.  
Recently, there has been an increasing interest in understanding how microbiota can affect the course of 
diseases215, especially after discovering the close relationship between brain and gut (the gut-brain axis)216,217. 
The influence of the microbiota on the brain and other organs can be mediated by the dissemination of 
molecules, including biochemical signals in the host218, and/or by the priming/activation/interaction with 
circulating cells such as immune cells. For example, it has been shown that gut microbiota can affect stroke 
outcome219 and modulate anxiety220,221. By utilizing DISCO methods, the relationship between so many distant 
components would be easier and faster to assess. The task of tracking and detecting fluorescent circulating 
cells that are known to interact with intestine bacteria would become easier, for example. 
Cancer research represents another possible application of our technology. An example would be to exploit 
vDISCO to study animal models of the dissemination of metastases (which are often the main cause of the 
death of cancer patients) from the primary fluorescent tumor into the whole organism222. So far, the screening 
of metastases has been performed using poor resolving systems such as bioluminescence imaging which are 
unable to detect isolated single metastatic cells3. The high resolution reached by our pipeline can overcome 
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this problem because it allows the detection and analysis of micrometastases in the whole-body. This will help 
to understand the distribution and the localization of each single metastatic cell in every part of the body and 
also to evaluate the performance of therapeutical agents in reaching these cells (e.g anti-tumor antibodies 
conjugated to fluorescent dyes).  
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6 Conclusion 
With this PhD project I developed new technologies that allow the systemic assessment of whole bodies, 
laying the foundation of a new histological approach to study in an unbiased way biological phenomena: 
considering the high complexity of biological systems. Importantly, the findings reached by our technology 
demonstrate that using this approach we could uncover unknown biological information that was not 
accessible before. Thus, I discovered peripheral degeneration after TBI, extensive multi organ inflammation 
after spinal cord injury and the existence of SMCs between the skull and the brain. These results contribute to 
the better understanding of the physiology and pathology of biological phenomena and will pave the way for 
future research lines aiming to elucidate the mechanisms behind these events. 
Taken together, we believe that our DISCO technology will greatly contribute not only to the study of 
neuronal pathological conditions, allowing the detection of whole-organisms changes, but also to investigate 
the systemic phenomena of known whole-body diseases such as metabolic diseases or diabetes and to uncover 
new distal effects of many other pathologies. 
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